 
# GREAT version 3.0.0	Species assembly: hg19	Association rule: Basal+extension: 5000 bp upstream, 1000 bp downstream, 1000000 bp max extension, curated regulatory domains included
# Ontology summary statistics are provided in the footer.
#
# Ontology	ID	Desc	BinomRank	BinomP	BinomBonfP	BinomFdrQ	RegionFoldEnrich	ExpRegions	ObsRegions	GenomeFrac	SetCov	HyperRank	HyperP	HyperBonfP	HyperFdrQ	GeneFoldEnrich	ExpGenes	ObsGenes	TotalGenes	GeneSetCov	TermCov	Regions	Genes
GO Molecular Function	GO:0004597	peptide-aspartate beta-dioxygenase activity	1	3.337541e-4	1.000000e+0	1.000000e+0	2.996218e+3	3.337541e-4	1	3.337541e-4	1.000000e+0	1	1.108586e-4	4.088465e-1	4.088465e-1	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	ASPH
GO Molecular Function	GO:0080025	phosphatidylinositol-3,5-bisphosphate binding	2	2.334075e-3	1.000000e+0	1.000000e+0	4.284352e+2	2.334075e-3	1	2.334075e-3	1.000000e+0	2	1.440682e-3	1.000000e+0	1.000000e+0	6.938846e+2	1.441162e-3	1	13	5.000000e-1	7.692308e-2	unnamed	CLVS1
GO Molecular Function	GO:0008307	structural constituent of muscle	3	4.499924e-3	1.000000e+0	1.000000e+0	2.222260e+2	4.499924e-3	1	4.499924e-3	1.000000e+0	4	5.093135e-3	1.000000e+0	1.000000e+0	1.960978e+2	5.099496e-3	1	46	5.000000e-1	2.173913e-2	unnamed	ASPH
GO Molecular Function	GO:0016706	oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors	4	5.376871e-3	1.000000e+0	1.000000e+0	1.859818e+2	5.376871e-3	1	5.376871e-3	1.000000e+0	3	4.982553e-3	1.000000e+0	1.000000e+0	2.004556e+2	4.988637e-3	1	45	5.000000e-1	2.222222e-2	unnamed	ASPH
GO Molecular Function	GO:0009055	electron carrier activity	5	5.710295e-3	1.000000e+0	1.000000e+0	1.751223e+2	5.710295e-3	1	5.710295e-3	1.000000e+0	8	9.180352e-3	1.000000e+0	1.000000e+0	1.086807e+2	9.201264e-3	1	83	5.000000e-1	1.204819e-2	unnamed	ASPH
GO Molecular Function	GO:0051213	dioxygenase activity	6	8.072355e-3	1.000000e+0	1.000000e+0	1.238796e+2	8.072355e-3	1	8.072355e-3	1.000000e+0	7	9.069997e-3	1.000000e+0	1.000000e+0	1.100061e+2	9.090405e-3	1	82	5.000000e-1	1.219512e-2	unnamed	ASPH
GO Molecular Function	GO:1901981	phosphatidylinositol phosphate binding	7	9.129982e-3	1.000000e+0	1.000000e+0	1.095292e+2	9.129982e-3	1	9.129982e-3	1.000000e+0	5	7.966112e-3	1.000000e+0	1.000000e+0	1.252847e+2	7.981819e-3	1	72	5.000000e-1	1.388889e-2	unnamed	CLVS1
GO Molecular Function	GO:0044325	ion channel binding	8	1.154337e-2	1.000000e+0	1.000000e+0	8.662980e+1	1.154337e-2	1	1.154337e-2	1.000000e+0	6	8.076528e-3	1.000000e+0	1.000000e+0	1.235685e+2	8.092678e-3	1	73	5.000000e-1	1.369863e-2	unnamed	ASPH
GO Molecular Function	GO:0016705	oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen	9	1.379212e-2	1.000000e+0	1.000000e+0	7.250518e+1	1.379212e-2	1	1.379212e-2	1.000000e+0	9	1.743944e-2	1.000000e+0	1.000000e+0	5.709177e+1	1.751566e-2	1	158	5.000000e-1	6.329114e-3	unnamed	ASPH
GO Molecular Function	GO:0035091	phosphatidylinositol binding	10	1.969745e-2	1.000000e+0	1.000000e+0	5.076798e+1	1.969745e-2	1	1.969745e-2	1.000000e+0	10	1.787895e-2	1.000000e+0	1.000000e+0	5.568210e+1	1.795909e-2	1	162	5.000000e-1	6.172840e-3	unnamed	CLVS1
GO Molecular Function	GO:0005198	structural molecule activity	11	4.640896e-2	1.000000e+0	1.000000e+0	2.154756e+1	4.640896e-2	1	4.640896e-2	1.000000e+0	12	6.915822e-2	1.000000e+0	1.000000e+0	1.420551e+1	7.039521e-2	1	635	5.000000e-1	1.574803e-3	unnamed	ASPH
GO Molecular Function	GO:0016491	oxidoreductase activity	12	6.045513e-2	1.000000e+0	1.000000e+0	1.654119e+1	6.045513e-2	1	6.045513e-2	1.000000e+0	14	7.769532e-2	1.000000e+0	1.000000e+0	1.261608e+1	7.926390e-2	1	715	5.000000e-1	1.398601e-3	unnamed	ASPH
GO Molecular Function	GO:0005543	phospholipid binding	13	6.199769e-2	1.000000e+0	1.000000e+0	1.612963e+1	6.199769e-2	1	6.199769e-2	1.000000e+0	11	5.530932e-2	1.000000e+0	1.000000e+0	1.782708e+1	5.609445e-2	1	506	5.000000e-1	1.976285e-3	unnamed	CLVS1
GO Molecular Function	GO:0008289	lipid binding	14	8.303762e-2	1.000000e+0	1.000000e+0	1.204273e+1	8.303762e-2	1	8.303762e-2	1.000000e+0	15	8.194912e-2	1.000000e+0	1.000000e+0	1.194768e+1	8.369824e-2	1	755	5.000000e-1	1.324503e-3	unnamed	CLVS1
GO Molecular Function	GO:0005509	calcium ion binding	15	8.363577e-2	1.000000e+0	1.000000e+0	1.195661e+1	8.363577e-2	1	8.363577e-2	1.000000e+0	13	7.396518e-2	1.000000e+0	1.000000e+0	1.326544e+1	7.538385e-2	1	680	5.000000e-1	1.470588e-3	unnamed	ASPH
GO Molecular Function	GO:0005215	transporter activity	16	1.089898e-1	1.000000e+0	1.000000e+0	9.175171e+0	1.089898e-1	1	1.089898e-1	1.000000e+0	17	1.269529e-1	1.000000e+0	1.000000e+0	7.618666e+0	1.312566e-1	1	1184	5.000000e-1	8.445946e-4	unnamed	CLVS1
GO Molecular Function	GO:0043168	anion binding	17	2.579088e-1	1.000000e+0	1.000000e+0	3.877340e+0	2.579088e-1	1	2.579088e-1	1.000000e+0	18	2.792822e-1	1.000000e+0	1.000000e+0	3.310275e+0	3.020897e-1	1	2725	5.000000e-1	3.669725e-4	unnamed	CLVS1
GO Molecular Function	GO:0046872	metal ion binding	18	3.527991e-1	1.000000e+0	1.000000e+0	2.834474e+0	3.527991e-1	1	3.527991e-1	1.000000e+0	19	3.911753e-1	1.000000e+0	1.000000e+0	2.275605e+0	4.394435e-1	1	3964	5.000000e-1	2.522704e-4	unnamed	ASPH
GO Molecular Function	GO:0043169	cation binding	19	3.606111e-1	1.000000e+0	1.000000e+0	2.773071e+0	3.606111e-1	1	3.606111e-1	1.000000e+0	20	3.968711e-1	1.000000e+0	1.000000e+0	2.238337e+0	4.467602e-1	1	4030	5.000000e-1	2.481390e-4	unnamed	ASPH
GO Molecular Function	GO:0003824	catalytic activity	20	4.361959e-1	1.000000e+0	1.000000e+0	2.292548e+0	4.361959e-1	1	4.361959e-1	1.000000e+0	22	5.163312e-1	1.000000e+0	1.000000e+0	1.641882e+0	6.090571e-1	1	5494	5.000000e-1	1.820167e-4	unnamed	ASPH
GO Molecular Function	GO:0043167	ion binding	21	5.095070e-1	1.000000e+0	1.000000e+0	1.962682e+0	5.095070e-1	1	5.095070e-1	1.000000e+0	16	1.118514e-1	1.000000e+0	1.000000e+0	2.989891e+0	6.689208e-1	2	6034	1.000000e+0	3.314551e-4	unnamed	ASPH,CLVS1
GO Molecular Function	GO:0005515	protein binding	22	6.181781e-1	1.000000e+0	1.000000e+0	1.617657e+0	6.181781e-1	1	6.181781e-1	1.000000e+0	23	6.900633e-1	1.000000e+0	1.000000e+0	1.127985e+0	8.865362e-1	1	7997	5.000000e-1	1.250469e-4	unnamed	ASPH
GO Molecular Function	GO:0005488	binding	23	8.171102e-1	1.000000e+0	1.000000e+0	1.223825e+0	8.171102e-1	1	8.171102e-1	1.000000e+0	21	4.553379e-1	1.000000e+0	1.000000e+0	1.481929e+0	1.349593e+0	2	12174	1.000000e+0	1.642845e-4	unnamed	ASPH,CLVS1
GO Biological Process	GO:0042264	peptidyl-aspartic acid hydroxylation	1	4.070943e-4	1.000000e+0	1.000000e+0	2.456433e+3	4.070943e-4	1	4.070943e-4	1.000000e+0	1	2.217111e-4	1.000000e+0	1.000000e+0	4.510250e+3	2.217172e-4	1	2	5.000000e-1	5.000000e-1	unnamed	ASPH
GO Biological Process	GO:0031585	regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity	2	4.905563e-4	1.000000e+0	1.000000e+0	2.038502e+3	4.905563e-4	1	4.905563e-4	1.000000e+0	2	3.325574e-4	1.000000e+0	1.000000e+0	3.006833e+3	3.325758e-4	1	3	5.000000e-1	3.333333e-1	unnamed	ASPH
GO Biological Process	GO:0018126	protein hydroxylation	3	9.404088e-4	1.000000e+0	1.000000e+0	1.063367e+3	9.404088e-4	1	9.404088e-4	1.000000e+0	3	4.433975e-4	1.000000e+0	1.000000e+0	2.255125e+3	4.434344e-4	1	4	5.000000e-1	2.500000e-1	unnamed	ASPH
GO Biological Process	GO:0032237	activation of store-operated calcium channel activity	4	1.194959e-3	1.000000e+0	1.000000e+0	8.368488e+2	1.194959e-3	1	1.194959e-3	1.000000e+0	4	5.542315e-4	1.000000e+0	1.000000e+0	1.804100e+3	5.542930e-4	1	5	5.000000e-1	2.000000e-1	unnamed	ASPH
GO Biological Process	GO:1901339	regulation of store-operated calcium channel activity	5	1.223341e-3	1.000000e+0	1.000000e+0	8.174335e+2	1.223341e-3	1	1.223341e-3	1.000000e+0	5	6.650594e-4	1.000000e+0	1.000000e+0	1.503417e+3	6.651516e-4	1	6	5.000000e-1	1.666667e-1	unnamed	ASPH
GO Biological Process	GO:0060316	positive regulation of ryanodine-sensitive calcium-release channel activity	6	1.826747e-3	1.000000e+0	1.000000e+0	5.474211e+2	1.826747e-3	1	1.826747e-3	1.000000e+0	7	1.108309e-3	1.000000e+0	1.000000e+0	9.020500e+2	1.108586e-3	1	10	5.000000e-1	1.000000e-1	unnamed	ASPH
GO Biological Process	GO:0010649	regulation of cell communication by electrical coupling	7	1.854132e-3	1.000000e+0	1.000000e+0	5.393360e+2	1.854132e-3	1	1.854132e-3	1.000000e+0	6	8.866967e-4	1.000000e+0	1.000000e+0	1.127562e+3	8.868688e-4	1	8	5.000000e-1	1.250000e-1	unnamed	ASPH
GO Biological Process	GO:0033198	response to ATP	8	2.016336e-3	1.000000e+0	1.000000e+0	4.959492e+2	2.016336e-3	1	2.016336e-3	1.000000e+0	12	2.326740e-3	1.000000e+0	1.000000e+0	4.295476e+2	2.328031e-3	1	21	5.000000e-1	4.761905e-2	unnamed	ASPH
GO Biological Process	GO:0007040	lysosome organization	9	2.440679e-3	1.000000e+0	1.000000e+0	4.097221e+2	2.440679e-3	1	2.440679e-3	1.000000e+0	19	3.765745e-3	1.000000e+0	1.000000e+0	2.653088e+2	3.769192e-3	1	34	5.000000e-1	2.941176e-2	unnamed	CLVS1
GO Biological Process	GO:0005513	detection of calcium ion	10	2.876204e-3	1.000000e+0	1.000000e+0	3.476805e+2	2.876204e-3	1	2.876204e-3	1.000000e+0	8	1.551461e-3	1.000000e+0	1.000000e+0	6.443214e+2	1.552020e-3	1	14	5.000000e-1	7.142857e-2	unnamed	ASPH
GO Biological Process	GO:0010524	positive regulation of calcium ion transport into cytosol	11	2.893837e-3	1.000000e+0	1.000000e+0	3.455620e+2	2.893837e-3	1	2.893837e-3	1.000000e+0	16	3.323085e-3	1.000000e+0	1.000000e+0	3.006833e+2	3.325758e-3	1	30	5.000000e-1	3.333333e-2	unnamed	ASPH
GO Biological Process	GO:1901021	positive regulation of calcium ion transmembrane transporter activity	12	3.206045e-3	1.000000e+0	1.000000e+0	3.119108e+2	3.206045e-3	1	3.206045e-3	1.000000e+0	9	1.883760e-3	1.000000e+0	1.000000e+0	5.306176e+2	1.884596e-3	1	17	5.000000e-1	5.882353e-2	unnamed	ASPH
GO Biological Process	GO:0010881	regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion	13	3.589736e-3	1.000000e+0	1.000000e+0	2.785720e+2	3.589736e-3	1	3.589736e-3	1.000000e+0	10	1.994515e-3	1.000000e+0	1.000000e+0	5.011389e+2	1.995455e-3	1	18	5.000000e-1	5.555556e-2	unnamed	ASPH
GO Biological Process	GO:2001259	positive regulation of cation channel activity	14	3.819624e-3	1.000000e+0	1.000000e+0	2.618059e+2	3.819624e-3	1	3.819624e-3	1.000000e+0	12	2.326740e-3	1.000000e+0	1.000000e+0	4.295476e+2	2.328031e-3	1	21	5.000000e-1	4.761905e-2	unnamed	ASPH
GO Biological Process	GO:0010882	regulation of cardiac muscle contraction by calcium ion signaling	15	3.992045e-3	1.000000e+0	1.000000e+0	2.504982e+2	3.992045e-3	1	3.992045e-3	1.000000e+0	11	2.105263e-3	1.000000e+0	1.000000e+0	4.747632e+2	2.106313e-3	1	19	5.000000e-1	5.263158e-2	unnamed	ASPH
GO Biological Process	GO:0071277	cellular response to calcium ion	16	4.179165e-3	1.000000e+0	1.000000e+0	2.392822e+2	4.179165e-3	1	4.179165e-3	1.000000e+0	18	3.544427e-3	1.000000e+0	1.000000e+0	2.818906e+2	3.547475e-3	1	32	5.000000e-1	3.125000e-2	unnamed	ASPH
GO Biological Process	GO:0060314	regulation of ryanodine-sensitive calcium-release channel activity	17	4.380687e-3	1.000000e+0	1.000000e+0	2.282747e+2	4.380687e-3	1	4.380687e-3	1.000000e+0	14	2.658910e-3	1.000000e+0	1.000000e+0	3.758542e+2	2.660606e-3	1	24	5.000000e-1	4.166667e-2	unnamed	ASPH
GO Biological Process	GO:1901879	regulation of protein depolymerization	18	4.861600e-3	1.000000e+0	1.000000e+0	2.056936e+2	4.861600e-3	1	4.861600e-3	1.000000e+0	29	6.419641e-3	1.000000e+0	1.000000e+0	1.555259e+2	6.429799e-3	1	58	5.000000e-1	1.724138e-2	unnamed	ASPH
GO Biological Process	GO:0010880	regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum	19	5.007195e-3	1.000000e+0	1.000000e+0	1.997126e+2	5.007195e-3	1	5.007195e-3	1.000000e+0	14	2.658910e-3	1.000000e+0	1.000000e+0	3.758542e+2	2.660606e-3	1	24	5.000000e-1	4.166667e-2	unnamed	ASPH
GO Biological Process	GO:0060325	face morphogenesis	20	5.026043e-3	1.000000e+0	1.000000e+0	1.989637e+2	5.026043e-3	1	5.026043e-3	1.000000e+0	16	3.323085e-3	1.000000e+0	1.000000e+0	3.006833e+2	3.325758e-3	1	30	5.000000e-1	3.333333e-2	unnamed	ASPH
GO Biological Process	GO:0007033	vacuole organization	21	5.192366e-3	1.000000e+0	1.000000e+0	1.925904e+2	5.192366e-3	1	5.192366e-3	1.000000e+0	30	6.640639e-3	1.000000e+0	1.000000e+0	1.503417e+2	6.651516e-3	1	60	5.000000e-1	1.666667e-2	unnamed	CLVS1
GO Biological Process	GO:0043244	regulation of protein complex disassembly	22	5.214875e-3	1.000000e+0	1.000000e+0	1.917591e+2	5.214875e-3	1	5.214875e-3	1.000000e+0	36	7.634827e-3	1.000000e+0	1.000000e+0	1.307319e+2	7.649243e-3	1	69	5.000000e-1	1.449275e-2	unnamed	ASPH
GO Biological Process	GO:0060323	head morphogenesis	23	5.313072e-3	1.000000e+0	1.000000e+0	1.882150e+2	5.313072e-3	1	5.313072e-3	1.000000e+0	19	3.765745e-3	1.000000e+0	1.000000e+0	2.653088e+2	3.769192e-3	1	34	5.000000e-1	2.941176e-2	unnamed	ASPH
GO Biological Process	GO:0032414	positive regulation of ion transmembrane transporter activity	24	5.921538e-3	1.000000e+0	1.000000e+0	1.688750e+2	5.921538e-3	1	5.921538e-3	1.000000e+0	19	3.765745e-3	1.000000e+0	1.000000e+0	2.653088e+2	3.769192e-3	1	34	5.000000e-1	2.941176e-2	unnamed	ASPH
GO Biological Process	GO:0051928	positive regulation of calcium ion transport	25	6.358634e-3	1.000000e+0	1.000000e+0	1.572665e+2	6.358634e-3	1	6.358634e-3	1.000000e+0	31	6.861613e-3	1.000000e+0	1.000000e+0	1.454919e+2	6.873233e-3	1	62	5.000000e-1	1.612903e-2	unnamed	ASPH
GO Biological Process	GO:0032411	positive regulation of transporter activity	26	6.551429e-3	1.000000e+0	1.000000e+0	1.526385e+2	6.551429e-3	1	6.551429e-3	1.000000e+0	24	4.540164e-3	1.000000e+0	1.000000e+0	2.200122e+2	4.545203e-3	1	41	5.000000e-1	2.439024e-2	unnamed	ASPH
GO Biological Process	GO:0010171	body morphogenesis	27	6.565425e-3	1.000000e+0	1.000000e+0	1.523131e+2	6.565425e-3	1	6.565425e-3	1.000000e+0	25	4.761371e-3	1.000000e+0	1.000000e+0	2.097791e+2	4.766920e-3	1	43	5.000000e-1	2.325581e-2	unnamed	ASPH
GO Biological Process	GO:1901019	regulation of calcium ion transmembrane transporter activity	28	6.746398e-3	1.000000e+0	1.000000e+0	1.482272e+2	6.746398e-3	1	6.746398e-3	1.000000e+0	23	4.318932e-3	1.000000e+0	1.000000e+0	2.312949e+2	4.323485e-3	1	39	5.000000e-1	2.564103e-2	unnamed	ASPH
GO Biological Process	GO:0060324	face development	29	6.819452e-3	1.000000e+0	1.000000e+0	1.466394e+2	6.819452e-3	1	6.819452e-3	1.000000e+0	22	4.208307e-3	1.000000e+0	1.000000e+0	2.373816e+2	4.212627e-3	1	38	5.000000e-1	2.631579e-2	unnamed	ASPH
GO Biological Process	GO:0051279	regulation of release of sequestered calcium ion into cytosol	30	7.096583e-3	1.000000e+0	1.000000e+0	1.409129e+2	7.096583e-3	1	7.096583e-3	1.000000e+0	26	5.093135e-3	1.000000e+0	1.000000e+0	1.960978e+2	5.099496e-3	1	46	5.000000e-1	2.173913e-2	unnamed	ASPH
GO Biological Process	GO:0071248	cellular response to metal ion	31	7.115213e-3	1.000000e+0	1.000000e+0	1.405439e+2	7.115213e-3	1	7.115213e-3	1.000000e+0	41	9.180352e-3	1.000000e+0	1.000000e+0	1.086807e+2	9.201264e-3	1	83	5.000000e-1	1.204819e-2	unnamed	ASPH
GO Biological Process	GO:0045862	positive regulation of proteolysis	32	7.482603e-3	1.000000e+0	1.000000e+0	1.336433e+2	7.482603e-3	1	7.482603e-3	1.000000e+0	39	8.297342e-3	1.000000e+0	1.000000e+0	1.202733e+2	8.314395e-3	1	75	5.000000e-1	1.333333e-2	unnamed	ASPH
GO Biological Process	GO:0032846	positive regulation of homeostatic process	33	7.943270e-3	1.000000e+0	1.000000e+0	1.258927e+2	7.943270e-3	1	7.943270e-3	1.000000e+0	31	6.861613e-3	1.000000e+0	1.000000e+0	1.454919e+2	6.873233e-3	1	62	5.000000e-1	1.612903e-2	unnamed	ASPH
GO Biological Process	GO:2001257	regulation of cation channel activity	34	7.998134e-3	1.000000e+0	1.000000e+0	1.250292e+2	7.998134e-3	1	7.998134e-3	1.000000e+0	27	5.314281e-3	1.000000e+0	1.000000e+0	1.879271e+2	5.321213e-3	1	48	5.000000e-1	2.083333e-2	unnamed	ASPH
GO Biological Process	GO:0097202	activation of cysteine-type endopeptidase activity	35	8.095585e-3	1.000000e+0	1.000000e+0	1.235241e+2	8.095585e-3	1	8.095585e-3	1.000000e+0	42	9.842351e-3	1.000000e+0	1.000000e+0	1.013539e+2	9.866415e-3	1	89	5.000000e-1	1.123596e-2	unnamed	ASPH
GO Biological Process	GO:0071241	cellular response to inorganic substance	36	8.138409e-3	1.000000e+0	1.000000e+0	1.228741e+2	8.138409e-3	1	8.138409e-3	1.000000e+0	42	9.842351e-3	1.000000e+0	1.000000e+0	1.013539e+2	9.866415e-3	1	89	5.000000e-1	1.123596e-2	unnamed	ASPH
GO Biological Process	GO:0010522	regulation of calcium ion transport into cytosol	37	8.317622e-3	1.000000e+0	1.000000e+0	1.202267e+2	8.317622e-3	1	8.317622e-3	1.000000e+0	33	6.972090e-3	1.000000e+0	1.000000e+0	1.431825e+2	6.984092e-3	1	63	5.000000e-1	1.587302e-2	unnamed	ASPH
GO Biological Process	GO:0060322	head development	38	8.423382e-3	1.000000e+0	1.000000e+0	1.187172e+2	8.423382e-3	1	8.423382e-3	1.000000e+0	28	5.756499e-3	1.000000e+0	1.000000e+0	1.734712e+2	5.764647e-3	1	52	5.000000e-1	1.923077e-2	unnamed	ASPH
GO Biological Process	GO:0010469	regulation of receptor activity	39	9.060264e-3	1.000000e+0	1.000000e+0	1.103721e+2	9.060264e-3	1	9.060264e-3	1.000000e+0	35	7.524386e-3	1.000000e+0	1.000000e+0	1.326544e+2	7.538385e-3	1	68	5.000000e-1	1.470588e-2	unnamed	ASPH
GO Biological Process	GO:2001056	positive regulation of cysteine-type endopeptidase activity	40	9.886692e-3	1.000000e+0	1.000000e+0	1.011461e+2	9.886692e-3	1	9.886692e-3	1.000000e+0	51	1.270846e-2	1.000000e+0	1.000000e+0	7.843913e+1	1.274874e-2	1	115	5.000000e-1	8.695652e-3	unnamed	ASPH
GO Biological Process	GO:0046683	response to organophosphorus	41	1.030301e-2	1.000000e+0	1.000000e+0	9.705900e+1	1.030301e-2	1	1.030301e-2	1.000000e+0	46	1.149638e-2	1.000000e+0	1.000000e+0	8.673558e+1	1.152929e-2	1	104	5.000000e-1	9.615385e-3	unnamed	ASPH
GO Biological Process	GO:0010950	positive regulation of endopeptidase activity	42	1.046505e-2	1.000000e+0	1.000000e+0	9.555614e+1	1.046505e-2	1	1.046505e-2	1.000000e+0	54	1.347939e-2	1.000000e+0	1.000000e+0	7.393852e+1	1.352475e-2	1	122	5.000000e-1	8.196721e-3	unnamed	ASPH
GO Biological Process	GO:0031647	regulation of protein stability	43	1.096885e-2	1.000000e+0	1.000000e+0	9.116725e+1	1.096885e-2	1	1.096885e-2	1.000000e+0	49	1.237796e-2	1.000000e+0	1.000000e+0	8.054018e+1	1.241616e-2	1	112	5.000000e-1	8.928571e-3	unnamed	ASPH
GO Biological Process	GO:0055117	regulation of cardiac muscle contraction	44	1.124704e-2	1.000000e+0	1.000000e+0	8.891230e+1	1.124704e-2	1	1.124704e-2	1.000000e+0	34	7.303486e-3	1.000000e+0	1.000000e+0	1.366742e+2	7.316668e-3	1	66	5.000000e-1	1.515152e-2	unnamed	ASPH
GO Biological Process	GO:0051592	response to calcium ion	45	1.127596e-2	1.000000e+0	1.000000e+0	8.868425e+1	1.127596e-2	1	1.127596e-2	1.000000e+0	44	1.028356e-2	1.000000e+0	1.000000e+0	9.699462e+1	1.030985e-2	1	93	5.000000e-1	1.075269e-2	unnamed	ASPH
GO Biological Process	GO:0010952	positive regulation of peptidase activity	46	1.135752e-2	1.000000e+0	1.000000e+0	8.804741e+1	1.135752e-2	1	1.135752e-2	1.000000e+0	57	1.447015e-2	1.000000e+0	1.000000e+0	6.885878e+1	1.452248e-2	1	131	5.000000e-1	7.633588e-3	unnamed	ASPH
GO Biological Process	GO:0014074	response to purine-containing compound	47	1.141315e-2	1.000000e+0	1.000000e+0	8.761825e+1	1.141315e-2	1	1.141315e-2	1.000000e+0	53	1.292876e-2	1.000000e+0	1.000000e+0	7.709829e+1	1.297046e-2	1	117	5.000000e-1	8.547009e-3	unnamed	ASPH
GO Biological Process	GO:0006942	regulation of striated muscle contraction	48	1.155241e-2	1.000000e+0	1.000000e+0	8.656202e+1	1.155241e-2	1	1.155241e-2	1.000000e+0	40	8.407740e-3	1.000000e+0	1.000000e+0	1.186908e+2	8.425254e-3	1	76	5.000000e-1	1.315789e-2	unnamed	ASPH
GO Biological Process	GO:0019722	calcium-mediated signaling	49	1.164214e-2	1.000000e+0	1.000000e+0	8.589489e+1	1.164214e-2	1	1.164214e-2	1.000000e+0	38	8.186938e-3	1.000000e+0	1.000000e+0	1.218986e+2	8.203536e-3	1	74	5.000000e-1	1.351351e-2	unnamed	ASPH
GO Biological Process	GO:0090316	positive regulation of intracellular protein transport	50	1.278808e-2	1.000000e+0	1.000000e+0	7.819781e+1	1.278808e-2	1	1.278808e-2	1.000000e+0	49	1.237796e-2	1.000000e+0	1.000000e+0	8.054018e+1	1.241616e-2	1	112	5.000000e-1	8.928571e-3	unnamed	ASPH
GO Biological Process	GO:0070588	calcium ion transmembrane transport	51	1.411157e-2	1.000000e+0	1.000000e+0	7.086383e+1	1.411157e-2	1	1.411157e-2	1.000000e+0	48	1.160660e-2	1.000000e+0	1.000000e+0	8.590952e+1	1.164015e-2	1	105	5.000000e-1	9.523810e-3	unnamed	ASPH
GO Biological Process	GO:0060021	palate development	52	1.442378e-2	1.000000e+0	1.000000e+0	6.932995e+1	1.442378e-2	1	1.442378e-2	1.000000e+0	37	8.076528e-3	1.000000e+0	1.000000e+0	1.235685e+2	8.092678e-3	1	73	5.000000e-1	1.369863e-2	unnamed	ASPH
GO Biological Process	GO:0043270	positive regulation of ion transport	53	1.444820e-2	1.000000e+0	1.000000e+0	6.921278e+1	1.444820e-2	1	1.444820e-2	1.000000e+0	56	1.402987e-2	1.000000e+0	1.000000e+0	7.102756e+1	1.407904e-2	1	127	5.000000e-1	7.874016e-3	unnamed	ASPH
GO Biological Process	GO:0032412	regulation of ion transmembrane transporter activity	54	1.489571e-2	1.000000e+0	1.000000e+0	6.713344e+1	1.489571e-2	1	1.489571e-2	1.000000e+0	45	1.105544e-2	1.000000e+0	1.000000e+0	9.020500e+1	1.108586e-2	1	100	5.000000e-1	1.000000e-2	unnamed	ASPH
GO Biological Process	GO:0022898	regulation of transmembrane transporter activity	55	1.538379e-2	1.000000e+0	1.000000e+0	6.500348e+1	1.538379e-2	1	1.538379e-2	1.000000e+0	46	1.149638e-2	1.000000e+0	1.000000e+0	8.673558e+1	1.152929e-2	1	104	5.000000e-1	9.615385e-3	unnamed	ASPH
GO Biological Process	GO:0030162	regulation of proteolysis	56	1.596185e-2	1.000000e+0	1.000000e+0	6.264936e+1	1.596185e-2	1	1.596185e-2	1.000000e+0	66	1.963603e-2	1.000000e+0	1.000000e+0	5.067697e+1	1.973283e-2	1	178	5.000000e-1	5.617978e-3	unnamed	ASPH
GO Biological Process	GO:0009593	detection of chemical stimulus	57	1.618199e-2	1.000000e+0	1.000000e+0	6.179711e+1	1.618199e-2	1	1.618199e-2	1.000000e+0	92	4.850873e-2	1.000000e+0	1.000000e+0	2.036230e+1	4.911036e-2	1	443	5.000000e-1	2.257336e-3	unnamed	ASPH
GO Biological Process	GO:0032388	positive regulation of intracellular transport	58	1.641483e-2	1.000000e+0	1.000000e+0	6.092053e+1	1.641483e-2	1	1.641483e-2	1.000000e+0	65	1.743944e-2	1.000000e+0	1.000000e+0	5.709177e+1	1.751566e-2	1	158	5.000000e-1	6.329114e-3	unnamed	ASPH
GO Biological Process	GO:0032409	regulation of transporter activity	59	1.679752e-2	1.000000e+0	1.000000e+0	5.953259e+1	1.679752e-2	1	1.679752e-2	1.000000e+0	51	1.270846e-2	1.000000e+0	1.000000e+0	7.843913e+1	1.274874e-2	1	115	5.000000e-1	8.695652e-3	unnamed	ASPH
GO Biological Process	GO:2000021	regulation of ion homeostasis	60	1.698652e-2	1.000000e+0	1.000000e+0	5.887021e+1	1.698652e-2	1	1.698652e-2	1.000000e+0	59	1.524040e-2	1.000000e+0	1.000000e+0	6.536594e+1	1.529849e-2	1	138	5.000000e-1	7.246377e-3	unnamed	ASPH
GO Biological Process	GO:0051924	regulation of calcium ion transport	61	1.698978e-2	1.000000e+0	1.000000e+0	5.885891e+1	1.698978e-2	1	1.698978e-2	1.000000e+0	62	1.612031e-2	1.000000e+0	1.000000e+0	6.178425e+1	1.618536e-2	1	146	5.000000e-1	6.849315e-3	unnamed	ASPH
GO Biological Process	GO:0006937	regulation of muscle contraction	62	1.867020e-2	1.000000e+0	1.000000e+0	5.356128e+1	1.867020e-2	1	1.867020e-2	1.000000e+0	58	1.469025e-2	1.000000e+0	1.000000e+0	6.782331e+1	1.474419e-2	1	133	5.000000e-1	7.518797e-3	unnamed	ASPH
GO Biological Process	GO:2000116	regulation of cysteine-type endopeptidase activity	63	1.903819e-2	1.000000e+0	1.000000e+0	5.252601e+1	1.903819e-2	1	1.903819e-2	1.000000e+0	67	2.106249e-2	1.000000e+0	1.000000e+0	4.722775e+1	2.117399e-2	1	191	5.000000e-1	5.235602e-3	unnamed	ASPH
GO Biological Process	GO:0019932	second-messenger-mediated signaling	64	1.992378e-2	1.000000e+0	1.000000e+0	5.019128e+1	1.992378e-2	1	1.992378e-2	1.000000e+0	55	1.391979e-2	1.000000e+0	1.000000e+0	7.159127e+1	1.396818e-2	1	126	5.000000e-1	7.936508e-3	unnamed	ASPH
GO Biological Process	GO:0051222	positive regulation of protein transport	65	2.010013e-2	1.000000e+0	1.000000e+0	4.975093e+1	2.010013e-2	1	2.010013e-2	1.000000e+0	69	2.150119e-2	1.000000e+0	1.000000e+0	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	ASPH
GO Biological Process	GO:0008016	regulation of heart contraction	66	2.188096e-2	1.000000e+0	1.000000e+0	4.570183e+1	2.188096e-2	1	2.188096e-2	1.000000e+0	59	1.524040e-2	1.000000e+0	1.000000e+0	6.536594e+1	1.529849e-2	1	138	5.000000e-1	7.246377e-3	unnamed	ASPH
GO Biological Process	GO:0010038	response to metal ion	67	2.200656e-2	1.000000e+0	1.000000e+0	4.544100e+1	2.200656e-2	1	2.200656e-2	1.000000e+0	75	2.500727e-2	1.000000e+0	1.000000e+0	3.973789e+1	2.516490e-2	1	227	5.000000e-1	4.405286e-3	unnamed	ASPH
GO Biological Process	GO:0033157	regulation of intracellular protein transport	68	2.216024e-2	1.000000e+0	1.000000e+0	4.512586e+1	2.216024e-2	1	2.216024e-2	1.000000e+0	68	2.128185e-2	1.000000e+0	1.000000e+0	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	ASPH
GO Biological Process	GO:0090257	regulation of muscle system process	69	2.283758e-2	1.000000e+0	1.000000e+0	4.378747e+1	2.283758e-2	1	2.283758e-2	1.000000e+0	64	1.732955e-2	1.000000e+0	1.000000e+0	5.745541e+1	1.740480e-2	1	157	5.000000e-1	6.369427e-3	unnamed	ASPH
GO Biological Process	GO:0006936	muscle contraction	70	2.298877e-2	1.000000e+0	1.000000e+0	4.349949e+1	2.298877e-2	1	2.298877e-2	1.000000e+0	70	2.226868e-2	1.000000e+0	1.000000e+0	4.465594e+1	2.239344e-2	1	202	5.000000e-1	4.950495e-3	unnamed	ASPH
GO Biological Process	GO:0052548	regulation of endopeptidase activity	71	2.520400e-2	1.000000e+0	1.000000e+0	3.967625e+1	2.520400e-2	1	2.520400e-2	1.000000e+0	78	2.981786e-2	1.000000e+0	1.000000e+0	3.328598e+1	3.004268e-2	1	271	5.000000e-1	3.690037e-3	unnamed	ASPH
GO Biological Process	GO:0006816	calcium ion transport	72	2.547860e-2	1.000000e+0	1.000000e+0	3.924862e+1	2.547860e-2	1	2.547860e-2	1.000000e+0	70	2.226868e-2	1.000000e+0	1.000000e+0	4.465594e+1	2.239344e-2	1	202	5.000000e-1	4.950495e-3	unnamed	ASPH
GO Biological Process	GO:0010959	regulation of metal ion transport	73	2.558306e-2	1.000000e+0	1.000000e+0	3.908837e+1	2.558306e-2	1	2.558306e-2	1.000000e+0	72	2.281671e-2	1.000000e+0	1.000000e+0	4.357729e+1	2.294773e-2	1	207	5.000000e-1	4.830918e-3	unnamed	ASPH
GO Biological Process	GO:0035108	limb morphogenesis	74	2.643661e-2	1.000000e+0	1.000000e+0	3.782633e+1	2.643661e-2	1	2.643661e-2	1.000000e+0	61	1.546041e-2	1.000000e+0	1.000000e+0	6.443214e+1	1.552020e-2	1	140	5.000000e-1	7.142857e-3	unnamed	ASPH
GO Biological Process	GO:0070838	divalent metal ion transport	75	2.712662e-2	1.000000e+0	1.000000e+0	3.686416e+1	2.712662e-2	1	2.712662e-2	1.000000e+0	73	2.435036e-2	1.000000e+0	1.000000e+0	4.081674e+1	2.449975e-2	1	221	5.000000e-1	4.524887e-3	unnamed	ASPH
GO Biological Process	GO:0072511	divalent inorganic cation transport	76	2.750986e-2	1.000000e+0	1.000000e+0	3.635061e+1	2.750986e-2	1	2.750986e-2	1.000000e+0	74	2.478833e-2	1.000000e+0	1.000000e+0	4.009111e+1	2.494318e-2	1	225	5.000000e-1	4.444444e-3	unnamed	ASPH
GO Biological Process	GO:0003012	muscle system process	77	2.838486e-2	1.000000e+0	1.000000e+0	3.523005e+1	2.838486e-2	1	2.838486e-2	1.000000e+0	76	2.664858e-2	1.000000e+0	1.000000e+0	3.727479e+1	2.682778e-2	1	242	5.000000e-1	4.132231e-3	unnamed	ASPH
GO Biological Process	GO:0060173	limb development	78	2.847939e-2	1.000000e+0	1.000000e+0	3.511312e+1	2.847939e-2	1	2.847939e-2	1.000000e+0	63	1.688991e-2	1.000000e+0	1.000000e+0	5.895752e+1	1.696137e-2	1	153	5.000000e-1	6.535948e-3	unnamed	ASPH
GO Biological Process	GO:0052547	regulation of peptidase activity	79	2.932475e-2	1.000000e+0	1.000000e+0	3.410088e+1	2.932475e-2	1	2.932475e-2	1.000000e+0	86	3.777282e-2	1.000000e+0	1.000000e+0	2.622238e+1	3.813536e-2	1	344	5.000000e-1	2.906977e-3	unnamed	ASPH
GO Biological Process	GO:0010035	response to inorganic substance	80	3.091140e-2	1.000000e+0	1.000000e+0	3.235052e+1	3.091140e-2	1	3.091140e-2	1.000000e+0	83	3.581436e-2	1.000000e+0	1.000000e+0	2.767025e+1	3.613990e-2	1	326	5.000000e-1	3.067485e-3	unnamed	ASPH
GO Biological Process	GO:0010608	posttranscriptional regulation of gene expression	81	3.378331e-2	1.000000e+0	1.000000e+0	2.960041e+1	3.378331e-2	1	3.378331e-2	1.000000e+0	88	4.374465e-2	1.000000e+0	1.000000e+0	2.260777e+1	4.423258e-2	1	399	5.000000e-1	2.506266e-3	unnamed	ASPH
GO Biological Process	GO:0051223	regulation of protein transport	82	3.428315e-2	1.000000e+0	1.000000e+0	2.916884e+1	3.428315e-2	1	3.428315e-2	1.000000e+0	84	3.614091e-2	1.000000e+0	1.000000e+0	2.741793e+1	3.647248e-2	1	329	5.000000e-1	3.039514e-3	unnamed	ASPH
GO Biological Process	GO:0051606	detection of stimulus	83	3.568719e-2	1.000000e+0	1.000000e+0	2.802126e+1	3.568719e-2	1	3.568719e-2	1.000000e+0	101	6.830235e-2	1.000000e+0	1.000000e+0	1.438676e+1	6.950834e-2	1	627	5.000000e-1	1.594896e-3	unnamed	ASPH
GO Biological Process	GO:0032844	regulation of homeostatic process	84	3.631679e-2	1.000000e+0	1.000000e+0	2.753547e+1	3.631679e-2	1	3.631679e-2	1.000000e+0	80	3.047293e-2	1.000000e+0	1.000000e+0	3.256498e+1	3.070783e-2	1	277	5.000000e-1	3.610108e-3	unnamed	ASPH
GO Biological Process	GO:0032386	regulation of intracellular transport	85	3.683590e-2	1.000000e+0	1.000000e+0	2.714743e+1	3.683590e-2	1	3.683590e-2	1.000000e+0	85	3.733778e-2	1.000000e+0	1.000000e+0	2.653088e+1	3.769192e-2	1	340	5.000000e-1	2.941176e-3	unnamed	ASPH
GO Biological Process	GO:0034765	regulation of ion transmembrane transport	86	3.928698e-2	1.000000e+0	1.000000e+0	2.545372e+1	3.928698e-2	1	3.928698e-2	1.000000e+0	77	2.916257e-2	1.000000e+0	1.000000e+0	3.403962e+1	2.937753e-2	1	265	5.000000e-1	3.773585e-3	unnamed	ASPH
GO Biological Process	GO:0034762	regulation of transmembrane transport	87	3.988279e-2	1.000000e+0	1.000000e+0	2.507347e+1	3.988279e-2	1	3.988279e-2	1.000000e+0	79	3.014542e-2	1.000000e+0	1.000000e+0	3.292153e+1	3.037526e-2	1	274	5.000000e-1	3.649635e-3	unnamed	ASPH
GO Biological Process	GO:0070201	regulation of establishment of protein localization	88	4.131349e-2	1.000000e+0	1.000000e+0	2.420517e+1	4.131349e-2	1	4.131349e-2	1.000000e+0	87	4.168376e-2	1.000000e+0	1.000000e+0	2.373816e+1	4.212627e-2	1	380	5.000000e-1	2.631579e-3	unnamed	ASPH
GO Biological Process	GO:0032880	regulation of protein localization	89	4.731536e-2	1.000000e+0	1.000000e+0	2.113479e+1	4.731536e-2	1	4.731536e-2	1.000000e+0	91	4.840059e-2	1.000000e+0	1.000000e+0	2.040837e+1	4.899950e-2	1	442	5.000000e-1	2.262443e-3	unnamed	ASPH
GO Biological Process	GO:0034220	ion transmembrane transport	90	5.009827e-2	1.000000e+0	1.000000e+0	1.996077e+1	5.009827e-2	1	5.009827e-2	1.000000e+0	94	5.045424e-2	1.000000e+0	1.000000e+0	1.956725e+1	5.110581e-2	1	461	5.000000e-1	2.169197e-3	unnamed	ASPH
GO Biological Process	GO:0043269	regulation of ion transport	91	5.622673e-2	1.000000e+0	1.000000e+0	1.778513e+1	5.622673e-2	1	5.622673e-2	1.000000e+0	90	4.753523e-2	1.000000e+0	1.000000e+0	2.078456e+1	4.811263e-2	1	434	5.000000e-1	2.304147e-3	unnamed	ASPH
GO Biological Process	GO:0051050	positive regulation of transport	92	6.143757e-2	1.000000e+0	1.000000e+0	1.627669e+1	6.143757e-2	1	6.143757e-2	1.000000e+0	96	5.821639e-2	1.000000e+0	1.000000e+0	1.692402e+1	5.908763e-2	1	533	5.000000e-1	1.876173e-3	unnamed	ASPH
GO Biological Process	GO:0030001	metal ion transport	93	6.152617e-2	1.000000e+0	1.000000e+0	1.625325e+1	6.152617e-2	1	6.152617e-2	1.000000e+0	97	5.972199e-2	1.000000e+0	1.000000e+0	1.649086e+1	6.063965e-2	1	547	5.000000e-1	1.828154e-3	unnamed	ASPH
GO Biological Process	GO:0018193	peptidyl-amino acid modification	94	6.275838e-2	1.000000e+0	1.000000e+0	1.593413e+1	6.275838e-2	1	6.275838e-2	1.000000e+0	99	6.466050e-2	1.000000e+0	1.000000e+0	1.521164e+1	6.573915e-2	1	593	5.000000e-1	1.686341e-3	unnamed	ASPH
GO Biological Process	GO:0007389	pattern specification process	95	6.366023e-2	1.000000e+0	1.000000e+0	1.570839e+1	6.366023e-2	1	6.366023e-2	1.000000e+0	89	4.645297e-2	1.000000e+0	1.000000e+0	2.127476e+1	4.700405e-2	1	424	5.000000e-1	2.358491e-3	unnamed	ASPH
GO Biological Process	GO:0044057	regulation of system process	96	6.822429e-2	1.000000e+0	1.000000e+0	1.465754e+1	6.822429e-2	1	6.822429e-2	1.000000e+0	95	5.390802e-2	1.000000e+0	1.000000e+0	1.829716e+1	5.465329e-2	1	493	5.000000e-1	2.028398e-3	unnamed	ASPH
GO Biological Process	GO:0010243	response to organonitrogen compound	97	6.859350e-2	1.000000e+0	1.000000e+0	1.457864e+1	6.859350e-2	1	6.859350e-2	1.000000e+0	102	6.894429e-2	1.000000e+0	1.000000e+0	1.425039e+1	7.017349e-2	1	633	5.000000e-1	1.579779e-3	unnamed	ASPH
GO Biological Process	GO:0051345	positive regulation of hydrolase activity	98	6.945880e-2	1.000000e+0	1.000000e+0	1.439702e+1	6.945880e-2	1	6.945880e-2	1.000000e+0	103	6.947907e-2	1.000000e+0	1.000000e+0	1.413871e+1	7.072779e-2	1	638	5.000000e-1	1.567398e-3	unnamed	ASPH
GO Biological Process	GO:0014070	response to organic cyclic compound	99	6.953782e-2	1.000000e+0	1.000000e+0	1.438066e+1	6.953782e-2	1	6.953782e-2	1.000000e+0	100	6.594667e-2	1.000000e+0	1.000000e+0	1.490992e+1	6.706945e-2	1	605	5.000000e-1	1.652893e-3	unnamed	ASPH
GO Biological Process	GO:1901698	response to nitrogen compound	100	7.125062e-2	1.000000e+0	1.000000e+0	1.403497e+1	7.125062e-2	1	7.125062e-2	1.000000e+0	104	7.332497e-2	1.000000e+0	1.000000e+0	1.338353e+1	7.471870e-2	1	674	5.000000e-1	1.483680e-3	unnamed	ASPH
GO Biological Process	GO:0006812	cation transport	101	7.387615e-2	1.000000e+0	1.000000e+0	1.353617e+1	7.387615e-2	1	7.387615e-2	1.000000e+0	105	7.471181e-2	1.000000e+0	1.000000e+0	1.313028e+1	7.615986e-2	1	687	5.000000e-1	1.455604e-3	unnamed	ASPH
GO Biological Process	GO:0008285	negative regulation of cell proliferation	102	7.420861e-2	1.000000e+0	1.000000e+0	1.347553e+1	7.420861e-2	1	7.420861e-2	1.000000e+0	98	6.058180e-2	1.000000e+0	1.000000e+0	1.625315e+1	6.152652e-2	1	555	5.000000e-1	1.801802e-3	unnamed	ASPH
GO Biological Process	GO:0055114	oxidation-reduction process	103	7.921377e-2	1.000000e+0	1.000000e+0	1.262407e+1	7.921377e-2	1	7.921377e-2	1.000000e+0	109	9.970771e-2	1.000000e+0	1.000000e+0	9.773023e+0	1.023225e-1	1	923	5.000000e-1	1.083424e-3	unnamed	ASPH
GO Biological Process	GO:0055085	transmembrane transport	104	8.563981e-2	1.000000e+0	1.000000e+0	1.167681e+1	8.563981e-2	1	8.563981e-2	1.000000e+0	108	9.602230e-2	1.000000e+0	1.000000e+0	1.015822e+1	9.844244e-2	1	888	5.000000e-1	1.126126e-3	unnamed	ASPH
GO Biological Process	GO:0032270	positive regulation of cellular protein metabolic process	105	9.043716e-2	1.000000e+0	1.000000e+0	1.105740e+1	9.043716e-2	1	9.043716e-2	1.000000e+0	107	9.433504e-2	1.000000e+0	1.000000e+0	1.034461e+1	9.666870e-2	1	872	5.000000e-1	1.146789e-3	unnamed	ASPH
GO Biological Process	GO:0060341	regulation of cellular localization	106	9.081570e-2	1.000000e+0	1.000000e+0	1.101131e+1	9.081570e-2	1	9.081570e-2	1.000000e+0	106	8.354176e-2	1.000000e+0	1.000000e+0	1.171494e+1	8.536112e-2	1	770	5.000000e-1	1.298701e-3	unnamed	ASPH
GO Biological Process	GO:0051247	positive regulation of protein metabolic process	107	1.002750e-1	1.000000e+0	1.000000e+0	9.972575e+0	1.002750e-1	1	1.002750e-1	1.000000e+0	110	1.030706e-1	1.000000e+0	1.000000e+0	9.445550e+0	1.058700e-1	1	955	5.000000e-1	1.047120e-3	unnamed	ASPH
GO Biological Process	GO:0051336	regulation of hydrolase activity	108	1.030572e-1	1.000000e+0	1.000000e+0	9.703349e+0	1.030572e-1	1	1.030572e-1	1.000000e+0	111	1.073702e-1	1.000000e+0	1.000000e+0	9.056727e+0	1.104152e-1	1	996	5.000000e-1	1.004016e-3	unnamed	ASPH
GO Biological Process	GO:0006811	ion transport	109	1.070764e-1	1.000000e+0	1.000000e+0	9.339125e+0	1.070764e-1	1	1.070764e-1	1.000000e+0	114	1.160425e-1	1.000000e+0	1.000000e+0	8.360056e+0	1.196164e-1	1	1079	5.000000e-1	9.267841e-4	unnamed	ASPH
GO Biological Process	GO:1901700	response to oxygen-containing compound	110	1.089184e-1	1.000000e+0	1.000000e+0	9.181188e+0	1.089184e-1	1	1.089184e-1	1.000000e+0	112	1.115549e-1	1.000000e+0	1.000000e+0	8.707046e+0	1.148495e-1	1	1036	5.000000e-1	9.652510e-4	unnamed	ASPH
GO Biological Process	GO:0043085	positive regulation of catalytic activity	111	1.192177e-1	1.000000e+0	1.000000e+0	8.388019e+0	1.192177e-1	1	1.192177e-1	1.000000e+0	115	1.198949e-1	1.000000e+0	1.000000e+0	8.082885e+0	1.237182e-1	1	1116	5.000000e-1	8.960573e-4	unnamed	ASPH
GO Biological Process	GO:0009719	response to endogenous stimulus	112	1.264308e-1	1.000000e+0	1.000000e+0	7.909468e+0	1.264308e-1	1	1.264308e-1	1.000000e+0	117	1.223892e-1	1.000000e+0	1.000000e+0	7.912719e+0	1.263788e-1	1	1140	5.000000e-1	8.771930e-4	unnamed	ASPH
GO Biological Process	GO:0045893	positive regulation of transcription, DNA-dependent	113	1.366972e-1	1.000000e+0	1.000000e+0	7.315436e+0	1.366972e-1	1	1.366972e-1	1.000000e+0	113	1.155213e-1	1.000000e+0	1.000000e+0	8.398976e+0	1.190621e-1	1	1074	5.000000e-1	9.310987e-4	unnamed	ASPH
GO Biological Process	GO:0032268	regulation of cellular protein metabolic process	114	1.389785e-1	1.000000e+0	1.000000e+0	7.195356e+0	1.389785e-1	1	1.389785e-1	1.000000e+0	128	1.498997e-1	1.000000e+0	1.000000e+0	6.411158e+0	1.559780e-1	1	1407	5.000000e-1	7.107321e-4	unnamed	ASPH
GO Biological Process	GO:0051049	regulation of transport	115	1.390239e-1	1.000000e+0	1.000000e+0	7.193009e+0	1.390239e-1	1	1.390239e-1	1.000000e+0	119	1.304713e-1	1.000000e+0	1.000000e+0	7.405993e+0	1.350258e-1	1	1218	5.000000e-1	8.210181e-4	unnamed	ASPH
GO Biological Process	GO:0051254	positive regulation of RNA metabolic process	116	1.403288e-1	1.000000e+0	1.000000e+0	7.126123e+0	1.403288e-1	1	1.403288e-1	1.000000e+0	116	1.219737e-1	1.000000e+0	1.000000e+0	7.940581e+0	1.259354e-1	1	1136	5.000000e-1	8.802817e-4	unnamed	ASPH
GO Biological Process	GO:0044093	positive regulation of molecular function	117	1.422599e-1	1.000000e+0	1.000000e+0	7.029386e+0	1.422599e-1	1	1.422599e-1	1.000000e+0	124	1.401616e-1	1.000000e+0	1.000000e+0	6.875381e+0	1.454465e-1	1	1312	5.000000e-1	7.621951e-4	unnamed	ASPH
GO Biological Process	GO:0010628	positive regulation of gene expression	118	1.480202e-1	1.000000e+0	1.000000e+0	6.755834e+0	1.480202e-1	1	1.480202e-1	1.000000e+0	118	1.249837e-1	1.000000e+0	1.000000e+0	7.742918e+0	1.291503e-1	1	1165	5.000000e-1	8.583691e-4	unnamed	ASPH
GO Biological Process	GO:0042127	regulation of cell proliferation	119	1.497663e-1	1.000000e+0	1.000000e+0	6.677069e+0	1.497663e-1	1	1.497663e-1	1.000000e+0	120	1.334666e-1	1.000000e+0	1.000000e+0	7.233761e+0	1.382407e-1	1	1247	5.000000e-1	8.019246e-4	unnamed	ASPH
GO Biological Process	GO:0010557	positive regulation of macromolecule biosynthetic process	120	1.506028e-1	1.000000e+0	1.000000e+0	6.639981e+0	1.506028e-1	1	1.506028e-1	1.000000e+0	121	1.356324e-1	1.000000e+0	1.000000e+0	7.113959e+0	1.405687e-1	1	1268	5.000000e-1	7.886435e-4	unnamed	ASPH
GO Biological Process	GO:0035556	intracellular signal transduction	121	1.533855e-1	1.000000e+0	1.000000e+0	6.519521e+0	1.533855e-1	1	1.533855e-1	1.000000e+0	129	1.538815e-1	1.000000e+0	1.000000e+0	6.238243e+0	1.603015e-1	1	1446	5.000000e-1	6.915629e-4	unnamed	ASPH
GO Biological Process	GO:0045935	positive regulation of nucleobase-containing compound metabolic process	122	1.543505e-1	1.000000e+0	1.000000e+0	6.478762e+0	1.543505e-1	1	1.543505e-1	1.000000e+0	122	1.361477e-1	1.000000e+0	1.000000e+0	7.086017e+0	1.411230e-1	1	1273	5.000000e-1	7.855460e-4	unnamed	ASPH
GO Biological Process	GO:0051246	regulation of protein metabolic process	123	1.559232e-1	1.000000e+0	1.000000e+0	6.413414e+0	1.559232e-1	1	1.559232e-1	1.000000e+0	130	1.698159e-1	1.000000e+0	1.000000e+0	5.627261e+0	1.777063e-1	1	1603	5.000000e-1	6.238303e-4	unnamed	ASPH
GO Biological Process	GO:0051173	positive regulation of nitrogen compound metabolic process	124	1.569956e-1	1.000000e+0	1.000000e+0	6.369604e+0	1.569956e-1	1	1.569956e-1	1.000000e+0	123	1.389275e-1	1.000000e+0	1.000000e+0	6.938846e+0	1.441162e-1	1	1300	5.000000e-1	7.692308e-4	unnamed	ASPH
GO Biological Process	GO:0051128	regulation of cellular component organization	125	1.583941e-1	1.000000e+0	1.000000e+0	6.313365e+0	1.583941e-1	1	1.583941e-1	1.000000e+0	127	1.493886e-1	1.000000e+0	1.000000e+0	6.434023e+0	1.554238e-1	1	1402	5.000000e-1	7.132668e-4	unnamed	ASPH
GO Biological Process	GO:0031328	positive regulation of cellular biosynthetic process	126	1.595607e-1	1.000000e+0	1.000000e+0	6.267208e+0	1.595607e-1	1	1.595607e-1	1.000000e+0	125	1.447813e-1	1.000000e+0	1.000000e+0	6.647384e+0	1.504351e-1	1	1357	5.000000e-1	7.369197e-4	unnamed	ASPH
GO Biological Process	GO:0009891	positive regulation of biosynthetic process	127	1.621017e-1	1.000000e+0	1.000000e+0	6.168967e+0	1.621017e-1	1	1.621017e-1	1.000000e+0	126	1.471377e-1	1.000000e+0	1.000000e+0	6.536594e+0	1.529849e-1	1	1380	5.000000e-1	7.246377e-4	unnamed	ASPH
GO Biological Process	GO:0050790	regulation of catalytic activity	128	1.756788e-1	1.000000e+0	1.000000e+0	5.692208e+0	1.756788e-1	1	1.756788e-1	1.000000e+0	132	1.830959e-1	1.000000e+0	1.000000e+0	5.199135e+0	1.923397e-1	1	1735	5.000000e-1	5.763689e-4	unnamed	ASPH
GO Biological Process	GO:0070887	cellular response to chemical stimulus	129	1.826020e-1	1.000000e+0	1.000000e+0	5.476391e+0	1.826020e-1	1	1.826020e-1	1.000000e+0	133	1.959705e-1	1.000000e+0	1.000000e+0	4.839324e+0	2.066404e-1	1	1864	5.000000e-1	5.364807e-4	unnamed	ASPH
GO Biological Process	GO:0032879	regulation of localization	130	1.871404e-1	1.000000e+0	1.000000e+0	5.343583e+0	1.871404e-1	1	1.871404e-1	1.000000e+0	131	1.713304e-1	1.000000e+0	1.000000e+0	5.575093e+0	1.793692e-1	1	1618	5.000000e-1	6.180470e-4	unnamed	ASPH
GO Biological Process	GO:0003008	system process	131	1.967197e-1	1.000000e+0	1.000000e+0	5.083376e+0	1.967197e-1	1	1.967197e-1	1.000000e+0	135	2.046945e-1	1.000000e+0	1.000000e+0	4.621158e+0	2.163960e-1	1	1952	5.000000e-1	5.122951e-4	unnamed	ASPH
GO Biological Process	GO:0006996	organelle organization	132	1.979117e-1	1.000000e+0	1.000000e+0	5.052758e+0	1.979117e-1	1	1.979117e-1	1.000000e+0	144	2.321362e-1	1.000000e+0	1.000000e+0	4.041443e+0	2.474364e-1	1	2232	5.000000e-1	4.480287e-4	unnamed	CLVS1
GO Biological Process	GO:0010033	response to organic substance	133	2.019131e-1	1.000000e+0	1.000000e+0	4.952626e+0	2.019131e-1	1	2.019131e-1	1.000000e+0	140	2.147469e-1	1.000000e+0	1.000000e+0	4.391675e+0	2.277036e-1	1	2054	5.000000e-1	4.868549e-4	unnamed	ASPH
GO Biological Process	GO:0006464	cellular protein modification process	134	2.092214e-1	1.000000e+0	1.000000e+0	4.779626e+0	2.092214e-1	1	2.092214e-1	1.000000e+0	143	2.280507e-1	1.000000e+0	1.000000e+0	4.118950e+0	2.427803e-1	1	2190	5.000000e-1	4.566210e-4	unnamed	ASPH
GO Biological Process	GO:0065009	regulation of molecular function	135	2.156945e-1	1.000000e+0	1.000000e+0	4.636187e+0	2.156945e-1	1	2.156945e-1	1.000000e+0	141	2.197492e-1	1.000000e+0	1.000000e+0	4.285273e+0	2.333574e-1	1	2105	5.000000e-1	4.750594e-4	unnamed	ASPH
GO Biological Process	GO:0043412	macromolecule modification	136	2.160048e-1	1.000000e+0	1.000000e+0	4.629527e+0	2.160048e-1	1	2.160048e-1	1.000000e+0	147	2.399849e-1	1.000000e+0	1.000000e+0	3.899914e+0	2.564159e-1	1	2313	5.000000e-1	4.323390e-4	unnamed	ASPH
GO Biological Process	GO:0009966	regulation of signal transduction	137	2.171476e-1	1.000000e+0	1.000000e+0	4.605162e+0	2.171476e-1	1	2.171476e-1	1.000000e+0	138	2.126825e-1	1.000000e+0	1.000000e+0	4.437039e+0	2.253755e-1	1	2033	5.000000e-1	4.918839e-4	unnamed	ASPH
GO Biological Process	GO:0010604	positive regulation of macromolecule metabolic process	138	2.215598e-1	1.000000e+0	1.000000e+0	4.513455e+0	2.215598e-1	1	2.215598e-1	1.000000e+0	137	2.091373e-1	1.000000e+0	1.000000e+0	4.517026e+0	2.213846e-1	1	1997	5.000000e-1	5.007511e-4	unnamed	ASPH
GO Biological Process	GO:0031325	positive regulation of cellular metabolic process	139	2.230682e-1	1.000000e+0	1.000000e+0	4.482934e+0	2.230682e-1	1	2.230682e-1	1.000000e+0	139	2.132726e-1	1.000000e+0	1.000000e+0	4.423982e+0	2.260407e-1	1	2039	5.000000e-1	4.904365e-4	unnamed	ASPH
GO Biological Process	GO:0044765	single-organism transport	140	2.288177e-1	1.000000e+0	1.000000e+0	4.370291e+0	2.288177e-1	1	2.288177e-1	1.000000e+0	148	2.680389e-1	1.000000e+0	1.000000e+0	3.461435e+0	2.888975e-1	1	2606	5.000000e-1	3.837299e-4	unnamed	ASPH
GO Biological Process	GO:0009893	positive regulation of metabolic process	141	2.357828e-1	1.000000e+0	1.000000e+0	4.241191e+0	2.357828e-1	1	2.357828e-1	1.000000e+0	142	2.244425e-1	1.000000e+0	1.000000e+0	4.189735e+0	2.386786e-1	1	2153	5.000000e-1	4.644682e-4	unnamed	ASPH
GO Biological Process	GO:0051239	regulation of multicellular organismal process	142	2.372698e-1	1.000000e+0	1.000000e+0	4.214612e+0	2.372698e-1	1	2.372698e-1	1.000000e+0	136	2.076578e-1	1.000000e+0	1.000000e+0	4.551211e+0	2.197217e-1	1	1982	5.000000e-1	5.045409e-4	unnamed	ASPH
GO Biological Process	GO:0009653	anatomical structure morphogenesis	143	2.467616e-1	1.000000e+0	1.000000e+0	4.052494e+0	2.467616e-1	1	2.467616e-1	1.000000e+0	134	1.993468e-1	1.000000e+0	1.000000e+0	4.752634e+0	2.104096e-1	1	1898	5.000000e-1	5.268704e-4	unnamed	ASPH
GO Biological Process	GO:0010646	regulation of cell communication	144	2.469539e-1	1.000000e+0	1.000000e+0	4.049338e+0	2.469539e-1	1	2.469539e-1	1.000000e+0	146	2.372763e-1	1.000000e+0	1.000000e+0	3.947702e+0	2.533119e-1	1	2285	5.000000e-1	4.376368e-4	unnamed	ASPH
GO Biological Process	GO:0023051	regulation of signaling	145	2.471337e-1	1.000000e+0	1.000000e+0	4.046392e+0	2.471337e-1	1	2.471337e-1	1.000000e+0	145	2.369858e-1	1.000000e+0	1.000000e+0	3.952892e+0	2.529793e-1	1	2282	5.000000e-1	4.382121e-4	unnamed	ASPH
GO Biological Process	GO:0044710	single-organism metabolic process	146	2.517961e-1	1.000000e+0	1.000000e+0	3.971468e+0	2.517961e-1	1	2.517961e-1	1.000000e+0	153	3.105584e-1	1.000000e+0	1.000000e+0	2.946913e+0	3.393382e-1	1	3061	5.000000e-1	3.266906e-4	unnamed	ASPH
GO Biological Process	GO:0044267	cellular protein metabolic process	147	2.533433e-1	1.000000e+0	1.000000e+0	3.947214e+0	2.533433e-1	1	2.533433e-1	1.000000e+0	151	2.989111e-1	1.000000e+0	1.000000e+0	3.073424e+0	3.253700e-1	1	2935	5.000000e-1	3.407155e-4	unnamed	ASPH
GO Biological Process	GO:0048583	regulation of response to stimulus	148	2.696284e-1	1.000000e+0	1.000000e+0	3.708809e+0	2.696284e-1	1	2.696284e-1	1.000000e+0	149	2.749464e-1	1.000000e+0	1.000000e+0	3.367115e+0	2.969902e-1	1	2679	5.000000e-1	3.732736e-4	unnamed	ASPH
GO Biological Process	GO:0065008	regulation of biological quality	149	2.713082e-1	1.000000e+0	1.000000e+0	3.685845e+0	2.713082e-1	1	2.713082e-1	1.000000e+0	150	2.887566e-1	1.000000e+0	1.000000e+0	3.191967e+0	3.132864e-1	1	2826	5.000000e-1	3.538570e-4	unnamed	ASPH
GO Biological Process	GO:0006810	transport	150	2.770578e-1	1.000000e+0	1.000000e+0	3.609355e+0	2.770578e-1	1	2.770578e-1	1.000000e+0	81	3.272428e-2	1.000000e+0	1.000000e+0	5.527267e+0	3.618425e-1	2	3264	1.000000e+0	6.127451e-4	unnamed	ASPH,CLVS1
GO Biological Process	GO:0051234	establishment of localization	151	2.827781e-1	1.000000e+0	1.000000e+0	3.536342e+0	2.827781e-1	1	2.827781e-1	1.000000e+0	82	3.373470e-2	1.000000e+0	1.000000e+0	5.443874e+0	3.673854e-1	2	3314	1.000000e+0	6.035003e-4	unnamed	ASPH,CLVS1
GO Biological Process	GO:0042221	response to chemical stimulus	152	2.954524e-1	1.000000e+0	1.000000e+0	3.384640e+0	2.954524e-1	1	2.954524e-1	1.000000e+0	157	3.326549e-1	1.000000e+0	1.000000e+0	2.731002e+0	3.661660e-1	1	3303	5.000000e-1	3.027551e-4	unnamed	ASPH
GO Biological Process	GO:0019538	protein metabolic process	153	2.975455e-1	1.000000e+0	1.000000e+0	3.360830e+0	2.975455e-1	1	2.975455e-1	1.000000e+0	162	3.508235e-1	1.000000e+0	1.000000e+0	2.573609e+0	3.885594e-1	1	3505	5.000000e-1	2.853067e-4	unnamed	ASPH
GO Biological Process	GO:0006355	regulation of transcription, DNA-dependent	154	3.043461e-1	1.000000e+0	1.000000e+0	3.285733e+0	3.043461e-1	1	3.043461e-1	1.000000e+0	155	3.260273e-1	1.000000e+0	1.000000e+0	2.792724e+0	3.580733e-1	1	3230	5.000000e-1	3.095975e-4	unnamed	ASPH
GO Biological Process	GO:2001141	regulation of RNA biosynthetic process	155	3.046463e-1	1.000000e+0	1.000000e+0	3.282495e+0	3.046463e-1	1	3.046463e-1	1.000000e+0	156	3.275736e-1	1.000000e+0	1.000000e+0	2.778103e+0	3.599579e-1	1	3247	5.000000e-1	3.079766e-4	unnamed	ASPH
GO Biological Process	GO:0051252	regulation of RNA metabolic process	156	3.113245e-1	1.000000e+0	1.000000e+0	3.212082e+0	3.113245e-1	1	3.113245e-1	1.000000e+0	160	3.336507e-1	1.000000e+0	1.000000e+0	2.721937e+0	3.673854e-1	1	3314	5.000000e-1	3.017502e-4	unnamed	ASPH
GO Biological Process	GO:0048523	negative regulation of cellular process	157	3.146568e-1	1.000000e+0	1.000000e+0	3.178065e+0	3.146568e-1	1	3.146568e-1	1.000000e+0	152	3.089005e-1	1.000000e+0	1.000000e+0	2.964344e+0	3.373427e-1	1	3043	5.000000e-1	3.286231e-4	unnamed	ASPH
GO Biological Process	GO:2000112	regulation of cellular macromolecule biosynthetic process	158	3.236874e-1	1.000000e+0	1.000000e+0	3.089400e+0	3.236874e-1	1	3.236874e-1	1.000000e+0	162	3.508235e-1	1.000000e+0	1.000000e+0	2.573609e+0	3.885594e-1	1	3505	5.000000e-1	2.853067e-4	unnamed	ASPH
GO Biological Process	GO:0010556	regulation of macromolecule biosynthetic process	159	3.285042e-1	1.000000e+0	1.000000e+0	3.044101e+0	3.285042e-1	1	3.285042e-1	1.000000e+0	164	3.578608e-1	1.000000e+0	1.000000e+0	2.516881e+0	3.973172e-1	1	3584	5.000000e-1	2.790179e-4	unnamed	ASPH
GO Biological Process	GO:0048519	negative regulation of biological process	160	3.368683e-1	1.000000e+0	1.000000e+0	2.968519e+0	3.368683e-1	1	3.368683e-1	1.000000e+0	161	3.341936e-1	1.000000e+0	1.000000e+0	2.717018e+0	3.680506e-1	1	3320	5.000000e-1	3.012048e-4	unnamed	ASPH
GO Biological Process	GO:0048522	positive regulation of cellular process	161	3.411192e-1	1.000000e+0	1.000000e+0	2.931526e+0	3.411192e-1	1	3.411192e-1	1.000000e+0	158	3.331076e-1	1.000000e+0	1.000000e+0	2.726874e+0	3.667202e-1	1	3308	5.000000e-1	3.022975e-4	unnamed	ASPH
GO Biological Process	GO:0031326	regulation of cellular biosynthetic process	162	3.434354e-1	1.000000e+0	1.000000e+0	2.911756e+0	3.434354e-1	1	3.434354e-1	1.000000e+0	166	3.710294e-1	1.000000e+0	1.000000e+0	2.416421e+0	4.138352e-1	1	3733	5.000000e-1	2.678811e-4	unnamed	ASPH
GO Biological Process	GO:0010468	regulation of gene expression	163	3.434880e-1	1.000000e+0	1.000000e+0	2.911310e+0	3.434880e-1	1	3.434880e-1	1.000000e+0	167	3.723475e-1	1.000000e+0	1.000000e+0	2.406750e+0	4.154980e-1	1	3748	5.000000e-1	2.668090e-4	unnamed	ASPH
GO Biological Process	GO:0009889	regulation of biosynthetic process	164	3.455319e-1	1.000000e+0	1.000000e+0	2.894089e+0	3.455319e-1	1	3.455319e-1	1.000000e+0	168	3.736643e-1	1.000000e+0	1.000000e+0	2.397157e+0	4.171609e-1	1	3763	5.000000e-1	2.657454e-4	unnamed	ASPH
GO Biological Process	GO:0051179	localization	165	3.597525e-1	1.000000e+0	1.000000e+0	2.779689e+0	3.597525e-1	1	3.597525e-1	1.000000e+0	93	4.993858e-2	1.000000e+0	1.000000e+0	4.474454e+0	4.469819e-1	2	4032	1.000000e+0	4.960317e-4	unnamed	ASPH,CLVS1
GO Biological Process	GO:0019219	regulation of nucleobase-containing compound metabolic process	166	3.657269e-1	1.000000e+0	1.000000e+0	2.734281e+0	3.657269e-1	1	3.657269e-1	1.000000e+0	171	3.879706e-1	1.000000e+0	1.000000e+0	2.297046e+0	4.353417e-1	1	3927	5.000000e-1	2.546473e-4	unnamed	ASPH
GO Biological Process	GO:0051171	regulation of nitrogen compound metabolic process	167	3.708892e-1	1.000000e+0	1.000000e+0	2.696223e+0	3.708892e-1	1	3.708892e-1	1.000000e+0	173	3.955790e-1	1.000000e+0	1.000000e+0	2.246700e+0	4.450973e-1	1	4015	5.000000e-1	2.490660e-4	unnamed	ASPH
GO Biological Process	GO:0048518	positive regulation of biological process	168	3.729968e-1	1.000000e+0	1.000000e+0	2.680988e+0	3.729968e-1	1	3.729968e-1	1.000000e+0	165	3.689175e-1	1.000000e+0	1.000000e+0	2.432057e+0	4.111745e-1	1	3709	5.000000e-1	2.696145e-4	unnamed	ASPH
GO Biological Process	GO:0044767	single-organism developmental process	169	3.730678e-1	1.000000e+0	1.000000e+0	2.680478e+0	3.730678e-1	1	3.730678e-1	1.000000e+0	158	3.331076e-1	1.000000e+0	1.000000e+0	2.726874e+0	3.667202e-1	1	3308	5.000000e-1	3.022975e-4	unnamed	ASPH
GO Biological Process	GO:0016043	cellular component organization	170	3.831577e-1	1.000000e+0	1.000000e+0	2.609891e+0	3.831577e-1	1	3.831577e-1	1.000000e+0	174	3.965267e-1	1.000000e+0	1.000000e+0	2.240561e+0	4.463167e-1	1	4026	5.000000e-1	2.483855e-4	unnamed	CLVS1
GO Biological Process	GO:0071840	cellular component organization or biogenesis	171	3.897194e-1	1.000000e+0	1.000000e+0	2.565949e+0	3.897194e-1	1	3.897194e-1	1.000000e+0	175	4.070731e-1	1.000000e+0	1.000000e+0	2.174138e+0	4.599523e-1	1	4149	5.000000e-1	2.410219e-4	unnamed	CLVS1
GO Biological Process	GO:0007165	signal transduction	172	3.912589e-1	1.000000e+0	1.000000e+0	2.555852e+0	3.912589e-1	1	3.912589e-1	1.000000e+0	176	4.201465e-1	1.000000e+0	1.000000e+0	2.096328e+0	4.770246e-1	1	4303	5.000000e-1	2.323960e-4	unnamed	ASPH
GO Biological Process	GO:0060255	regulation of macromolecule metabolic process	173	4.100897e-1	1.000000e+0	1.000000e+0	2.438491e+0	4.100897e-1	1	4.100897e-1	1.000000e+0	178	4.477526e-1	1.000000e+0	1.000000e+0	1.946590e+0	5.137188e-1	1	4634	5.000000e-1	2.157963e-4	unnamed	ASPH
GO Biological Process	GO:0048856	anatomical structure development	174	4.234725e-1	1.000000e+0	1.000000e+0	2.361429e+0	4.234725e-1	1	4.234725e-1	1.000000e+0	170	3.845834e-1	1.000000e+0	1.000000e+0	2.320087e+0	4.310182e-1	1	3888	5.000000e-1	2.572016e-4	unnamed	ASPH
GO Biological Process	GO:0007275	multicellular organismal development	175	4.357034e-1	1.000000e+0	1.000000e+0	2.295139e+0	4.357034e-1	1	4.357034e-1	1.000000e+0	172	3.919536e-1	1.000000e+0	1.000000e+0	2.270451e+0	4.404412e-1	1	3973	5.000000e-1	2.516990e-4	unnamed	ASPH
GO Biological Process	GO:0080090	regulation of primary metabolic process	176	4.363900e-1	1.000000e+0	1.000000e+0	2.291528e+0	4.363900e-1	1	4.363900e-1	1.000000e+0	181	4.714664e-1	1.000000e+0	1.000000e+0	1.831574e+0	5.459786e-1	1	4925	5.000000e-1	2.030457e-4	unnamed	ASPH
GO Biological Process	GO:0044700	single organism signaling	177	4.371810e-1	1.000000e+0	1.000000e+0	2.287382e+0	4.371810e-1	1	4.371810e-1	1.000000e+0	179	4.576762e-1	1.000000e+0	1.000000e+0	1.897056e+0	5.271326e-1	1	4755	5.000000e-1	2.103049e-4	unnamed	ASPH
GO Biological Process	GO:0031323	regulation of cellular metabolic process	178	4.406599e-1	1.000000e+0	1.000000e+0	2.269324e+0	4.406599e-1	1	4.406599e-1	1.000000e+0	182	4.760505e-1	1.000000e+0	1.000000e+0	1.810618e+0	5.522975e-1	1	4982	5.000000e-1	2.007226e-4	unnamed	ASPH
GO Biological Process	GO:0007154	cell communication	179	4.446638e-1	1.000000e+0	1.000000e+0	2.248890e+0	4.446638e-1	1	4.446638e-1	1.000000e+0	180	4.676716e-1	1.000000e+0	1.000000e+0	1.849221e+0	5.407683e-1	1	4878	5.000000e-1	2.050021e-4	unnamed	ASPH
GO Biological Process	GO:0051716	cellular response to stimulus	180	4.562761e-1	1.000000e+0	1.000000e+0	2.191655e+0	4.562761e-1	1	4.562761e-1	1.000000e+0	183	5.039946e-1	1.000000e+0	1.000000e+0	1.690815e+0	5.914306e-1	1	5335	5.000000e-1	1.874414e-4	unnamed	ASPH
GO Biological Process	GO:0032502	developmental process	181	4.657420e-1	1.000000e+0	1.000000e+0	2.147111e+0	4.657420e-1	1	4.657420e-1	1.000000e+0	177	4.306509e-1	1.000000e+0	1.000000e+0	2.037150e+0	4.908819e-1	1	4428	5.000000e-1	2.258356e-4	unnamed	ASPH
GO Biological Process	GO:0019222	regulation of metabolic process	182	4.728179e-1	1.000000e+0	1.000000e+0	2.114979e+0	4.728179e-1	1	4.728179e-1	1.000000e+0	184	5.177180e-1	1.000000e+0	1.000000e+0	1.636520e+0	6.110526e-1	1	5512	5.000000e-1	1.814224e-4	unnamed	ASPH
GO Biological Process	GO:0044260	cellular macromolecule metabolic process	183	4.901841e-1	1.000000e+0	1.000000e+0	2.040050e+0	4.901841e-1	1	4.901841e-1	1.000000e+0	188	5.672657e-1	1.000000e+0	1.000000e+0	1.461283e+0	6.843301e-1	1	6173	5.000000e-1	1.619958e-4	unnamed	ASPH
GO Biological Process	GO:0043170	macromolecule metabolic process	184	5.266956e-1	1.000000e+0	1.000000e+0	1.898630e+0	5.266956e-1	1	5.266956e-1	1.000000e+0	189	6.104699e-1	1.000000e+0	1.000000e+0	1.330261e+0	7.517322e-1	1	6781	5.000000e-1	1.474709e-4	unnamed	ASPH
GO Biological Process	GO:0044707	single-multicellular organism process	185	5.372858e-1	1.000000e+0	1.000000e+0	1.861207e+0	5.372858e-1	1	5.372858e-1	1.000000e+0	185	5.291973e-1	1.000000e+0	1.000000e+0	1.593165e+0	6.276814e-1	1	5662	5.000000e-1	1.766160e-4	unnamed	ASPH
GO Biological Process	GO:0050896	response to stimulus	186	5.533212e-1	1.000000e+0	1.000000e+0	1.807268e+0	5.533212e-1	1	5.533212e-1	1.000000e+0	190	6.177696e-1	1.000000e+0	1.000000e+0	1.309787e+0	7.634832e-1	1	6887	5.000000e-1	1.452011e-4	unnamed	ASPH
GO Biological Process	GO:0032501	multicellular organismal process	187	5.539872e-1	1.000000e+0	1.000000e+0	1.805096e+0	5.539872e-1	1	5.539872e-1	1.000000e+0	186	5.461571e-1	1.000000e+0	1.000000e+0	1.532275e+0	6.526246e-1	1	5887	5.000000e-1	1.698658e-4	unnamed	ASPH
GO Biological Process	GO:0044237	cellular metabolic process	188	6.001923e-1	1.000000e+0	1.000000e+0	1.666133e+0	6.001923e-1	1	6.001923e-1	1.000000e+0	191	7.045181e-1	1.000000e+0	1.000000e+0	1.095519e+0	9.128097e-1	1	8234	5.000000e-1	1.214477e-4	unnamed	ASPH
GO Biological Process	GO:0044238	primary metabolic process	189	6.053666e-1	1.000000e+0	1.000000e+0	1.651892e+0	6.053666e-1	1	6.053666e-1	1.000000e+0	192	7.093792e-1	1.000000e+0	1.000000e+0	1.084847e+0	9.217893e-1	1	8315	5.000000e-1	1.202646e-4	unnamed	ASPH
GO Biological Process	GO:0071704	organic substance metabolic process	190	6.199145e-1	1.000000e+0	1.000000e+0	1.613126e+0	6.199145e-1	1	6.199145e-1	1.000000e+0	193	7.239536e-1	1.000000e+0	1.000000e+0	1.053551e+0	9.491713e-1	1	8562	5.000000e-1	1.167951e-4	unnamed	ASPH
GO Biological Process	GO:0008152	metabolic process	191	6.507895e-1	1.000000e+0	1.000000e+0	1.536595e+0	6.507895e-1	1	6.507895e-1	1.000000e+0	195	7.596471e-1	1.000000e+0	1.000000e+0	9.809156e-1	1.019456e+0	1	9196	5.000000e-1	1.087429e-4	unnamed	ASPH
GO Biological Process	GO:0050794	regulation of cellular process	192	6.759845e-1	1.000000e+0	1.000000e+0	1.479324e+0	6.759845e-1	1	6.759845e-1	1.000000e+0	194	7.406997e-1	1.000000e+0	1.000000e+0	1.018805e+0	9.815420e-1	1	8854	5.000000e-1	1.129433e-4	unnamed	ASPH
GO Biological Process	GO:0050789	regulation of biological process	193	6.921477e-1	1.000000e+0	1.000000e+0	1.444778e+0	6.921477e-1	1	6.921477e-1	1.000000e+0	196	7.668214e-1	1.000000e+0	1.000000e+0	9.669311e-1	1.034200e+0	1	9329	5.000000e-1	1.071926e-4	unnamed	ASPH
GO Biological Process	GO:0065007	biological regulation	194	7.151977e-1	1.000000e+0	1.000000e+0	1.398215e+0	7.151977e-1	1	7.151977e-1	1.000000e+0	197	7.940293e-1	1.000000e+0	1.000000e+0	9.155080e-1	1.092290e+0	1	9853	5.000000e-1	1.014919e-4	unnamed	ASPH
GO Biological Process	GO:0044763	single-organism cellular process	195	7.497126e-1	1.000000e+0	1.000000e+0	1.333844e+0	7.497126e-1	1	7.497126e-1	1.000000e+0	154	3.141478e-1	1.000000e+0	1.000000e+0	1.784118e+0	1.121002e+0	2	10112	1.000000e+0	1.977848e-4	unnamed	ASPH,CLVS1
GO Biological Process	GO:0044699	single-organism process	196	7.935590e-1	1.000000e+0	1.000000e+0	1.260146e+0	7.935590e-1	1	7.935590e-1	1.000000e+0	169	3.800402e-1	1.000000e+0	1.000000e+0	1.622100e+0	1.232969e+0	2	11122	1.000000e+0	1.798238e-4	unnamed	ASPH,CLVS1
GO Biological Process	GO:0009987	cellular process	197	8.656787e-1	1.000000e+0	1.000000e+0	1.155163e+0	8.656787e-1	1	8.656787e-1	1.000000e+0	187	5.606826e-1	1.000000e+0	1.000000e+0	1.335480e+0	1.497589e+0	2	13509	1.000000e+0	1.480494e-4	unnamed	ASPH,CLVS1
GO Cellular Component	GO:0032541	cortical endoplasmic reticulum	1	4.189674e-4	5.299938e-1	5.299938e-1	2.386821e+3	4.189674e-4	1	4.189674e-4	1.000000e+0	1	2.217111e-4	2.804645e-1	2.804645e-1	4.510250e+3	2.217172e-4	1	2	5.000000e-1	5.000000e-1	unnamed	ASPH
GO Cellular Component	GO:0071782	endoplasmic reticulum tubular network	2	5.071761e-4	6.415778e-1	3.207889e-1	1.971702e+3	5.071761e-4	1	5.071761e-4	1.000000e+0	2	3.325574e-4	4.206851e-1	2.103426e-1	3.006833e+3	3.325758e-4	1	3	5.000000e-1	3.333333e-1	unnamed	ASPH
GO Cellular Component	GO:0033018	sarcoplasmic reticulum lumen	3	8.737689e-4	1.000000e+0	3.684392e-1	1.144467e+3	8.737689e-4	1	8.737689e-4	1.000000e+0	3	8.866967e-4	1.000000e+0	3.738904e-1	1.127562e+3	8.868688e-4	1	8	5.000000e-1	1.250000e-1	unnamed	ASPH
GO Cellular Component	GO:0014701	junctional sarcoplasmic reticulum membrane	4	1.730773e-3	1.000000e+0	5.473570e-1	5.777764e+2	1.730773e-3	1	1.730773e-3	1.000000e+0	4	1.108309e-3	1.000000e+0	3.505027e-1	9.020500e+2	1.108586e-3	1	10	5.000000e-1	1.000000e-1	unnamed	ASPH
GO Cellular Component	GO:0033017	sarcoplasmic reticulum membrane	5	4.258822e-3	1.000000e+0	1.000000e+0	2.348067e+2	4.258822e-3	1	4.258822e-3	1.000000e+0	5	3.765745e-3	1.000000e+0	9.527335e-1	2.653088e+2	3.769192e-3	1	34	5.000000e-1	2.941176e-2	unnamed	ASPH
GO Cellular Component	GO:0016529	sarcoplasmic reticulum	6	6.649800e-3	1.000000e+0	1.000000e+0	1.503805e+2	6.649800e-3	1	6.649800e-3	1.000000e+0	7	6.088097e-3	1.000000e+0	1.000000e+0	1.640091e+2	6.097223e-3	1	55	5.000000e-1	1.818182e-2	unnamed	ASPH
GO Cellular Component	GO:0030176	integral to endoplasmic reticulum membrane	7	6.890849e-3	1.000000e+0	1.000000e+0	1.451200e+2	6.890849e-3	1	6.890849e-3	1.000000e+0	10	1.127592e-2	1.000000e+0	1.000000e+0	8.843627e+1	1.130758e-2	1	102	5.000000e-1	9.803922e-3	unnamed	ASPH
GO Cellular Component	GO:0031227	intrinsic to endoplasmic reticulum membrane	8	7.444431e-3	1.000000e+0	1.000000e+0	1.343286e+2	7.444431e-3	1	7.444431e-3	1.000000e+0	12	1.204742e-2	1.000000e+0	1.000000e+0	8.275688e+1	1.208359e-2	1	109	5.000000e-1	9.174312e-3	unnamed	ASPH
GO Cellular Component	GO:0016528	sarcoplasm	9	7.489853e-3	1.000000e+0	1.000000e+0	1.335140e+2	7.489853e-3	1	7.489853e-3	1.000000e+0	8	6.751129e-3	1.000000e+0	1.000000e+0	1.478770e+2	6.762375e-3	1	61	5.000000e-1	1.639344e-2	unnamed	ASPH
GO Cellular Component	GO:0034704	calcium channel complex	10	7.769119e-3	1.000000e+0	9.827936e-1	1.287147e+2	7.769119e-3	1	7.769119e-3	1.000000e+0	6	5.977571e-3	1.000000e+0	1.000000e+0	1.670463e+2	5.986364e-3	1	54	5.000000e-1	1.851852e-2	unnamed	ASPH
GO Cellular Component	GO:0044448	cell cortex part	11	8.936855e-3	1.000000e+0	1.000000e+0	1.118962e+2	8.936855e-3	1	8.936855e-3	1.000000e+0	10	1.127592e-2	1.000000e+0	1.000000e+0	8.843627e+1	1.130758e-2	1	102	5.000000e-1	9.803922e-3	unnamed	ASPH
GO Cellular Component	GO:0031901	early endosome membrane	12	9.475949e-3	1.000000e+0	9.989230e-1	1.055303e+2	9.475949e-3	1	9.475949e-3	1.000000e+0	9	9.621709e-3	1.000000e+0	1.000000e+0	1.036839e+2	9.644698e-3	1	87	5.000000e-1	1.149425e-2	unnamed	CLVS1
GO Cellular Component	GO:0005802	trans-Golgi network	13	1.164606e-2	1.000000e+0	1.000000e+0	8.586594e+1	1.164606e-2	1	1.164606e-2	1.000000e+0	13	1.369960e-2	1.000000e+0	1.000000e+0	7.274597e+1	1.374647e-2	1	124	5.000000e-1	8.064516e-3	unnamed	CLVS1
GO Cellular Component	GO:0005788	endoplasmic reticulum lumen	14	1.603023e-2	1.000000e+0	1.000000e+0	6.238214e+1	1.603023e-2	1	1.603023e-2	1.000000e+0	15	1.941648e-2	1.000000e+0	1.000000e+0	5.125284e+1	1.951111e-2	1	176	5.000000e-1	5.681818e-3	unnamed	ASPH
GO Cellular Component	GO:0031301	integral to organelle membrane	15	1.662657e-2	1.000000e+0	1.000000e+0	6.014471e+1	1.662657e-2	1	1.662657e-2	1.000000e+0	18	2.259752e-2	1.000000e+0	1.000000e+0	4.400244e+1	2.272601e-2	1	205	5.000000e-1	4.878049e-3	unnamed	ASPH
GO Cellular Component	GO:0031300	intrinsic to organelle membrane	16	1.765472e-2	1.000000e+0	1.000000e+0	5.664208e+1	1.765472e-2	1	1.765472e-2	1.000000e+0	21	2.391230e-2	1.000000e+0	1.000000e+0	4.156912e+1	2.405632e-2	1	217	5.000000e-1	4.608295e-3	unnamed	ASPH
GO Cellular Component	GO:0034703	cation channel complex	17	2.098342e-2	1.000000e+0	1.000000e+0	4.765668e+1	2.098342e-2	1	2.098342e-2	1.000000e+0	14	1.590037e-2	1.000000e+0	1.000000e+0	6.264236e+1	1.596364e-2	1	144	5.000000e-1	6.944444e-3	unnamed	ASPH
GO Cellular Component	GO:0005769	early endosome	18	2.101225e-2	1.000000e+0	1.000000e+0	4.759130e+1	2.101225e-2	1	2.101225e-2	1.000000e+0	20	2.347414e-2	1.000000e+0	1.000000e+0	4.234977e+1	2.361288e-2	1	213	5.000000e-1	4.694836e-3	unnamed	CLVS1
GO Cellular Component	GO:0005938	cell cortex	19	2.279802e-2	1.000000e+0	1.000000e+0	4.386345e+1	2.279802e-2	1	2.279802e-2	1.000000e+0	19	2.303588e-2	1.000000e+0	1.000000e+0	4.316029e+1	2.316945e-2	1	209	5.000000e-1	4.784689e-3	unnamed	ASPH
GO Cellular Component	GO:0030136	clathrin-coated vesicle	20	2.363000e-2	1.000000e+0	1.000000e+0	4.231909e+1	2.363000e-2	1	2.363000e-2	1.000000e+0	17	2.237830e-2	1.000000e+0	1.000000e+0	4.443596e+1	2.250430e-2	1	203	5.000000e-1	4.926108e-3	unnamed	CLVS1
GO Cellular Component	GO:0030135	coated vesicle	21	2.701547e-2	1.000000e+0	1.000000e+0	3.701582e+1	2.701547e-2	1	2.701547e-2	1.000000e+0	23	2.763270e-2	1.000000e+0	1.000000e+0	3.593825e+1	2.782551e-2	1	251	5.000000e-1	3.984064e-3	unnamed	CLVS1
GO Cellular Component	GO:0010008	endosome membrane	22	3.045322e-2	1.000000e+0	1.000000e+0	3.283725e+1	3.045322e-2	1	3.045322e-2	1.000000e+0	24	3.635858e-2	1.000000e+0	1.000000e+0	2.725227e+1	3.669420e-2	1	331	5.000000e-1	3.021148e-3	unnamed	CLVS1
GO Cellular Component	GO:0044440	endosomal part	23	3.120904e-2	1.000000e+0	1.000000e+0	3.204200e+1	3.120904e-2	1	3.120904e-2	1.000000e+0	25	3.733778e-2	1.000000e+0	1.000000e+0	2.653088e+1	3.769192e-2	1	340	5.000000e-1	2.941176e-3	unnamed	CLVS1
GO Cellular Component	GO:0034702	ion channel complex	24	3.762356e-2	1.000000e+0	1.000000e+0	2.657909e+1	3.762356e-2	1	3.762356e-2	1.000000e+0	22	2.697668e-2	1.000000e+0	1.000000e+0	3.681837e+1	2.716036e-2	1	245	5.000000e-1	4.081633e-3	unnamed	ASPH
GO Cellular Component	GO:0005768	endosome	25	5.727050e-2	1.000000e+0	1.000000e+0	1.746100e+1	5.727050e-2	1	5.727050e-2	1.000000e+0	26	6.562521e-2	1.000000e+0	1.000000e+0	1.498422e+1	6.673688e-2	1	602	5.000000e-1	1.661130e-3	unnamed	CLVS1
GO Cellular Component	GO:0005789	endoplasmic reticulum membrane	26	6.490642e-2	1.000000e+0	1.000000e+0	1.540680e+1	6.490642e-2	1	6.490642e-2	1.000000e+0	27	8.534508e-2	1.000000e+0	1.000000e+0	1.146188e+1	8.724572e-2	1	787	5.000000e-1	1.270648e-3	unnamed	ASPH
GO Cellular Component	GO:0042175	nuclear outer membrane-endoplasmic reticulum membrane network	27	6.714499e-2	1.000000e+0	1.000000e+0	1.489314e+1	6.714499e-2	1	6.714499e-2	1.000000e+0	28	8.735845e-2	1.000000e+0	1.000000e+0	1.119169e+1	8.935203e-2	1	806	5.000000e-1	1.240695e-3	unnamed	ASPH
GO Cellular Component	GO:0044432	endoplasmic reticulum part	28	7.857548e-2	1.000000e+0	1.000000e+0	1.272662e+1	7.857548e-2	1	7.857548e-2	1.000000e+0	30	1.014950e-1	1.000000e+0	1.000000e+0	9.596277e+0	1.042071e-1	1	940	5.000000e-1	1.063830e-3	unnamed	ASPH
GO Cellular Component	GO:0016023	cytoplasmic membrane-bounded vesicle	29	8.772555e-2	1.000000e+0	1.000000e+0	1.139919e+1	8.772555e-2	1	8.772555e-2	1.000000e+0	29	9.949731e-2	1.000000e+0	1.000000e+0	9.794245e+0	1.021008e-1	1	921	5.000000e-1	1.085776e-3	unnamed	CLVS1
GO Cellular Component	GO:0031988	membrane-bounded vesicle	30	9.310199e-2	1.000000e+0	1.000000e+0	1.074091e+1	9.310199e-2	1	9.310199e-2	1.000000e+0	31	1.061128e-1	1.000000e+0	1.000000e+0	9.167175e+0	1.090849e-1	1	984	5.000000e-1	1.016260e-3	unnamed	CLVS1
GO Cellular Component	GO:0031410	cytoplasmic vesicle	31	9.330829e-2	1.000000e+0	1.000000e+0	1.071716e+1	9.330829e-2	1	9.330829e-2	1.000000e+0	32	1.070559e-1	1.000000e+0	1.000000e+0	9.084089e+0	1.100826e-1	1	993	5.000000e-1	1.007049e-3	unnamed	CLVS1
GO Cellular Component	GO:0031982	vesicle	32	1.007261e-1	1.000000e+0	1.000000e+0	9.927917e+0	1.007261e-1	1	1.007261e-1	1.000000e+0	33	1.159383e-1	1.000000e+0	1.000000e+0	8.367811e+0	1.195056e-1	1	1078	5.000000e-1	9.276438e-4	unnamed	CLVS1
GO Cellular Component	GO:0005783	endoplasmic reticulum	33	1.167593e-1	1.000000e+0	1.000000e+0	8.564628e+0	1.167593e-1	1	1.167593e-1	1.000000e+0	37	1.436532e-1	1.000000e+0	1.000000e+0	6.701709e+0	1.492157e-1	1	1346	5.000000e-1	7.429421e-4	unnamed	ASPH
GO Cellular Component	GO:0005794	Golgi apparatus	34	1.250692e-1	1.000000e+0	1.000000e+0	7.995574e+0	1.250692e-1	1	1.250692e-1	1.000000e+0	35	1.300577e-1	1.000000e+0	1.000000e+0	7.430395e+0	1.345823e-1	1	1214	5.000000e-1	8.237232e-4	unnamed	CLVS1
GO Cellular Component	GO:0012505	endomembrane system	35	1.513815e-1	1.000000e+0	1.000000e+0	6.605825e+0	1.513815e-1	1	1.513815e-1	1.000000e+0	39	1.741537e-1	1.000000e+0	1.000000e+0	5.480255e+0	1.824733e-1	1	1646	5.000000e-1	6.075334e-4	unnamed	ASPH
GO Cellular Component	GO:0031090	organelle membrane	36	2.131131e-1	1.000000e+0	1.000000e+0	4.692344e+0	2.131131e-1	1	2.131131e-1	1.000000e+0	16	2.034938e-2	1.000000e+0	1.000000e+0	7.008936e+0	2.853500e-1	2	2574	1.000000e+0	7.770008e-4	unnamed	ASPH,CLVS1
GO Cellular Component	GO:0070013	intracellular organelle lumen	37	2.178720e-1	1.000000e+0	1.000000e+0	4.589852e+0	2.178720e-1	1	2.178720e-1	1.000000e+0	42	2.759844e-1	1.000000e+0	1.000000e+0	3.353346e+0	2.982096e-1	1	2690	5.000000e-1	3.717472e-4	unnamed	ASPH
GO Cellular Component	GO:0043233	organelle lumen	38	2.231770e-1	1.000000e+0	1.000000e+0	4.480748e+0	2.231770e-1	1	2.231770e-1	1.000000e+0	43	2.816332e-1	1.000000e+0	1.000000e+0	3.280182e+0	3.048611e-1	1	2750	5.000000e-1	3.636364e-4	unnamed	ASPH
GO Cellular Component	GO:0031974	membrane-enclosed lumen	39	2.255118e-1	1.000000e+0	1.000000e+0	4.434357e+0	2.255118e-1	1	2.255118e-1	1.000000e+0	44	2.863237e-1	1.000000e+0	1.000000e+0	3.221607e+0	3.104041e-1	1	2800	5.000000e-1	3.571429e-4	unnamed	ASPH
GO Cellular Component	GO:0043234	protein complex	40	3.027166e-1	1.000000e+0	1.000000e+0	3.303419e+0	3.027166e-1	1	3.027166e-1	1.000000e+0	47	3.630030e-1	1.000000e+0	1.000000e+0	2.476798e+0	4.037470e-1	1	3642	5.000000e-1	2.745744e-4	unnamed	ASPH
GO Cellular Component	GO:0032991	macromolecular complex	41	3.347910e-1	1.000000e+0	1.000000e+0	2.986938e+0	3.347910e-1	1	3.347910e-1	1.000000e+0	50	4.132884e-1	1.000000e+0	1.000000e+0	2.136547e+0	4.680450e-1	1	4222	5.000000e-1	2.368546e-4	unnamed	ASPH
GO Cellular Component	GO:0005886	plasma membrane	42	4.126577e-1	1.000000e+0	1.000000e+0	2.423316e+0	4.126577e-1	1	4.126577e-1	1.000000e+0	51	4.264607e-1	1.000000e+0	1.000000e+0	2.060416e+0	4.853390e-1	1	4378	5.000000e-1	2.284148e-4	unnamed	ASPH
GO Cellular Component	GO:0071944	cell periphery	43	4.194602e-1	1.000000e+0	1.000000e+0	2.384017e+0	4.194602e-1	1	4.194602e-1	1.000000e+0	52	4.347424e-1	1.000000e+0	1.000000e+0	2.014854e+0	4.963140e-1	1	4477	5.000000e-1	2.233639e-4	unnamed	ASPH
GO Cellular Component	GO:0016021	integral to membrane	44	4.578656e-1	1.000000e+0	1.000000e+0	2.184047e+0	4.578656e-1	1	4.578656e-1	1.000000e+0	54	4.982001e-1	1.000000e+0	1.000000e+0	1.714598e+0	5.832271e-1	1	5261	5.000000e-1	1.900779e-4	unnamed	ASPH
GO Cellular Component	GO:0031224	intrinsic to membrane	45	4.694206e-1	1.000000e+0	1.000000e+0	2.130286e+0	4.694206e-1	1	4.694206e-1	1.000000e+0	56	5.070350e-1	1.000000e+0	1.000000e+0	1.678545e+0	5.957541e-1	1	5374	5.000000e-1	1.860811e-4	unnamed	ASPH
GO Cellular Component	GO:0044446	intracellular organelle part	46	4.732075e-1	1.000000e+0	1.000000e+0	2.113238e+0	4.732075e-1	1	4.732075e-1	1.000000e+0	34	1.292379e-1	1.000000e+0	1.000000e+0	2.781529e+0	7.190289e-1	2	6486	1.000000e+0	3.083565e-4	unnamed	ASPH,CLVS1
GO Cellular Component	GO:0044422	organelle part	47	4.814989e-1	1.000000e+0	1.000000e+0	2.076848e+0	4.814989e-1	1	4.814989e-1	1.000000e+0	36	1.337401e-1	1.000000e+0	1.000000e+0	2.734313e+0	7.314450e-1	2	6598	1.000000e+0	3.031222e-4	unnamed	ASPH,CLVS1
GO Cellular Component	GO:0044444	cytoplasmic part	48	5.199381e-1	1.000000e+0	1.000000e+0	1.923306e+0	5.199381e-1	1	5.199381e-1	1.000000e+0	38	1.519576e-1	1.000000e+0	1.000000e+0	2.565193e+0	7.796685e-1	2	7033	1.000000e+0	2.843737e-4	unnamed	ASPH,CLVS1
GO Cellular Component	GO:0044425	membrane part	49	5.293034e-1	1.000000e+0	1.000000e+0	1.889276e+0	5.293034e-1	1	5.293034e-1	1.000000e+0	57	5.687230e-1	1.000000e+0	1.000000e+0	1.456564e+0	6.865473e-1	1	6193	5.000000e-1	1.614726e-4	unnamed	ASPH
GO Cellular Component	GO:0016020	membrane	50	6.308744e-1	1.000000e+0	1.000000e+0	1.585102e+0	6.308744e-1	1	6.308744e-1	1.000000e+0	40	1.895088e-1	1.000000e+0	1.000000e+0	2.297046e+0	8.706834e-1	2	7854	1.000000e+0	2.546473e-4	unnamed	ASPH,CLVS1
GO Cellular Component	GO:0005737	cytoplasm	51	6.734732e-1	1.000000e+0	1.000000e+0	1.484840e+0	6.734732e-1	1	6.734732e-1	1.000000e+0	41	2.746502e-1	1.000000e+0	1.000000e+0	1.908091e+0	1.048168e+0	2	9455	1.000000e+0	2.115283e-4	unnamed	ASPH,CLVS1
GO Cellular Component	GO:0043231	intracellular membrane-bounded organelle	52	6.973299e-1	1.000000e+0	1.000000e+0	1.434041e+0	6.973299e-1	1	6.973299e-1	1.000000e+0	45	3.079649e-1	1.000000e+0	1.000000e+0	1.801938e+0	1.109916e+0	2	10012	1.000000e+0	1.997603e-4	unnamed	ASPH,CLVS1
GO Cellular Component	GO:0043227	membrane-bounded organelle	53	6.992039e-1	1.000000e+0	1.000000e+0	1.430198e+0	6.992039e-1	1	6.992039e-1	1.000000e+0	46	3.100602e-1	1.000000e+0	1.000000e+0	1.795839e+0	1.113685e+0	2	10046	1.000000e+0	1.990842e-4	unnamed	ASPH,CLVS1
GO Cellular Component	GO:0043229	intracellular organelle	54	7.399473e-1	1.000000e+0	1.000000e+0	1.351448e+0	7.399473e-1	1	7.399473e-1	1.000000e+0	48	3.712075e-1	1.000000e+0	1.000000e+0	1.641285e+0	1.218558e+0	2	10992	1.000000e+0	1.819505e-4	unnamed	ASPH,CLVS1
GO Cellular Component	GO:0043226	organelle	55	7.415866e-1	1.000000e+0	1.000000e+0	1.348460e+0	7.415866e-1	1	7.415866e-1	1.000000e+0	49	3.733721e-1	1.000000e+0	1.000000e+0	1.636520e+0	1.222105e+0	2	11024	1.000000e+0	1.814224e-4	unnamed	ASPH,CLVS1
GO Cellular Component	GO:0044424	intracellular part	56	8.017695e-1	1.000000e+0	1.000000e+0	1.247241e+0	8.017695e-1	1	8.017695e-1	1.000000e+0	53	4.860618e-1	1.000000e+0	1.000000e+0	1.434330e+0	1.394379e+0	2	12578	1.000000e+0	1.590078e-4	unnamed	ASPH,CLVS1
GO Cellular Component	GO:0005622	intracellular	57	8.064789e-1	1.000000e+0	1.000000e+0	1.239958e+0	8.064789e-1	1	8.064789e-1	1.000000e+0	55	4.992900e-1	1.000000e+0	1.000000e+0	1.415202e+0	1.413225e+0	2	12748	1.000000e+0	1.568874e-4	unnamed	ASPH,CLVS1
GO Cellular Component	GO:0044464	cell part	58	8.908971e-1	1.000000e+0	1.000000e+0	1.122464e+0	8.908971e-1	1	8.908971e-1	1.000000e+0	58	6.728810e-1	1.000000e+0	1.000000e+0	1.219069e+0	1.640596e+0	2	14799	1.000000e+0	1.351443e-4	unnamed	ASPH,CLVS1
GO Cellular Component	GO:0005623	cell	59	8.910977e-1	1.000000e+0	1.000000e+0	1.122211e+0	8.910977e-1	1	8.910977e-1	1.000000e+0	59	6.729719e-1	1.000000e+0	1.000000e+0	1.218986e+0	1.640707e+0	2	14800	1.000000e+0	1.351351e-4	unnamed	ASPH,CLVS1
Mouse Phenotype	MP:0008950	ventricular tachycardia	1	2.607116e-3	1.000000e+0	1.000000e+0	3.835656e+2	2.607116e-3	1	2.607116e-3	1.000000e+0	1	1.440682e-3	1.000000e+0	1.000000e+0	6.938846e+2	1.441162e-3	1	13	5.000000e-1	7.692308e-2	unnamed	ASPH
Mouse Phenotype	MP:0005599	increased cardiac muscle contractility	2	5.258435e-3	1.000000e+0	1.000000e+0	1.901706e+2	5.258435e-3	1	5.258435e-3	1.000000e+0	2	3.876395e-3	1.000000e+0	1.000000e+0	2.577286e+2	3.880051e-3	1	35	5.000000e-1	2.857143e-2	unnamed	ASPH
Mouse Phenotype	MP:0006141	abnormal atrioventricular node conduction	3	6.627189e-3	1.000000e+0	1.000000e+0	1.508935e+2	6.627189e-3	1	6.627189e-3	1.000000e+0	3	5.424845e-3	1.000000e+0	1.000000e+0	1.840918e+2	5.432071e-3	1	49	5.000000e-1	2.040816e-2	unnamed	ASPH
Mouse Phenotype	MP:0010279	increased gastrointestinal tumor incidence	4	9.719407e-3	1.000000e+0	1.000000e+0	1.028869e+2	9.719407e-3	1	9.719407e-3	1.000000e+0	7	1.116569e-2	1.000000e+0	1.000000e+0	8.931188e+1	1.119672e-2	1	101	5.000000e-1	9.900990e-3	unnamed	ASPH
Mouse Phenotype	MP:0002626	increased heart rate	5	9.950567e-3	1.000000e+0	1.000000e+0	1.004968e+2	9.950567e-3	1	9.950567e-3	1.000000e+0	4	7.193027e-3	1.000000e+0	1.000000e+0	1.387769e+2	7.205809e-3	1	65	5.000000e-1	1.538462e-2	unnamed	ASPH
Mouse Phenotype	MP:0010292	increased alimentary system tumor incidence	6	1.051172e-2	1.000000e+0	1.000000e+0	9.513187e+1	1.051172e-2	1	1.051172e-2	1.000000e+0	9	1.259830e-2	1.000000e+0	1.000000e+0	7.912719e+1	1.263788e-2	1	114	5.000000e-1	8.771930e-3	unnamed	ASPH
Mouse Phenotype	MP:0004484	altered response of heart to induced stress	7	1.177259e-2	1.000000e+0	1.000000e+0	8.494304e+1	1.177259e-2	1	1.177259e-2	1.000000e+0	5	8.959636e-3	1.000000e+0	1.000000e+0	1.113642e+2	8.979547e-3	1	81	5.000000e-1	1.234568e-2	unnamed	ASPH
Mouse Phenotype	MP:0003137	abnormal impulse conducting system conduction	8	1.408524e-2	1.000000e+0	1.000000e+0	7.099632e+1	1.408524e-2	1	1.408524e-2	1.000000e+0	6	1.072467e-2	1.000000e+0	1.000000e+0	9.299485e+1	1.075328e-2	1	97	5.000000e-1	1.030928e-2	unnamed	ASPH
Mouse Phenotype	MP:0004215	abnormal myocardial fiber physiology	9	1.874220e-2	1.000000e+0	1.000000e+0	5.335553e+1	1.874220e-2	1	1.874220e-2	1.000000e+0	11	1.480029e-2	1.000000e+0	1.000000e+0	6.731716e+1	1.485505e-2	1	134	5.000000e-1	7.462687e-3	unnamed	ASPH
Mouse Phenotype	MP:0000564	syndactyly	10	1.895436e-2	1.000000e+0	1.000000e+0	5.275830e+1	1.895436e-2	1	1.895436e-2	1.000000e+0	8	1.204742e-2	1.000000e+0	1.000000e+0	8.275688e+1	1.208359e-2	1	109	5.000000e-1	9.174312e-3	unnamed	ASPH
Mouse Phenotype	MP:0000445	short snout	11	1.932633e-2	1.000000e+0	1.000000e+0	5.174288e+1	1.932633e-2	1	1.932633e-2	1.000000e+0	10	1.303889e-2	1.000000e+0	1.000000e+0	7.644492e+1	1.308131e-2	1	118	5.000000e-1	8.474576e-3	unnamed	ASPH
Mouse Phenotype	MP:0000443	abnormal snout morphology	12	2.720766e-2	1.000000e+0	1.000000e+0	3.675435e+1	2.720766e-2	1	2.720766e-2	1.000000e+0	12	1.787895e-2	1.000000e+0	1.000000e+0	5.568210e+1	1.795909e-2	1	162	5.000000e-1	6.172840e-3	unnamed	ASPH
Mouse Phenotype	MP:0002972	abnormal cardiac muscle contractility	13	3.076905e-2	1.000000e+0	1.000000e+0	3.250019e+1	3.076905e-2	1	3.076905e-2	1.000000e+0	15	2.610163e-2	1.000000e+0	1.000000e+0	3.806118e+1	2.627349e-2	1	237	5.000000e-1	4.219409e-3	unnamed	ASPH
Mouse Phenotype	MP:0001629	abnormal heart rate	14	3.082246e-2	1.000000e+0	1.000000e+0	3.244387e+1	3.082246e-2	1	3.082246e-2	1.000000e+0	13	1.996530e-2	1.000000e+0	1.000000e+0	4.983702e+1	2.006541e-2	1	181	5.000000e-1	5.524862e-3	unnamed	ASPH
Mouse Phenotype	MP:0004085	abnormal heartbeat	15	3.710548e-2	1.000000e+0	1.000000e+0	2.695020e+1	3.710548e-2	1	3.710548e-2	1.000000e+0	14	2.478833e-2	1.000000e+0	1.000000e+0	4.009111e+1	2.494318e-2	1	225	5.000000e-1	4.444444e-3	unnamed	ASPH
Mouse Phenotype	MP:0001923	reduced female fertility	16	3.818286e-2	1.000000e+0	1.000000e+0	2.618976e+1	3.818286e-2	1	3.818286e-2	1.000000e+0	18	2.916257e-2	1.000000e+0	1.000000e+0	3.403962e+1	2.937753e-2	1	265	5.000000e-1	3.773585e-3	unnamed	ASPH
Mouse Phenotype	MP:0001935	decreased litter size	17	4.020414e-2	1.000000e+0	1.000000e+0	2.487306e+1	4.020414e-2	1	4.020414e-2	1.000000e+0	21	3.461655e-2	1.000000e+0	1.000000e+0	2.863651e+1	3.492046e-2	1	315	5.000000e-1	3.174603e-3	unnamed	ASPH
Mouse Phenotype	MP:0002110	abnormal digit morphology	18	4.029820e-2	1.000000e+0	1.000000e+0	2.481500e+1	4.029820e-2	1	4.029820e-2	1.000000e+0	17	2.806993e-2	1.000000e+0	1.000000e+0	3.537451e+1	2.826894e-2	1	255	5.000000e-1	3.921569e-3	unnamed	ASPH
Mouse Phenotype	MP:0001933	abnormal litter size	19	4.123688e-2	1.000000e+0	1.000000e+0	2.425014e+1	4.123688e-2	1	4.123688e-2	1.000000e+0	22	3.570550e-2	1.000000e+0	1.000000e+0	2.775538e+1	3.602904e-2	1	325	5.000000e-1	3.076923e-3	unnamed	ASPH
Mouse Phenotype	MP:0005620	abnormal muscle contractility	20	4.427201e-2	1.000000e+0	1.000000e+0	2.258763e+1	4.427201e-2	1	4.427201e-2	1.000000e+0	23	3.722900e-2	1.000000e+0	1.000000e+0	2.660914e+1	3.758107e-2	1	339	5.000000e-1	2.949853e-3	unnamed	ASPH
Mouse Phenotype	MP:0000111	cleft palate	21	4.472544e-2	1.000000e+0	1.000000e+0	2.235864e+1	4.472544e-2	1	4.472544e-2	1.000000e+0	16	2.752338e-2	1.000000e+0	1.000000e+0	3.608200e+1	2.771465e-2	1	250	5.000000e-1	4.000000e-3	unnamed	ASPH
Mouse Phenotype	MP:0000572	abnormal autopod morphology	22	4.767394e-2	1.000000e+0	1.000000e+0	2.097582e+1	4.767394e-2	1	4.767394e-2	1.000000e+0	20	3.385392e-2	1.000000e+0	1.000000e+0	2.928734e+1	3.414445e-2	1	308	5.000000e-1	3.246753e-3	unnamed	ASPH
Mouse Phenotype	MP:0005164	abnormal response to injury	23	5.017014e-2	1.000000e+0	1.000000e+0	1.993218e+1	5.017014e-2	1	5.017014e-2	1.000000e+0	26	5.088631e-2	1.000000e+0	1.000000e+0	1.939892e+1	5.154925e-2	1	465	5.000000e-1	2.150538e-3	unnamed	ASPH
Mouse Phenotype	MP:0003755	abnormal palate morphology	24	5.022570e-2	1.000000e+0	1.000000e+0	1.991013e+1	5.022570e-2	1	5.022570e-2	1.000000e+0	19	3.080038e-2	1.000000e+0	1.000000e+0	3.221607e+1	3.104041e-2	1	280	5.000000e-1	3.571429e-3	unnamed	ASPH
Mouse Phenotype	MP:0010274	increased organ/body region tumor incidence	25	5.980108e-2	1.000000e+0	1.000000e+0	1.672211e+1	5.980108e-2	1	5.980108e-2	1.000000e+0	27	5.907688e-2	1.000000e+0	1.000000e+0	1.667375e+1	5.997450e-2	1	541	5.000000e-1	1.848429e-3	unnamed	ASPH
Mouse Phenotype	MP:0002020	increased tumor incidence	26	7.037685e-2	1.000000e+0	1.000000e+0	1.420922e+1	7.037685e-2	1	7.037685e-2	1.000000e+0	31	6.873033e-2	1.000000e+0	1.000000e+0	1.429556e+1	6.995178e-2	1	631	5.000000e-1	1.584786e-3	unnamed	ASPH
Mouse Phenotype	MP:0000452	abnormal mouth morphology	27	7.052671e-2	1.000000e+0	1.000000e+0	1.417902e+1	7.052671e-2	1	7.052671e-2	1.000000e+0	24	4.948174e-2	1.000000e+0	1.000000e+0	1.995686e+1	5.010809e-2	1	452	5.000000e-1	2.212389e-3	unnamed	ASPH
Mouse Phenotype	MP:0003744	abnormal orofacial morphology	28	7.077154e-2	1.000000e+0	1.000000e+0	1.412997e+1	7.077154e-2	1	7.077154e-2	1.000000e+0	25	4.980596e-2	1.000000e+0	1.000000e+0	1.982527e+1	5.044066e-2	1	455	5.000000e-1	2.197802e-3	unnamed	ASPH
Mouse Phenotype	MP:0001921	reduced fertility	29	7.391314e-2	1.000000e+0	1.000000e+0	1.352939e+1	7.391314e-2	1	7.391314e-2	1.000000e+0	28	6.230023e-2	1.000000e+0	1.000000e+0	1.579772e+1	6.330026e-2	1	571	5.000000e-1	1.751313e-3	unnamed	ASPH
Mouse Phenotype	MP:0002019	abnormal tumor incidence	30	7.769090e-2	1.000000e+0	1.000000e+0	1.287152e+1	7.769090e-2	1	7.769090e-2	1.000000e+0	33	7.705640e-2	1.000000e+0	1.000000e+0	1.272285e+1	7.859875e-2	1	709	5.000000e-1	1.410437e-3	unnamed	ASPH
Mouse Phenotype	MP:0002166	altered tumor susceptibility	31	7.903444e-2	1.000000e+0	1.000000e+0	1.265271e+1	7.903444e-2	1	7.903444e-2	1.000000e+0	34	7.854686e-2	1.000000e+0	1.000000e+0	1.247649e+1	8.015077e-2	1	723	5.000000e-1	1.383126e-3	unnamed	ASPH
Mouse Phenotype	MP:0003699	abnormal female reproductive system physiology	32	7.951923e-2	1.000000e+0	1.000000e+0	1.257558e+1	7.951923e-2	1	7.951923e-2	1.000000e+0	32	6.979987e-2	1.000000e+0	1.000000e+0	1.407254e+1	7.106036e-2	1	641	5.000000e-1	1.560062e-3	unnamed	ASPH
Mouse Phenotype	MP:0002006	tumorigenesis	33	8.579997e-2	1.000000e+0	1.000000e+0	1.165502e+1	8.579997e-2	1	8.579997e-2	1.000000e+0	37	8.576913e-2	1.000000e+0	1.000000e+0	1.140392e+1	8.768915e-2	1	791	5.000000e-1	1.264223e-3	unnamed	ASPH
Mouse Phenotype	MP:0002109	abnormal limb morphology	34	8.631911e-2	1.000000e+0	1.000000e+0	1.158492e+1	8.631911e-2	1	8.631911e-2	1.000000e+0	30	6.594667e-2	1.000000e+0	1.000000e+0	1.490992e+1	6.706945e-2	1	605	5.000000e-1	1.652893e-3	unnamed	ASPH
Mouse Phenotype	MP:0003743	abnormal facial morphology	35	9.091439e-2	1.000000e+0	1.000000e+0	1.099936e+1	9.091439e-2	1	9.091439e-2	1.000000e+0	29	6.573237e-2	1.000000e+0	1.000000e+0	1.495937e+1	6.684774e-2	1	603	5.000000e-1	1.658375e-3	unnamed	ASPH
Mouse Phenotype	MP:0002106	abnormal muscle physiology	36	9.999719e-2	1.000000e+0	1.000000e+0	1.000028e+1	9.999719e-2	1	9.999719e-2	1.000000e+0	38	8.894639e-2	1.000000e+0	1.000000e+0	1.098721e+1	9.101491e-2	1	821	5.000000e-1	1.218027e-3	unnamed	ASPH
Mouse Phenotype	MP:0005371	limbs/digits/tail phenotype	37	1.059943e-1	1.000000e+0	1.000000e+0	9.434473e+0	1.059943e-1	1	1.059943e-1	1.000000e+0	36	8.332948e-2	1.000000e+0	1.000000e+0	1.174544e+1	8.513940e-2	1	768	5.000000e-1	1.302083e-3	unnamed	ASPH
Mouse Phenotype	MP:0000432	abnormal head morphology	38	1.086636e-1	1.000000e+0	1.000000e+0	9.202710e+0	1.086636e-1	1	1.086636e-1	1.000000e+0	35	8.152418e-2	1.000000e+0	1.000000e+0	1.201132e+1	8.325481e-2	1	751	5.000000e-1	1.331558e-3	unnamed	ASPH
Mouse Phenotype	MP:0000462	abnormal digestive system morphology	39	1.165265e-1	1.000000e+0	1.000000e+0	8.581738e+0	1.165265e-1	1	1.165265e-1	1.000000e+0	39	9.454603e-2	1.000000e+0	1.000000e+0	1.032094e+1	9.689042e-2	1	874	5.000000e-1	1.144165e-3	unnamed	ASPH
Mouse Phenotype	MP:0002161	abnormal fertility/fecundity	40	1.345122e-1	1.000000e+0	1.000000e+0	7.434268e+0	1.345122e-1	1	1.345122e-1	1.000000e+0	43	1.310914e-1	1.000000e+0	1.000000e+0	7.369690e+0	1.356909e-1	1	1224	5.000000e-1	8.169935e-4	unnamed	ASPH
Mouse Phenotype	MP:0005381	digestive/alimentary phenotype	41	1.385091e-1	1.000000e+0	1.000000e+0	7.219740e+0	1.385091e-1	1	1.385091e-1	1.000000e+0	41	1.223892e-1	1.000000e+0	1.000000e+0	7.912719e+0	1.263788e-1	1	1140	5.000000e-1	8.771930e-4	unnamed	ASPH
Mouse Phenotype	MP:0000428	abnormal craniofacial morphology	42	1.404613e-1	1.000000e+0	1.000000e+0	7.119400e+0	1.404613e-1	1	1.404613e-1	1.000000e+0	40	1.066368e-1	1.000000e+0	1.000000e+0	9.120829e+0	1.096392e-1	1	989	5.000000e-1	1.011122e-3	unnamed	ASPH
Mouse Phenotype	MP:0002083	premature death	43	1.449089e-1	1.000000e+0	1.000000e+0	6.900889e+0	1.449089e-1	1	1.449089e-1	1.000000e+0	44	1.369718e-1	1.000000e+0	1.000000e+0	7.041764e+0	1.420099e-1	1	1281	5.000000e-1	7.806401e-4	unnamed	ASPH
Mouse Phenotype	MP:0005369	muscle phenotype	44	1.492399e-1	1.000000e+0	1.000000e+0	6.700621e+0	1.492399e-1	1	1.492399e-1	1.000000e+0	42	1.300577e-1	1.000000e+0	1.000000e+0	7.430395e+0	1.345823e-1	1	1214	5.000000e-1	8.237232e-4	unnamed	ASPH
Mouse Phenotype	MP:0001919	abnormal reproductive system physiology	45	1.530473e-1	1.000000e+0	1.000000e+0	6.533929e+0	1.530473e-1	1	1.530473e-1	1.000000e+0	46	1.495931e-1	1.000000e+0	1.000000e+0	6.424858e+0	1.556455e-1	1	1404	5.000000e-1	7.122507e-4	unnamed	ASPH
Mouse Phenotype	MP:0001544	abnormal cardiovascular system physiology	46	1.606719e-1	1.000000e+0	1.000000e+0	6.223862e+0	1.606719e-1	1	1.606719e-1	1.000000e+0	45	1.384131e-1	1.000000e+0	1.000000e+0	6.965637e+0	1.435619e-1	1	1295	5.000000e-1	7.722008e-4	unnamed	ASPH
Mouse Phenotype	MP:0005389	reproductive system phenotype	47	1.774158e-1	1.000000e+0	1.000000e+0	5.636476e+0	1.774158e-1	1	1.774158e-1	1.000000e+0	47	1.715322e-1	1.000000e+0	1.000000e+0	5.568210e+0	1.795909e-1	1	1620	5.000000e-1	6.172840e-4	unnamed	ASPH
Mouse Phenotype	MP:0005385	cardiovascular system phenotype	48	2.326762e-1	1.000000e+0	1.000000e+0	4.297818e+0	2.326762e-1	1	2.326762e-1	1.000000e+0	48	2.103199e-1	1.000000e+0	1.000000e+0	4.490045e+0	2.227149e-1	1	2009	5.000000e-1	4.977601e-4	unnamed	ASPH
Mouse Phenotype	MP:0005376	homeostasis/metabolism phenotype	49	3.389663e-1	1.000000e+0	1.000000e+0	2.950146e+0	3.389663e-1	1	3.389663e-1	1.000000e+0	49	3.467977e-1	1.000000e+0	1.000000e+0	2.607081e+0	3.835708e-1	1	3460	5.000000e-1	2.890173e-4	unnamed	ASPH
Mouse Phenotype	MP:0010769	abnormal survival	50	3.982821e-1	1.000000e+0	1.000000e+0	2.510783e+0	3.982821e-1	1	3.982821e-1	1.000000e+0	50	3.748920e-1	1.000000e+0	1.000000e+0	2.388271e+0	4.187129e-1	1	3777	5.000000e-1	2.647604e-4	unnamed	ASPH
Mouse Phenotype	MP:0010768	mortality/aging	51	4.155501e-1	1.000000e+0	1.000000e+0	2.406449e+0	4.155501e-1	1	4.155501e-1	1.000000e+0	51	3.982479e-1	1.000000e+0	1.000000e+0	2.229486e+0	4.485339e-1	1	4046	5.000000e-1	2.471577e-4	unnamed	ASPH
Mouse Phenotype	MP:0000001	mammalian phenotype	52	6.422596e-1	1.000000e+0	1.000000e+0	1.557003e+0	6.422596e-1	1	6.422596e-1	1.000000e+0	52	6.601828e-1	1.000000e+0	1.000000e+0	1.198897e+0	8.341001e-1	1	7524	5.000000e-1	1.329080e-4	unnamed	ASPH
Disease Ontology	DOID:722	spontaneous abortion	1	5.907872e-3	1.000000e+0	1.000000e+0	1.692657e+2	5.907872e-3	1	5.907872e-3	1.000000e+0	1	6.972090e-3	1.000000e+0	1.000000e+0	1.431825e+2	6.984092e-3	1	63	5.000000e-1	1.587302e-2	unnamed	ASPH
Disease Ontology	DOID:9219	pregnancy complication	2	6.843688e-3	1.000000e+0	1.000000e+0	1.461200e+2	6.843688e-3	1	6.843688e-3	1.000000e+0	2	8.076528e-3	1.000000e+0	1.000000e+0	1.235685e+2	8.092678e-3	1	73	5.000000e-1	1.369863e-2	unnamed	ASPH
Disease Ontology	DOID:5366	pregnancy disease	3	7.627223e-3	1.000000e+0	1.000000e+0	1.311093e+2	7.627223e-3	1	7.627223e-3	1.000000e+0	3	8.959636e-3	1.000000e+0	1.000000e+0	1.113642e+2	8.979547e-3	1	81	5.000000e-1	1.234568e-2	unnamed	ASPH
Disease Ontology	DOID:4947	cholangiocarcinoma	4	1.226587e-2	1.000000e+0	1.000000e+0	8.152704e+1	1.226587e-2	1	1.226587e-2	1.000000e+0	4	1.325916e-2	1.000000e+0	1.000000e+0	7.517083e+1	1.330303e-2	1	120	5.000000e-1	8.333333e-3	unnamed	ASPH
Disease Ontology	DOID:4897	bile duct carcinoma	5	1.342514e-2	1.000000e+0	1.000000e+0	7.448712e+1	1.342514e-2	1	1.342514e-2	1.000000e+0	5	1.458020e-2	1.000000e+0	1.000000e+0	6.833712e+1	1.463334e-2	1	132	5.000000e-1	7.575758e-3	unnamed	ASPH
Disease Ontology	DOID:4606	bile duct cancer	6	1.345417e-2	1.000000e+0	1.000000e+0	7.432642e+1	1.345417e-2	1	1.345417e-2	1.000000e+0	6	1.469025e-2	1.000000e+0	1.000000e+0	6.782331e+1	1.474419e-2	1	133	5.000000e-1	7.518797e-3	unnamed	ASPH
Disease Ontology	DOID:4607	biliary tract cancer	7	1.820947e-2	1.000000e+0	1.000000e+0	5.491648e+1	1.820947e-2	1	1.820947e-2	1.000000e+0	7	1.897731e-2	1.000000e+0	1.000000e+0	5.244477e+1	1.906768e-2	1	172	5.000000e-1	5.813953e-3	unnamed	ASPH
Disease Ontology	DOID:4138	bile duct disease	8	1.956557e-2	1.000000e+0	1.000000e+0	5.111019e+1	1.956557e-2	1	1.956557e-2	1.000000e+0	8	2.237830e-2	1.000000e+0	1.000000e+0	4.443596e+1	2.250430e-2	1	203	5.000000e-1	4.926108e-3	unnamed	ASPH
Disease Ontology	DOID:9741	biliary tract disease	9	2.393130e-2	1.000000e+0	1.000000e+0	4.178628e+1	2.393130e-2	1	2.393130e-2	1.000000e+0	10	2.642982e-2	1.000000e+0	1.000000e+0	3.758542e+1	2.660606e-2	1	240	5.000000e-1	4.166667e-3	unnamed	ASPH
Disease Ontology	DOID:3117	hepatobiliary neoplasm	10	2.482426e-2	1.000000e+0	1.000000e+0	4.028318e+1	2.482426e-2	1	2.482426e-2	1.000000e+0	9	2.424086e-2	1.000000e+0	1.000000e+0	4.100227e+1	2.438889e-2	1	220	5.000000e-1	4.545455e-3	unnamed	ASPH
Disease Ontology	DOID:3119	gastrointestinal neoplasm	11	4.370194e-2	1.000000e+0	1.000000e+0	2.288228e+1	4.370194e-2	1	4.370194e-2	1.000000e+0	11	4.211781e-2	1.000000e+0	1.000000e+0	2.349089e+1	4.256970e-2	1	384	5.000000e-1	2.604167e-3	unnamed	ASPH
Disease Ontology	DOID:8377	digestive system cancer	12	4.455231e-2	1.000000e+0	1.000000e+0	2.244552e+1	4.455231e-2	1	4.455231e-2	1.000000e+0	12	4.255177e-2	1.000000e+0	1.000000e+0	2.324871e+1	4.301314e-2	1	388	5.000000e-1	2.577320e-3	unnamed	ASPH
Disease Ontology	DOID:229	female reproductive system disease	13	5.249388e-2	1.000000e+0	1.000000e+0	1.904984e+1	5.249388e-2	1	5.249388e-2	1.000000e+0	16	5.185810e-2	1.000000e+0	1.000000e+0	1.903059e+1	5.254698e-2	1	474	5.000000e-1	2.109705e-3	unnamed	ASPH
Disease Ontology	DOID:769	neuroblastoma	14	5.857072e-2	1.000000e+0	1.000000e+0	1.707338e+1	5.857072e-2	1	5.857072e-2	1.000000e+0	13	4.861687e-2	1.000000e+0	1.000000e+0	2.031644e+1	4.922122e-2	1	444	5.000000e-1	2.252252e-3	unnamed	ASPH
Disease Ontology	DOID:3369	Ewings sarcoma	15	5.884188e-2	1.000000e+0	1.000000e+0	1.699470e+1	5.884188e-2	1	5.884188e-2	1.000000e+0	14	4.883312e-2	1.000000e+0	1.000000e+0	2.022534e+1	4.944294e-2	1	446	5.000000e-1	2.242152e-3	unnamed	ASPH
Disease Ontology	DOID:2438	tumor of dermis	16	6.071436e-2	1.000000e+0	1.000000e+0	1.647057e+1	6.071436e-2	1	6.071436e-2	1.000000e+0	15	5.002208e-2	1.000000e+0	1.000000e+0	1.973851e+1	5.066238e-2	1	457	5.000000e-1	2.188184e-3	unnamed	ASPH
Disease Ontology	DOID:4159	skin cancer	17	6.228896e-2	1.000000e+0	1.000000e+0	1.605421e+1	6.228896e-2	1	6.228896e-2	1.000000e+0	18	5.261359e-2	1.000000e+0	1.000000e+0	1.875364e+1	5.332299e-2	1	481	5.000000e-1	2.079002e-3	unnamed	ASPH
Disease Ontology	DOID:1192	peripheral nervous system neoplasm	18	6.432174e-2	1.000000e+0	1.000000e+0	1.554684e+1	6.432174e-2	1	6.432174e-2	1.000000e+0	17	5.228984e-2	1.000000e+0	1.000000e+0	1.887134e+1	5.299041e-2	1	478	5.000000e-1	2.092050e-3	unnamed	ASPH
Disease Ontology	DOID:3118	hepatobiliary disease	19	6.824507e-2	1.000000e+0	1.000000e+0	1.465307e+1	6.824507e-2	1	6.824507e-2	1.000000e+0	26	8.109914e-2	1.000000e+0	1.000000e+0	1.207564e+1	8.281137e-2	1	747	5.000000e-1	1.338688e-3	unnamed	ASPH
Disease Ontology	DOID:168	primitive neuroectodermal tumor	20	6.935969e-2	1.000000e+0	1.000000e+0	1.441760e+1	6.935969e-2	1	6.935969e-2	1.000000e+0	19	5.789360e-2	1.000000e+0	1.000000e+0	1.701981e+1	5.875506e-2	1	530	5.000000e-1	1.886792e-3	unnamed	ASPH
Disease Ontology	DOID:688	embryonal cancer	21	7.040036e-2	1.000000e+0	1.000000e+0	1.420447e+1	7.040036e-2	1	7.040036e-2	1.000000e+0	20	5.961449e-2	1.000000e+0	1.000000e+0	1.652106e+1	6.052880e-2	1	546	5.000000e-1	1.831502e-3	unnamed	ASPH
Disease Ontology	DOID:1749	squamous cell carcinoma	22	7.192071e-2	1.000000e+0	1.000000e+0	1.390420e+1	7.192071e-2	1	7.192071e-2	1.000000e+0	23	7.652380e-2	1.000000e+0	1.000000e+0	1.281321e+1	7.804445e-2	1	704	5.000000e-1	1.420455e-3	unnamed	ASPH
Disease Ontology	DOID:2428	epithelioma	23	7.206581e-2	1.000000e+0	1.000000e+0	1.387621e+1	7.206581e-2	1	7.206581e-2	1.000000e+0	24	7.673686e-2	1.000000e+0	1.000000e+0	1.277691e+1	7.826617e-2	1	706	5.000000e-1	1.416431e-3	unnamed	ASPH
Disease Ontology	DOID:3347	osteosarcoma	24	7.547113e-2	1.000000e+0	1.000000e+0	1.325010e+1	7.547113e-2	1	7.547113e-2	1.000000e+0	21	6.498213e-2	1.000000e+0	1.000000e+0	1.513507e+1	6.607173e-2	1	596	5.000000e-1	1.677852e-3	unnamed	ASPH
Disease Ontology	DOID:183	bone tissue neoplasm	25	7.606199e-2	1.000000e+0	1.000000e+0	1.314717e+1	7.606199e-2	1	7.606199e-2	1.000000e+0	22	6.551805e-2	1.000000e+0	1.000000e+0	1.500915e+1	6.662602e-2	1	601	5.000000e-1	1.663894e-3	unnamed	ASPH
Disease Ontology	DOID:3168	squamous cell neoplasm	26	8.073938e-2	1.000000e+0	1.000000e+0	1.238553e+1	8.073938e-2	1	8.073938e-2	1.000000e+0	30	8.492093e-2	1.000000e+0	1.000000e+0	1.152043e+1	8.680228e-2	1	783	5.000000e-1	1.277139e-3	unnamed	ASPH
Disease Ontology	DOID:201	connective tissue neoplasm	27	8.800066e-2	1.000000e+0	1.000000e+0	1.136355e+1	8.800066e-2	1	8.800066e-2	1.000000e+0	25	7.716290e-2	1.000000e+0	1.000000e+0	1.270493e+1	7.870961e-2	1	710	5.000000e-1	1.408451e-3	unnamed	ASPH
Disease Ontology	DOID:15	reproductive system disease	28	8.872162e-2	1.000000e+0	1.000000e+0	1.127121e+1	8.872162e-2	1	8.872162e-2	1.000000e+0	27	8.290487e-2	1.000000e+0	1.000000e+0	1.180694e+1	8.469597e-2	1	764	5.000000e-1	1.308901e-3	unnamed	ASPH
Disease Ontology	DOID:684	hepatocellular carcinoma	29	9.124792e-2	1.000000e+0	1.000000e+0	1.095915e+1	9.124792e-2	1	9.124792e-2	1.000000e+0	32	9.211812e-2	1.000000e+0	1.000000e+0	1.059988e+1	9.434067e-2	1	851	5.000000e-1	1.175088e-3	unnamed	ASPH
Disease Ontology	DOID:686	liver and intrahepatic biliary tract carcinoma	30	9.251093e-2	1.000000e+0	1.000000e+0	1.080953e+1	9.251093e-2	1	9.251093e-2	1.000000e+0	33	9.338526e-2	1.000000e+0	1.000000e+0	1.045249e+1	9.567097e-2	1	863	5.000000e-1	1.158749e-3	unnamed	ASPH
Disease Ontology	DOID:1318	malignant neoplasm of central nervous system	31	9.457325e-2	1.000000e+0	1.000000e+0	1.057381e+1	9.457325e-2	1	9.457325e-2	1.000000e+0	28	8.396623e-2	1.000000e+0	1.000000e+0	1.165439e+1	8.580456e-2	1	774	5.000000e-1	1.291990e-3	unnamed	ASPH
Disease Ontology	DOID:4695	malignant neoplasm of nervous system	32	9.564362e-2	1.000000e+0	1.000000e+0	1.045548e+1	9.564362e-2	1	9.564362e-2	1.000000e+0	29	8.439060e-2	1.000000e+0	1.000000e+0	1.159447e+1	8.624799e-2	1	778	5.000000e-1	1.285347e-3	unnamed	ASPH
Disease Ontology	DOID:3070	malignant glioma	33	9.870456e-2	1.000000e+0	1.000000e+0	1.013124e+1	9.870456e-2	1	9.870456e-2	1.000000e+0	31	8.714662e-2	1.000000e+0	1.000000e+0	1.121953e+1	8.913031e-2	1	804	5.000000e-1	1.243781e-3	unnamed	ASPH
Disease Ontology	DOID:122	abdominal cancer	34	1.132547e-1	1.000000e+0	1.000000e+0	8.829653e+0	1.132547e-1	1	1.132547e-1	1.000000e+0	38	1.128084e-1	1.000000e+0	1.000000e+0	8.607347e+0	1.161798e-1	1	1048	5.000000e-1	9.541985e-4	unnamed	ASPH
Disease Ontology	DOID:3165	skin neoplasm	35	1.200813e-1	1.000000e+0	1.000000e+0	8.327690e+0	1.200813e-1	1	1.200813e-1	1.000000e+0	35	1.090453e-1	1.000000e+0	1.000000e+0	8.913538e+0	1.121889e-1	1	1012	5.000000e-1	9.881423e-4	unnamed	ASPH
Disease Ontology	DOID:65	connective tissue disease	36	1.230503e-1	1.000000e+0	1.000000e+0	8.126760e+0	1.230503e-1	1	1.230503e-1	1.000000e+0	41	1.217659e-1	1.000000e+0	1.000000e+0	7.954586e+0	1.257137e-1	1	1134	5.000000e-1	8.818342e-4	unnamed	ASPH
Disease Ontology	DOID:2627	glioma	37	1.253026e-1	1.000000e+0	1.000000e+0	7.980682e+0	1.253026e-1	1	1.253026e-1	1.000000e+0	34	1.084173e-1	1.000000e+0	1.000000e+0	8.966700e+0	1.115238e-1	1	1006	5.000000e-1	9.940358e-4	unnamed	ASPH
Disease Ontology	DOID:1319	brain neoplasm	38	1.265868e-1	1.000000e+0	1.000000e+0	7.899721e+0	1.265868e-1	1	1.265868e-1	1.000000e+0	36	1.094638e-1	1.000000e+0	1.000000e+0	8.878445e+0	1.126323e-1	1	1016	5.000000e-1	9.842520e-4	unnamed	ASPH
Disease Ontology	DOID:3620	central nervous system neoplasm	39	1.271973e-1	1.000000e+0	1.000000e+0	7.861801e+0	1.271973e-1	1	1.271973e-1	1.000000e+0	37	1.101959e-1	1.000000e+0	1.000000e+0	8.817693e+0	1.134083e-1	1	1023	5.000000e-1	9.775171e-4	unnamed	ASPH
Disease Ontology	DOID:171	neuroectodermal tumor	40	1.311969e-1	1.000000e+0	1.000000e+0	7.622132e+0	1.311969e-1	1	1.311969e-1	1.000000e+0	39	1.187505e-1	1.000000e+0	1.000000e+0	8.163348e+0	1.224988e-1	1	1105	5.000000e-1	9.049774e-4	unnamed	ASPH
Disease Ontology	DOID:3095	germ cell and embryonal cancer	41	1.321992e-1	1.000000e+0	1.000000e+0	7.564342e+0	1.321992e-1	1	1.321992e-1	1.000000e+0	40	1.204148e-1	1.000000e+0	1.000000e+0	8.046833e+0	1.242725e-1	1	1121	5.000000e-1	8.920607e-4	unnamed	ASPH
Disease Ontology	DOID:2994	germ cell cancer	42	1.346344e-1	1.000000e+0	1.000000e+0	7.427520e+0	1.346344e-1	1	1.346344e-1	1.000000e+0	42	1.229084e-1	1.000000e+0	1.000000e+0	7.878166e+0	1.269331e-1	1	1145	5.000000e-1	8.733624e-4	unnamed	ASPH
Disease Ontology	DOID:177	soft tissue neoplasm	43	1.450676e-1	1.000000e+0	1.000000e+0	6.893336e+0	1.450676e-1	1	1.450676e-1	1.000000e+0	43	1.364568e-1	1.000000e+0	1.000000e+0	7.069357e+0	1.414556e-1	1	1276	5.000000e-1	7.836991e-4	unnamed	ASPH
Disease Ontology	DOID:3350	mesenchymal cell neoplasm	44	1.453323e-1	1.000000e+0	1.000000e+0	6.880783e+0	1.453323e-1	1	1.453323e-1	1.000000e+0	44	1.369718e-1	1.000000e+0	1.000000e+0	7.041764e+0	1.420099e-1	1	1281	5.000000e-1	7.806401e-4	unnamed	ASPH
Disease Ontology	DOID:1115	sarcoma	45	1.495909e-1	1.000000e+0	1.000000e+0	6.684897e+0	1.495909e-1	1	1.495909e-1	1.000000e+0	45	1.416001e-1	1.000000e+0	1.000000e+0	6.802790e+0	1.469985e-1	1	1326	5.000000e-1	7.541478e-4	unnamed	ASPH
Disease Ontology	DOID:77	gastrointestinal system disease	46	1.566959e-1	1.000000e+0	1.000000e+0	6.381787e+0	1.566959e-1	1	1.566959e-1	1.000000e+0	51	1.749595e-1	1.000000e+0	1.000000e+0	5.453748e+0	1.833601e-1	1	1654	5.000000e-1	6.045949e-4	unnamed	ASPH
Disease Ontology	DOID:3094	neuroepithelial neoplasm	47	1.687017e-1	1.000000e+0	1.000000e+0	5.927623e+0	1.687017e-1	1	1.687017e-1	1.000000e+0	46	1.534735e-1	1.000000e+0	1.000000e+0	6.255548e+0	1.598581e-1	1	1442	5.000000e-1	6.934813e-4	unnamed	ASPH
Disease Ontology	DOID:3195	neural neoplasm	48	1.692055e-1	1.000000e+0	1.000000e+0	5.909975e+0	1.692055e-1	1	1.692055e-1	1.000000e+0	47	1.541874e-1	1.000000e+0	1.000000e+0	6.225328e+0	1.606341e-1	1	1449	5.000000e-1	6.901311e-4	unnamed	ASPH
Disease Ontology	DOID:299	adenocarcinoma	49	1.706462e-1	1.000000e+0	1.000000e+0	5.860077e+0	1.706462e-1	1	1.706462e-1	1.000000e+0	49	1.699169e-1	1.000000e+0	1.000000e+0	5.623753e+0	1.778172e-1	1	1604	5.000000e-1	6.234414e-4	unnamed	ASPH
Disease Ontology	DOID:3093	nervous system cancer	50	1.722624e-1	1.000000e+0	1.000000e+0	5.805099e+0	1.722624e-1	1	1.722624e-1	1.000000e+0	48	1.573451e-1	1.000000e+0	1.000000e+0	6.094932e+0	1.640707e-1	1	1480	5.000000e-1	6.756757e-4	unnamed	ASPH
Disease Ontology	DOID:197	glandular cell epithelial neoplasm	51	1.860840e-1	1.000000e+0	1.000000e+0	5.373918e+0	1.860840e-1	1	1.860840e-1	1.000000e+0	52	1.850986e-1	1.000000e+0	1.000000e+0	5.139886e+0	1.945568e-1	1	1755	5.000000e-1	5.698006e-4	unnamed	ASPH
Disease Ontology	DOID:936	brain disease	52	1.872681e-1	1.000000e+0	1.000000e+0	5.339937e+0	1.872681e-1	1	1.872681e-1	1.000000e+0	50	1.748588e-1	1.000000e+0	1.000000e+0	5.457048e+0	1.832493e-1	1	1653	5.000000e-1	6.049607e-4	unnamed	ASPH
Disease Ontology	DOID:17	musculoskeletal system disease	53	2.136568e-1	1.000000e+0	1.000000e+0	4.680403e+0	2.136568e-1	1	2.136568e-1	1.000000e+0	54	2.140591e-1	1.000000e+0	1.000000e+0	4.406693e+0	2.269276e-1	1	2047	5.000000e-1	4.885198e-4	unnamed	ASPH
Disease Ontology	DOID:157	epithelial carcinoma	54	2.158701e-1	1.000000e+0	1.000000e+0	4.632416e+0	2.158701e-1	1	2.158701e-1	1.000000e+0	55	2.169067e-1	1.000000e+0	1.000000e+0	4.345135e+0	2.301425e-1	1	2076	5.000000e-1	4.816956e-4	unnamed	ASPH
Disease Ontology	DOID:155	glandular and epithelial neoplasm	55	2.196335e-1	1.000000e+0	1.000000e+0	4.553039e+0	2.196335e-1	1	2.196335e-1	1.000000e+0	53	2.107139e-1	1.000000e+0	1.000000e+0	4.481123e+0	2.231584e-1	1	2013	5.000000e-1	4.967710e-4	unnamed	ASPH
Disease Ontology	DOID:331	central nervous system disease	56	2.247960e-1	1.000000e+0	1.000000e+0	4.448477e+0	2.247960e-1	1	2.247960e-1	1.000000e+0	56	2.201408e-1	1.000000e+0	1.000000e+0	4.277146e+0	2.338008e-1	1	2109	5.000000e-1	4.741584e-4	unnamed	ASPH
Disease Ontology	DOID:863	nervous system disease	57	2.662634e-1	1.000000e+0	1.000000e+0	3.755680e+0	2.662634e-1	1	2.662634e-1	1.000000e+0	57	2.652858e-1	1.000000e+0	1.000000e+0	3.500388e+0	2.856826e-1	1	2577	5.000000e-1	3.880481e-4	unnamed	ASPH
Disease Ontology	DOID:2985	chronic rejection of renal transplant	58	2.674662e-1	1.000000e+0	1.000000e+0	3.738791e+0	2.674662e-1	1	2.674662e-1	1.000000e+0	58	2.866046e-1	1.000000e+0	1.000000e+0	3.218159e+0	3.107367e-1	1	2803	5.000000e-1	3.567606e-4	unnamed	ASPH
Disease Ontology	DOID:2108	transplant-related disease	59	2.674780e-1	1.000000e+0	1.000000e+0	3.738626e+0	2.674780e-1	1	2.674780e-1	1.000000e+0	59	2.866982e-1	1.000000e+0	1.000000e+0	3.217011e+0	3.108475e-1	1	2804	5.000000e-1	3.566334e-4	unnamed	ASPH
Disease Ontology	DOID:557	kidney disease	60	2.854845e-1	1.000000e+0	1.000000e+0	3.502817e+0	2.854845e-1	1	2.854845e-1	1.000000e+0	60	3.062252e-1	1.000000e+0	1.000000e+0	2.992867e+0	3.341278e-1	1	3014	5.000000e-1	3.317850e-4	unnamed	ASPH
Disease Ontology	DOID:18	urinary system disease	61	2.923209e-1	1.000000e+0	1.000000e+0	3.420898e+0	2.923209e-1	1	2.923209e-1	1.000000e+0	61	3.122143e-1	1.000000e+0	1.000000e+0	2.929685e+0	3.413336e-1	1	3079	5.000000e-1	3.247808e-4	unnamed	ASPH
Disease Ontology	DOID:2914	immune system disease	62	3.205063e-1	1.000000e+0	1.000000e+0	3.120063e+0	3.205063e-1	1	3.205063e-1	1.000000e+0	63	3.434783e-1	1.000000e+0	1.000000e+0	2.635261e+0	3.794690e-1	1	3423	5.000000e-1	2.921414e-4	unnamed	ASPH
Disease Ontology	DOID:305	carcinoma	63	3.218892e-1	1.000000e+0	1.000000e+0	3.106659e+0	3.218892e-1	1	3.218892e-1	1.000000e+0	62	3.253901e-1	1.000000e+0	1.000000e+0	2.798790e+0	3.572973e-1	1	3223	5.000000e-1	3.102699e-4	unnamed	ASPH
Disease Ontology	DOID:462	cancer by anatomical entity	64	3.485076e-1	1.000000e+0	1.000000e+0	2.869378e+0	3.485076e-1	1	3.485076e-1	1.000000e+0	64	3.467081e-1	1.000000e+0	1.000000e+0	2.607835e+0	3.834599e-1	1	3459	5.000000e-1	2.891009e-4	unnamed	ASPH
Disease Ontology	DOID:162	cancer	65	4.681931e-1	1.000000e+0	1.000000e+0	2.135871e+0	4.681931e-1	1	4.681931e-1	1.000000e+0	65	4.854768e-1	1.000000e+0	1.000000e+0	1.768725e+0	5.653789e-1	1	5100	5.000000e-1	1.960784e-4	unnamed	ASPH
Disease Ontology	DOID:7	disease of anatomical entity	66	5.144599e-1	1.000000e+0	1.000000e+0	1.943786e+0	5.144599e-1	1	5.144599e-1	1.000000e+0	66	5.469036e-1	1.000000e+0	1.000000e+0	1.529676e+0	6.537332e-1	1	5897	5.000000e-1	1.695778e-4	unnamed	ASPH
Disease Ontology	DOID:4	disease	67	6.581397e-1	1.000000e+0	1.000000e+0	1.519434e+0	6.581397e-1	1	6.581397e-1	1.000000e+0	67	6.831746e-1	1.000000e+0	1.000000e+0	1.143863e+0	8.742309e-1	1	7886	5.000000e-1	1.268070e-4	unnamed	ASPH
MSigDB Pathway	BIOCARTA_HIF_PATHWAY	Hypoxia-Inducible Factor in the Cardiovascular System	1	1.607823e-3	1.000000e+0	1.000000e+0	6.219591e+2	1.607823e-3	1	1.607823e-3	1.000000e+0	1	1.662234e-3	1.000000e+0	1.000000e+0	6.013667e+2	1.662879e-3	1	15	5.000000e-1	6.666667e-2	unnamed	ASPH
MGI Expression: Detected	14119	TS17_trunk	1	9.192350e-3	1.000000e+0	1.000000e+0	1.087861e+2	9.192350e-3	1	9.192350e-3	1.000000e+0	1	6.642913e-6	6.202488e-2	6.202488e-2	3.838511e+2	5.210354e-3	2	47	1.000000e+0	4.255319e-2	unnamed	ASPH,CLVS1
MGI Expression: Detected	15043	TS22_cerebral cortex subventricular zone	2	2.094408e-2	1.000000e+0	1.000000e+0	4.774619e+1	2.094408e-2	1	2.094408e-2	1.000000e+0	3	1.458020e-2	1.000000e+0	1.000000e+0	6.833712e+1	1.463334e-2	1	132	5.000000e-1	7.575758e-3	unnamed	CLVS1
MGI Expression: Detected	14110	TS17_head	3	2.578201e-2	1.000000e+0	1.000000e+0	3.878673e+1	2.578201e-2	1	2.578201e-2	1.000000e+0	2	6.775648e-5	6.326423e-1	3.163211e-1	1.210805e+2	1.651793e-2	2	149	1.000000e+0	1.342282e-2	unnamed	ASPH,CLVS1
MGI Expression: Detected	7575	TS26_heart	4	2.959308e-2	1.000000e+0	1.000000e+0	3.379168e+1	2.959308e-2	1	2.959308e-2	1.000000e+0	4	2.281671e-2	1.000000e+0	1.000000e+0	4.357729e+1	2.294773e-2	1	207	5.000000e-1	4.830918e-3	unnamed	ASPH
MGI Expression: Detected	7480	TS26_cardiovascular system	5	3.573264e-2	1.000000e+0	1.000000e+0	2.798562e+1	3.573264e-2	1	3.573264e-2	1.000000e+0	5	2.741405e-2	1.000000e+0	1.000000e+0	3.622691e+1	2.760379e-2	1	249	5.000000e-1	4.016064e-3	unnamed	ASPH
MGI Expression: Detected	5786	TS22_heart	6	1.580825e-1	1.000000e+0	1.000000e+0	6.325810e+0	1.580825e-1	1	1.580825e-1	1.000000e+0	11	1.308847e-1	1.000000e+0	1.000000e+0	7.381751e+0	1.354692e-1	1	1222	5.000000e-1	8.183306e-4	unnamed	ASPH
MGI Expression: Detected	5785	TS22_cardiovascular system	7	1.703620e-1	1.000000e+0	1.000000e+0	5.869853e+0	1.703620e-1	1	1.703620e-1	1.000000e+0	12	1.424216e-1	1.000000e+0	1.000000e+0	6.761994e+0	1.478854e-1	1	1334	5.000000e-1	7.496252e-4	unnamed	ASPH
MGI Expression: Detected	7103	TS28_heart	8	2.471289e-1	1.000000e+0	1.000000e+0	4.046471e+0	2.471289e-1	1	2.471289e-1	1.000000e+0	16	2.465427e-1	1.000000e+0	1.000000e+0	3.788534e+0	2.639543e-1	1	2381	5.000000e-1	4.199916e-4	unnamed	ASPH
MGI Expression: Detected	6415	TS22_cerebral cortex	9	2.536664e-1	1.000000e+0	1.000000e+0	3.942185e+0	2.536664e-1	1	2.536664e-1	1.000000e+0	13	2.132726e-1	1.000000e+0	1.000000e+0	4.423982e+0	2.260407e-1	1	2039	5.000000e-1	4.904365e-4	unnamed	CLVS1
MGI Expression: Detected	7098	TS28_cardiovascular system	10	2.541249e-1	1.000000e+0	1.000000e+0	3.935073e+0	2.541249e-1	1	2.541249e-1	1.000000e+0	17	2.524013e-1	1.000000e+0	1.000000e+0	3.693898e+0	2.707167e-1	1	2442	5.000000e-1	4.095004e-4	unnamed	ASPH
MGI Expression: Detected	6405	TS22_telencephalon	11	2.740885e-1	1.000000e+0	1.000000e+0	3.648457e+0	2.740885e-1	1	2.740885e-1	1.000000e+0	14	2.282455e-1	1.000000e+0	1.000000e+0	4.115192e+0	2.430021e-1	1	2192	5.000000e-1	4.562044e-4	unnamed	CLVS1
MGI Expression: Detected	7448	TS26_organ system	12	2.750733e-1	1.000000e+0	1.000000e+0	3.635395e+0	2.750733e-1	1	2.750733e-1	1.000000e+0	18	2.630034e-1	1.000000e+0	1.000000e+0	3.533294e+0	2.830220e-1	1	2553	5.000000e-1	3.916960e-4	unnamed	ASPH
MGI Expression: Detected	6366	TS22_forebrain	13	2.941681e-1	1.000000e+0	1.000000e+0	3.399417e+0	2.941681e-1	1	2.941681e-1	1.000000e+0	15	2.455801e-1	1.000000e+0	1.000000e+0	3.804513e+0	2.628457e-1	1	2371	5.000000e-1	4.217630e-4	unnamed	CLVS1
MGI Expression: Detected	6934	TS26_embryo	14	3.006505e-1	1.000000e+0	1.000000e+0	3.326122e+0	3.006505e-1	1	3.006505e-1	1.000000e+0	19	2.916520e-1	1.000000e+0	1.000000e+0	3.157333e+0	3.167230e-1	1	2857	5.000000e-1	3.500175e-4	unnamed	ASPH
MGI Expression: Detected	6933	Theiler_stage_26	15	3.012560e-1	1.000000e+0	1.000000e+0	3.319436e+0	3.012560e-1	1	3.012560e-1	1.000000e+0	20	2.923983e-1	1.000000e+0	1.000000e+0	3.148517e+0	3.176099e-1	1	2865	5.000000e-1	3.490401e-4	unnamed	ASPH
MGI Expression: Detected	6928	TS24_embryo	16	3.290828e-1	1.000000e+0	1.000000e+0	3.038749e+0	3.290828e-1	1	3.290828e-1	1.000000e+0	21	2.959376e-1	1.000000e+0	1.000000e+0	3.107303e+0	3.218225e-1	1	2903	5.000000e-1	3.444712e-4	unnamed	ASPH
MGI Expression: Detected	6927	Theiler_stage_24	17	3.296590e-1	1.000000e+0	1.000000e+0	3.033437e+0	3.296590e-1	1	3.296590e-1	1.000000e+0	22	2.964026e-1	1.000000e+0	1.000000e+0	3.101960e+0	3.223768e-1	1	2908	5.000000e-1	3.438790e-4	unnamed	ASPH
MGI Expression: Detected	6365	TS22_brain	18	3.486991e-1	1.000000e+0	1.000000e+0	2.867802e+0	3.486991e-1	1	3.486991e-1	1.000000e+0	23	2.970534e-1	1.000000e+0	1.000000e+0	3.094511e+0	3.231528e-1	1	2915	5.000000e-1	3.430532e-4	unnamed	CLVS1
MGI Expression: Detected	2023	TS17_embryo	19	3.504112e-1	1.000000e+0	1.000000e+0	2.853790e+0	3.504112e-1	1	3.504112e-1	1.000000e+0	6	3.250405e-2	1.000000e+0	1.000000e+0	5.545958e+0	3.606230e-1	2	3253	1.000000e+0	6.148171e-4	unnamed	ASPH,CLVS1
MGI Expression: Detected	2022	Theiler_stage_17	20	3.517739e-1	1.000000e+0	1.000000e+0	2.842735e+0	3.517739e-1	1	3.517739e-1	1.000000e+0	7	3.300565e-2	1.000000e+0	1.000000e+0	5.503661e+0	3.633945e-1	2	3278	1.000000e+0	6.101281e-4	unnamed	ASPH,CLVS1
MGI Expression: Detected	6351	TS22_central nervous system	21	3.611614e-1	1.000000e+0	1.000000e+0	2.768845e+0	3.611614e-1	1	3.611614e-1	1.000000e+0	24	3.110186e-1	1.000000e+0	1.000000e+0	2.942107e+0	3.398925e-1	1	3066	5.000000e-1	3.261579e-4	unnamed	CLVS1
MGI Expression: Detected	6350	TS22_nervous system	22	3.685477e-1	1.000000e+0	1.000000e+0	2.713353e+0	3.685477e-1	1	3.685477e-1	1.000000e+0	25	3.206469e-1	1.000000e+0	1.000000e+0	2.844686e+0	3.515326e-1	1	3171	5.000000e-1	3.153579e-4	unnamed	CLVS1
MGI Expression: Detected	5784	TS22_organ system	23	4.769468e-1	1.000000e+0	1.000000e+0	2.096670e+0	4.769468e-1	1	4.769468e-1	1.000000e+0	8	6.517131e-2	1.000000e+0	1.000000e+0	3.916848e+0	5.106147e-1	2	4606	1.000000e+0	4.342162e-4	unnamed	ASPH,CLVS1
MGI Expression: Detected	5741	TS22_embryo	24	5.012384e-1	1.000000e+0	1.000000e+0	1.995059e+0	5.012384e-1	1	5.012384e-1	1.000000e+0	9	7.591070e-2	1.000000e+0	1.000000e+0	3.629250e+0	5.510781e-1	2	4971	1.000000e+0	4.023335e-4	unnamed	ASPH,CLVS1
MGI Expression: Detected	5740	Theiler_stage_22	25	5.025708e-1	1.000000e+0	1.000000e+0	1.989769e+0	5.025708e-1	1	5.025708e-1	1.000000e+0	10	7.664554e-2	1.000000e+0	1.000000e+0	3.611812e+0	5.537387e-1	2	4995	1.000000e+0	4.004004e-4	unnamed	ASPH,CLVS1
MGI Expression: Detected	6944	TS28_organ system	26	6.191523e-1	1.000000e+0	1.000000e+0	1.615112e+0	6.191523e-1	1	6.191523e-1	1.000000e+0	26	6.326325e-1	1.000000e+0	1.000000e+0	1.269420e+0	7.877612e-1	1	7106	5.000000e-1	1.407261e-4	unnamed	ASPH
MGI Expression: Detected	6937	TS28_postnatal mouse	27	6.225233e-1	1.000000e+0	1.000000e+0	1.606366e+0	6.225233e-1	1	6.225233e-1	1.000000e+0	27	6.373878e-1	1.000000e+0	1.000000e+0	1.256862e+0	7.956322e-1	1	7177	5.000000e-1	1.393340e-4	unnamed	ASPH
MSigDB Perturbation	IKEDA_MIR133_TARGETS_DN	Genes down-regulated in hypertrophic hearts (due to expression of constitutively active form of PPP3CA [GeneID=5530]) and predicted to be targets of miR-133 microRNA.	1	1.763064e-3	1.000000e+0	1.000000e+0	5.671945e+2	1.763064e-3	1	1.763064e-3	1.000000e+0	4	7.758812e-4	1.000000e+0	6.525161e-1	1.288643e+3	7.760102e-4	1	7	5.000000e-1	1.428571e-1	unnamed	ASPH
MSigDB Perturbation	LIM_MAMMARY_LUMINAL_PROGENITOR_DN	Genes consistently down-regulated in mammary luminal progenitor cells both in mouse and human species.	2	1.920749e-3	1.000000e+0	1.000000e+0	5.206303e+2	1.920749e-3	1	1.920749e-3	1.000000e+0	5	1.551461e-3	1.000000e+0	1.000000e+0	6.443214e+2	1.552020e-3	1	14	5.000000e-1	7.142857e-2	unnamed	ASPH
MSigDB Perturbation	GENTILE_UV_RESPONSE_CLUSTER_D1	Cluster d1: genes down-regulated in WS1 cells (fibroblast) at 6 h after irradiation with high dose UV-C.	3	2.354059e-3	1.000000e+0	1.000000e+0	4.247982e+2	2.354059e-3	1	2.354059e-3	1.000000e+0	6	1.994515e-3	1.000000e+0	1.000000e+0	5.011389e+2	1.995455e-3	1	18	5.000000e-1	5.555556e-2	unnamed	ASPH
MSigDB Perturbation	YE_METASTATIC_LIVER_CANCER	Genes up-regulated in hepatocellular carcinoma (HCC) with intra-hepatic metastasis compared to the non-metastatic tumors.	4	2.359449e-3	1.000000e+0	1.000000e+0	4.238278e+2	2.359449e-3	1	2.359449e-3	1.000000e+0	8	2.880326e-3	1.000000e+0	1.000000e+0	3.469423e+2	2.882324e-3	1	26	5.000000e-1	3.846154e-2	unnamed	ASPH
MSigDB Perturbation	STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_DN	Genes down-regulated by estradiol [PubChem=5757] and down-regulated by ESRRA [GeneID=2101] in MCF-7 cells (breast cancer).	5	4.189664e-3	1.000000e+0	1.000000e+0	2.386826e+2	4.189664e-3	1	4.189664e-3	1.000000e+0	11	4.540164e-3	1.000000e+0	1.000000e+0	2.200122e+2	4.545203e-3	1	41	5.000000e-1	2.439024e-2	unnamed	ASPH
MSigDB Perturbation	KRIEG_HYPOXIA_VIA_KDM3A	Genes dependent on KDM3A [GeneID=55818] for hypoxic induction in RCC4 cells (renal carcinoma) expressing VHL [GeneID=7428].	6	4.925481e-3	1.000000e+0	1.000000e+0	2.030259e+2	4.925481e-3	1	4.925481e-3	1.000000e+0	13	5.867038e-3	1.000000e+0	1.000000e+0	1.701981e+2	5.875506e-3	1	53	5.000000e-1	1.886792e-2	unnamed	ASPH
MSigDB Perturbation	HOWLIN_CITED1_TARGETS_1_DN	Genes down-regulated in mammary glands from the CITED1 [GeneID=4435] knockout mice: homozygotic vs. heterozygotic animals.	7	5.644917e-3	1.000000e+0	1.000000e+0	1.771505e+2	5.644917e-3	1	5.644917e-3	1.000000e+0	10	3.987038e-3	1.000000e+0	1.000000e+0	2.505694e+2	3.990910e-3	1	36	5.000000e-1	2.777778e-2	unnamed	ASPH
MSigDB Perturbation	BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_DN	Genes down-regulated in pre B lymphocyte after induction of physiological DNA double-strand breaks (DSB) by RAG2 [GeneID=5897]; the changes are independent of ATM [GeneID=472] signaling.	8	6.428058e-3	1.000000e+0	1.000000e+0	1.555680e+2	6.428058e-3	1	6.428058e-3	1.000000e+0	15	6.530143e-3	1.000000e+0	1.000000e+0	1.528898e+2	6.540657e-3	1	59	5.000000e-1	1.694915e-2	unnamed	ASPH
MSigDB Perturbation	JI_RESPONSE_TO_FSH_DN	Down-regulated in ovarian epithelial cells (MCV152) 72 hours following FSH treatment, compared to untreated	9	6.701550e-3	1.000000e+0	1.000000e+0	1.492192e+2	6.701550e-3	1	6.701550e-3	1.000000e+0	14	6.419641e-3	1.000000e+0	1.000000e+0	1.555259e+2	6.429799e-3	1	58	5.000000e-1	1.724138e-2	unnamed	ASPH
MSigDB Perturbation	IKEDA_MIR133_TARGETS_UP	Genes up-regulated in hypertrophic hearts (due to expression of constitutively active form of PPP3CA [GeneID=5530]) and predicted to be targets of miR-133 microRNA.	10	7.048483e-3	1.000000e+0	1.000000e+0	1.418745e+2	7.048483e-3	1	7.048483e-3	1.000000e+0	12	4.761371e-3	1.000000e+0	1.000000e+0	2.097791e+2	4.766920e-3	1	43	5.000000e-1	2.325581e-2	unnamed	ASPH
MSigDB Perturbation	WENDT_COHESIN_TARGETS_UP	Cohesin targets identified by ChIP-chip which were up-regulated after knockdown of CTCF and RAD21 [GeneID=10664;5885] by RNAi.	11	7.269402e-3	1.000000e+0	1.000000e+0	1.375629e+2	7.269402e-3	1	7.269402e-3	1.000000e+0	9	3.876395e-3	1.000000e+0	1.000000e+0	2.577286e+2	3.880051e-3	1	35	5.000000e-1	2.857143e-2	unnamed	ASPH
MSigDB Perturbation	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16	Genes co-regulated in uterus during a time course response to progesterone [PubChem=5994]: SOM cluster 16.	12	8.047211e-3	1.000000e+0	1.000000e+0	1.242667e+2	8.047211e-3	1	8.047211e-3	1.000000e+0	16	8.628517e-3	1.000000e+0	1.000000e+0	1.156474e+2	8.646971e-3	1	78	5.000000e-1	1.282051e-2	unnamed	CLVS1
MSigDB Perturbation	DARWICHE_SKIN_TUMOR_PROMOTER_UP	Genes up-regulated during skin tumor progression: epidermis treated with the carcinogen DMBA [PubChem=6001] followed by 20 weekly applications of the tumor promoter TPA [PubChem=4792], compared to the untreated skin.	13	9.796613e-3	1.000000e+0	1.000000e+0	1.020761e+2	9.796613e-3	1	9.796613e-3	1.000000e+0	27	1.513038e-2	1.000000e+0	1.000000e+0	6.584307e+1	1.518763e-2	1	137	5.000000e-1	7.299270e-3	unnamed	CLVS1
MSigDB Perturbation	SMID_BREAST_CANCER_ERBB2_UP	Genes up-regulated in the erbb2 subype of breast cancer samples, characterized by higher expression of ERBB2 [GeneID=2064].	14	1.010671e-2	1.000000e+0	1.000000e+0	9.894420e+1	1.010671e-2	1	1.010671e-2	1.000000e+0	26	1.469025e-2	1.000000e+0	1.000000e+0	6.782331e+1	1.474419e-2	1	133	5.000000e-1	7.518797e-3	unnamed	ASPH
MSigDB Perturbation	ROESSLER_LIVER_CANCER_METASTASIS_UP	Genes up-regulated in liver samples containing tumor thrombi in the major branches of the portal vein at surgery (PT) compared to those from metastasis-free HCC patients (PN) at the time of surgery and at follow-up.	15	1.026454e-2	1.000000e+0	1.000000e+0	9.742279e+1	1.026454e-2	1	1.026454e-2	1.000000e+0	20	1.171681e-2	1.000000e+0	1.000000e+0	8.509906e+1	1.175101e-2	1	106	5.000000e-1	9.433962e-3	unnamed	ASPH
MSigDB Perturbation	DARWICHE_PAPILLOMA_RISK_HIGH_UP	Genes up-regulated during skin tumor progression from normal skin to high risk papilloma.	16	1.029191e-2	1.000000e+0	1.000000e+0	9.716370e+1	1.029191e-2	1	1.029191e-2	1.000000e+0	31	1.579039e-2	1.000000e+0	1.000000e+0	6.308042e+1	1.585278e-2	1	143	5.000000e-1	6.993007e-3	unnamed	CLVS1
MSigDB Perturbation	UDAYAKUMAR_MED1_TARGETS_UP	Genes up-regulated in HeLa cells after knockdown of MED1 [GeneID=5469] by RNAi.	17	1.130485e-2	1.000000e+0	1.000000e+0	8.845760e+1	1.130485e-2	1	1.130485e-2	1.000000e+0	25	1.458020e-2	1.000000e+0	1.000000e+0	6.833712e+1	1.463334e-2	1	132	5.000000e-1	7.575758e-3	unnamed	ASPH
MSigDB Perturbation	DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP	Genes up-regulated in squamous cell carcinoma (SCC) compared to normal skin.	18	1.138715e-2	1.000000e+0	1.000000e+0	8.781828e+1	1.138715e-2	1	1.138715e-2	1.000000e+0	30	1.546041e-2	1.000000e+0	1.000000e+0	6.443214e+1	1.552020e-2	1	140	5.000000e-1	7.142857e-3	unnamed	CLVS1
MSigDB Perturbation	SENESE_HDAC2_TARGETS_UP	Genes up-regulated in U2OS cells (osteosarcoma) upon knockdown of HDAC2 [GeneID=3066] by RNAi.	19	1.180215e-2	1.000000e+0	1.000000e+0	8.473034e+1	1.180215e-2	1	1.180215e-2	1.000000e+0	21	1.204742e-2	1.000000e+0	1.000000e+0	8.275688e+1	1.208359e-2	1	109	5.000000e-1	9.174312e-3	unnamed	ASPH
MSigDB Perturbation	IGARASHI_ATF4_TARGETS_DN	Genes down-regulated in A549 cells (lung cancer) after knockdown of ATF4 [GeneID=468] by RNAi.	20	1.191435e-2	1.000000e+0	1.000000e+0	8.393242e+1	1.191435e-2	1	1.191435e-2	1.000000e+0	19	9.732033e-3	1.000000e+0	1.000000e+0	1.025057e+2	9.755557e-3	1	88	5.000000e-1	1.136364e-2	unnamed	ASPH
MSigDB Perturbation	BOYLAN_MULTIPLE_MYELOMA_D_UP	Genes up-regulated in group D of tumors arising from overexpression of BCL2L1 and MYC [GeneID=598;4609] in plasma cells.	21	1.304595e-2	1.000000e+0	1.000000e+0	7.665212e+1	1.304595e-2	1	1.304595e-2	1.000000e+0	18	9.511379e-3	1.000000e+0	1.000000e+0	1.048895e+2	9.533840e-3	1	86	5.000000e-1	1.162791e-2	unnamed	ASPH
MSigDB Perturbation	NIKOLSKY_BREAST_CANCER_8Q12_Q22_AMPLICON	Genes within amplicon 8q12-q22 identified in a copy number alterations study of 191 breast tumor samples.	22	1.327803e-2	1.000000e+0	1.000000e+0	7.531237e+1	1.327803e-2	1	1.327803e-2	1.000000e+0	2	4.839310e-5	1.627944e-1	8.139719e-2	1.431825e+2	1.396818e-2	2	126	1.000000e+0	1.587302e-2	unnamed	ASPH,CLVS1
MSigDB Perturbation	KIM_WT1_TARGETS_8HR_DN	Genes down-regulated in UB27 cells (osteosarcoma) at 8 hr after inducing the expression of a mutant form of WT1 [GeneID=7490].	23	1.348869e-2	1.000000e+0	1.000000e+0	7.413620e+1	1.348869e-2	1	1.348869e-2	1.000000e+0	22	1.380970e-2	1.000000e+0	1.000000e+0	7.216400e+1	1.385732e-2	1	125	5.000000e-1	8.000000e-3	unnamed	ASPH
MSigDB Perturbation	DARWICHE_PAPILLOMA_RISK_LOW_DN	Genes down-regulated during skin tumor progression from low risk papilloma vs normal skin.	24	1.408239e-2	1.000000e+0	1.000000e+0	7.101066e+1	1.408239e-2	1	1.408239e-2	1.000000e+0	33	1.688991e-2	1.000000e+0	1.000000e+0	5.895752e+1	1.696137e-2	1	153	5.000000e-1	6.535948e-3	unnamed	CLVS1
MSigDB Perturbation	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4	Genes regulated in MCF7 cells (breast cancer) by expression of the full-length and truncated (611-CTF) forms of ERBB2 [GeneID=2064] at 60 h time point.	25	1.430951e-2	1.000000e+0	1.000000e+0	6.988361e+1	1.430951e-2	1	1.430951e-2	1.000000e+0	1	3.041852e-5	1.023279e-1	1.023279e-1	1.804100e+2	1.108586e-2	2	100	1.000000e+0	2.000000e-2	unnamed	ASPH,CLVS1
MSigDB Perturbation	LEE_TARGETS_OF_PTCH1_AND_SUFU_DN	Genes down-regulated in medulloblastoma tumors from animals with  inactivating mutations of one copy of PTCH1 or SUFU [GeneID=5727;51684] in conjunction with TP53 [GeneID=7157] loss.	26	1.431135e-2	1.000000e+0	1.000000e+0	6.987463e+1	1.431135e-2	1	1.431135e-2	1.000000e+0	17	9.180352e-3	1.000000e+0	1.000000e+0	1.086807e+2	9.201264e-3	1	83	5.000000e-1	1.204819e-2	unnamed	ASPH
MSigDB Perturbation	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN	Genes down-regulated in patients at the incipient stage of Alzheimer's disease.	27	1.688317e-2	1.000000e+0	1.000000e+0	5.923057e+1	1.688317e-2	1	1.688317e-2	1.000000e+0	34	1.820853e-2	1.000000e+0	1.000000e+0	5.466970e+1	1.829167e-2	1	165	5.000000e-1	6.060606e-3	unnamed	ASPH
MSigDB Perturbation	PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN	Genes down-regulated in OV-90 cells (ovarian cancer) exposed to ascites which inhibited invasion.	28	1.751752e-2	1.000000e+0	1.000000e+0	5.708571e+1	1.751752e-2	1	1.751752e-2	1.000000e+0	32	1.590037e-2	1.000000e+0	1.000000e+0	6.264236e+1	1.596364e-2	1	144	5.000000e-1	6.944444e-3	unnamed	ASPH
MSigDB Perturbation	ALCALAY_AML_BY_NPM1_LOCALIZATION_UP	Genes up-regulated in acute myeloid leukemia (AML) with respect to cellular localization of NPM1 [GeneID=4869]: cytoplasmic vs. nucleolar.	29	1.753124e-2	1.000000e+0	1.000000e+0	5.704102e+1	1.753124e-2	1	1.753124e-2	1.000000e+0	28	1.535041e-2	1.000000e+0	1.000000e+0	6.489568e+1	1.540935e-2	1	139	5.000000e-1	7.194245e-3	unnamed	ASPH
MSigDB Perturbation	GOZGIT_ESR1_TARGETS_UP	Genes up-regulated in TMX2-28 cells (breast cancer) which do not express ESR1 [GeneID=2099]) compared to the parental MCF7 cells which do.	30	1.766136e-2	1.000000e+0	1.000000e+0	5.662077e+1	1.766136e-2	1	1.766136e-2	1.000000e+0	28	1.535041e-2	1.000000e+0	1.000000e+0	6.489568e+1	1.540935e-2	1	139	5.000000e-1	7.194245e-3	unnamed	ASPH
MSigDB Perturbation	ELVIDGE_HYPOXIA_BY_DMOG_UP	Genes up-regulated in MCF7 cells (breast cancer) treated with hypoxia mimetic DMOG [PubChem=3080614].	31	1.777575e-2	1.000000e+0	1.000000e+0	5.625643e+1	1.777575e-2	1	1.777575e-2	1.000000e+0	24	1.436009e-2	1.000000e+0	1.000000e+0	6.938846e+1	1.441162e-2	1	130	5.000000e-1	7.692308e-3	unnamed	ASPH
MSigDB Perturbation	INGRAM_SHH_TARGETS_UP	Genes up-regulated in 10T1/2 cells (multipotent mesoderma) by expression of SHH [GeneID=6469].	32	1.793194e-2	1.000000e+0	1.000000e+0	5.576641e+1	1.793194e-2	1	1.793194e-2	1.000000e+0	22	1.380970e-2	1.000000e+0	1.000000e+0	7.216400e+1	1.385732e-2	1	125	5.000000e-1	8.000000e-3	unnamed	CLVS1
MSigDB Perturbation	IWANAGA_CARCINOGENESIS_BY_KRAS_UP	Cluster 3: genes up-regulated in lung tissue samples from mice with tumor-bearing genotypes (activated KRAS [GeneID=3845] alone or together with inactivated PTEN [GeneID=5728]).	33	2.110968e-2	1.000000e+0	1.000000e+0	4.737163e+1	2.110968e-2	1	2.110968e-2	1.000000e+0	35	1.842821e-2	1.000000e+0	1.000000e+0	5.401497e+1	1.851339e-2	1	167	5.000000e-1	5.988024e-3	unnamed	ASPH
MSigDB Perturbation	PEDRIOLI_MIR31_TARGETS_UP	Genes up-regulated in primary LEC cells (lymphatic endothelum) upon overexpression of MIR31 [GeneID=407035].	34	2.222875e-2	1.000000e+0	1.000000e+0	4.498679e+1	2.222875e-2	1	2.222875e-2	1.000000e+0	37	2.183015e-2	1.000000e+0	1.000000e+0	4.555808e+1	2.195000e-2	1	198	5.000000e-1	5.050505e-3	unnamed	ASPH
MSigDB Perturbation	ELVIDGE_HYPOXIA_UP	Genes up-regulated in MCF7 cells (breast cancer) under hypoxia conditions.	35	2.251653e-2	1.000000e+0	1.000000e+0	4.441182e+1	2.251653e-2	1	2.251653e-2	1.000000e+0	36	1.875769e-2	1.000000e+0	1.000000e+0	5.306176e+1	1.884596e-2	1	170	5.000000e-1	5.882353e-3	unnamed	ASPH
MSigDB Perturbation	LIU_SOX4_TARGETS_DN	Genes down-regulated in LNCaP cells (prostate cancer) by overexpression of SOX4 [GeneID=6659] and up-regulated by its RNAi knockdown.	36	2.380380e-2	1.000000e+0	1.000000e+0	4.201010e+1	2.380380e-2	1	2.380380e-2	1.000000e+0	45	3.374495e-2	1.000000e+0	1.000000e+0	2.938274e+1	3.403359e-2	1	307	5.000000e-1	3.257329e-3	unnamed	ASPH
MSigDB Perturbation	MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED	Genes with high-CpG-density promoters (HCP) with unmethylated histone H3 in MEF cells (embryonic fibroblast).	37	2.453239e-2	1.000000e+0	1.000000e+0	4.076244e+1	2.453239e-2	1	2.453239e-2	1.000000e+0	39	2.336458e-2	1.000000e+0	1.000000e+0	4.254953e+1	2.350202e-2	1	212	5.000000e-1	4.716981e-3	unnamed	CLVS1
MSigDB Perturbation	KIM_WT1_TARGETS_12HR_DN	Genes down-regulated in UB27 cells (osteosarcoma) at 12 hr after inducing the expression of a mutated form of WT1 [GeneID=7490].	38	2.628066e-2	1.000000e+0	1.000000e+0	3.805080e+1	2.628066e-2	1	2.628066e-2	1.000000e+0	38	2.204943e-2	1.000000e+0	1.000000e+0	4.510250e+1	2.217172e-2	1	200	5.000000e-1	5.000000e-3	unnamed	ASPH
MSigDB Perturbation	PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP	Genes up-regulated in post-GC, BCL6 [GeneID=604] dependent B cell non-Hodgkin's lymphoma (B-NHL) vs MYC [GeneID=4609] driven pre-GC lymphoma.	39	2.796506e-2	1.000000e+0	1.000000e+0	3.575890e+1	2.796506e-2	1	2.796506e-2	1.000000e+0	3	2.281573e-4	7.675212e-1	2.558404e-1	6.608425e+1	3.026440e-2	2	273	1.000000e+0	7.326007e-3	unnamed	ASPH,CLVS1
MSigDB Perturbation	JIANG_HYPOXIA_NORMAL	Genes up-regulated in RPTEC cells (normal kidney) by hypoxia.	40	2.802354e-2	1.000000e+0	1.000000e+0	3.568428e+1	2.802354e-2	1	2.802354e-2	1.000000e+0	44	3.352698e-2	1.000000e+0	1.000000e+0	2.957541e+1	3.381187e-2	1	305	5.000000e-1	3.278689e-3	unnamed	ASPH
MSigDB Perturbation	DOANE_RESPONSE_TO_ANDROGEN_DN	Genes down-regulated in MDA-MB-453 cells (class A ER(-) [GeneID=2099] breast cancer) after exposure to the androgen R1881 [PubChem=13766].	41	2.973318e-2	1.000000e+0	1.000000e+0	3.363246e+1	2.973318e-2	1	2.973318e-2	1.000000e+0	41	2.544509e-2	1.000000e+0	1.000000e+0	3.904978e+1	2.560834e-2	1	231	5.000000e-1	4.329004e-3	unnamed	ASPH
MSigDB Perturbation	ZHENG_GLIOBLASTOMA_PLASTICITY_UP	The glioblastoma multiforme (GBM) plasticity signature: genes up-regulated in neural stem cells (NSC) with double knockout of TP53 and PTEN [GeneID=7157;5728] vs those with knockout of TP53 alone.	42	3.204692e-2	1.000000e+0	1.000000e+0	3.120425e+1	3.204692e-2	1	3.204692e-2	1.000000e+0	42	2.839779e-2	1.000000e+0	1.000000e+0	3.496318e+1	2.860152e-2	1	258	5.000000e-1	3.875969e-3	unnamed	ASPH
MSigDB Perturbation	MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP	The postradiation tumor escape signature: genes up-regulated in tumors from irradiated stroma vs those from non-irradiated stroma.	43	3.646957e-2	1.000000e+0	1.000000e+0	2.742012e+1	3.646957e-2	1	3.646957e-2	1.000000e+0	49	4.070677e-2	1.000000e+0	1.000000e+0	2.431402e+1	4.112854e-2	1	371	5.000000e-1	2.695418e-3	unnamed	ASPH
MSigDB Perturbation	STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN	Genes down-regulated in prefrontal cortex (PFC) of mice carrying a hemizygotic microdeletion in the 22q11.2 region.	44	3.826834e-2	1.000000e+0	1.000000e+0	2.613126e+1	3.826834e-2	1	3.826834e-2	1.000000e+0	57	5.509380e-2	1.000000e+0	1.000000e+0	1.789782e+1	5.587273e-2	1	504	5.000000e-1	1.984127e-3	unnamed	ASPH
MSigDB Perturbation	DELYS_THYROID_CANCER_DN	Genes down-regulated in papillary thyroid carcinoma (PTC) compared to normal tissue.	45	4.103729e-2	1.000000e+0	1.000000e+0	2.436808e+1	4.103729e-2	1	4.103729e-2	1.000000e+0	40	2.533565e-2	1.000000e+0	1.000000e+0	3.921957e+1	2.549748e-2	1	230	5.000000e-1	4.347826e-3	unnamed	ASPH
MSigDB Perturbation	GENTILE_UV_HIGH_DOSE_DN	Selected genes down-regulated in WS1 (fibroblast) in response to irradiation with high dose UV-C.	46	4.328671e-2	1.000000e+0	1.000000e+0	2.310178e+1	4.328671e-2	1	4.328671e-2	1.000000e+0	46	3.461655e-2	1.000000e+0	1.000000e+0	2.863651e+1	3.492046e-2	1	315	5.000000e-1	3.174603e-3	unnamed	ASPH
MSigDB Perturbation	BASAKI_YBX1_TARGETS_DN	Genes down-regulated in SKOC-3 cells (ovarian cancer) after YB-1 (YBX1) [GeneID=4904] knockdown by RNAi.	47	4.411758e-2	1.000000e+0	1.000000e+0	2.266670e+1	4.411758e-2	1	4.411758e-2	1.000000e+0	48	3.864260e-2	1.000000e+0	1.000000e+0	2.562642e+1	3.902223e-2	1	352	5.000000e-1	2.840909e-3	unnamed	ASPH
MSigDB Perturbation	JAATINEN_HEMATOPOIETIC_STEM_CELL_UP	Genes up-regulated in CD133+ [GeneID=8842] cells (hematopoietic stem cells, HSC) compared to the CD133- cells.	48	4.458995e-2	1.000000e+0	1.000000e+0	2.242658e+1	4.458995e-2	1	4.458995e-2	1.000000e+0	43	3.210963e-2	1.000000e+0	1.000000e+0	3.089212e+1	3.237071e-2	1	292	5.000000e-1	3.424658e-3	unnamed	ASPH
MSigDB Perturbation	LU_EZH2_TARGETS_DN	Genes down-regulated in SKOV3ip1 cells (ovarian cancer) upon knockdown of EZH2 [GeneID=2146] by RNAi.	49	4.532625e-2	1.000000e+0	1.000000e+0	2.206227e+1	4.532625e-2	1	4.532625e-2	1.000000e+0	50	4.124960e-2	1.000000e+0	1.000000e+0	2.399069e+1	4.168283e-2	1	376	5.000000e-1	2.659574e-3	unnamed	ASPH
MSigDB Perturbation	STEIN_ESRRA_TARGETS	Genes regulated by ESRRA [GeneID=2101] in MCF-7 cells (breast cancer).	50	4.591289e-2	1.000000e+0	1.000000e+0	2.178037e+1	4.591289e-2	1	4.591289e-2	1.000000e+0	58	5.724786e-2	1.000000e+0	1.000000e+0	1.721469e+1	5.808991e-2	1	524	5.000000e-1	1.908397e-3	unnamed	ASPH
MSigDB Perturbation	JOHNSTONE_PARVB_TARGETS_2_DN	Genes down-regulated upon overexpression of PARVB [GeneID=29780] in MDA-MB-231 cells (breast cancer) cultured in 3D collagen I and 3D Matrigel only.	51	4.806995e-2	1.000000e+0	1.000000e+0	2.080302e+1	4.806995e-2	1	4.806995e-2	1.000000e+0	47	3.537888e-2	1.000000e+0	1.000000e+0	2.801398e+1	3.569647e-2	1	322	5.000000e-1	3.105590e-3	unnamed	ASPH
MSigDB Perturbation	LIAO_METASTASIS	Genes up-regulated in the samples with intrahepatic metastatic hepatocellular carcinoma (HCC) vs primary HCC.	52	4.955050e-2	1.000000e+0	1.000000e+0	2.018143e+1	4.955050e-2	1	4.955050e-2	1.000000e+0	56	5.423149e-2	1.000000e+0	1.000000e+0	1.818649e+1	5.498587e-2	1	496	5.000000e-1	2.016129e-3	unnamed	ASPH
MSigDB Perturbation	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	Genes up-regulated during later stage of differentiation of Oli-Neu cells (oligodendroglial precursor) in response to PD174265 [PubChemID=4709].	53	4.971953e-2	1.000000e+0	1.000000e+0	2.011282e+1	4.971953e-2	1	4.971953e-2	1.000000e+0	59	5.961449e-2	1.000000e+0	1.000000e+0	1.652106e+1	6.052880e-2	1	546	5.000000e-1	1.831502e-3	unnamed	ASPH
MSigDB Perturbation	HAN_SATB1_TARGETS_DN	Genes down-regulated in MDA-MB-231 cells (breast cancer) after knockdown of SATB1 [GeneID=6304] by RNAi.	54	5.266731e-2	1.000000e+0	1.000000e+0	1.898711e+1	5.266731e-2	1	5.266731e-2	1.000000e+0	51	4.688595e-2	1.000000e+0	1.000000e+0	2.107593e+1	4.744748e-2	1	428	5.000000e-1	2.336449e-3	unnamed	ASPH
MSigDB Perturbation	SENESE_HDAC1_TARGETS_UP	Genes up-regulated in U2OS cells (osteosarcoma) upon knockdown of HDAC1 [GeneID=3065] by RNAi.	55	5.286044e-2	1.000000e+0	1.000000e+0	1.891774e+1	5.286044e-2	1	5.286044e-2	1.000000e+0	52	4.721062e-2	1.000000e+0	1.000000e+0	2.092923e+1	4.778006e-2	1	431	5.000000e-1	2.320186e-3	unnamed	ASPH
MSigDB Perturbation	PILON_KLF1_TARGETS_UP	Genes up-regulated in erythroid progenitor cells from fetal livers of E13.5 embryos with KLF1 [GeneID=10661] knockout compared to those from the wild type embryos.	56	5.387062e-2	1.000000e+0	1.000000e+0	1.856299e+1	5.387062e-2	1	5.387062e-2	1.000000e+0	54	5.347664e-2	1.000000e+0	1.000000e+0	1.844683e+1	5.420986e-2	1	489	5.000000e-1	2.044990e-3	unnamed	ASPH
MSigDB Perturbation	FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP	Genes up-regulated in monocyte-derived dendritic cells (MDDC) after stimulation with galecin-1 (lectin, LGALS1) [GeneID=3956] compared to that with bacterial lipopolysaccharide (LPS).	57	5.507944e-2	1.000000e+0	1.000000e+0	1.815559e+1	5.507944e-2	1	5.507944e-2	1.000000e+0	61	6.090412e-2	1.000000e+0	1.000000e+0	1.616577e+1	6.185910e-2	1	558	5.000000e-1	1.792115e-3	unnamed	ASPH
MSigDB Perturbation	BROWNE_HCMV_INFECTION_48HR_DN	Genes down-regulated in primary fibroblast cell culture after infection with HCMV (AD169 strain) at 48 h time point that were not down-regulated at the previous time point, 24 h.	58	5.544365e-2	1.000000e+0	1.000000e+0	1.803633e+1	5.544365e-2	1	5.544365e-2	1.000000e+0	55	5.369234e-2	1.000000e+0	1.000000e+0	1.837169e+1	5.443157e-2	1	491	5.000000e-1	2.036660e-3	unnamed	ASPH
MSigDB Perturbation	MARTINEZ_RB1_AND_TP53_TARGETS_UP	Genes up-regulated in mice with skin specific double knockout of both RB1 and TP53 [GeneID=5925;7157] by Cre-lox.	59	5.663788e-2	1.000000e+0	1.000000e+0	1.765603e+1	5.663788e-2	1	5.663788e-2	1.000000e+0	63	6.390983e-2	1.000000e+0	1.000000e+0	1.539334e+1	6.496314e-2	1	586	5.000000e-1	1.706485e-3	unnamed	ASPH
MSigDB Perturbation	MARTINEZ_TP53_TARGETS_UP	Genes up-regulated in mice with skin specific knockout of TP53 [GeneID=7157].	60	5.702439e-2	1.000000e+0	1.000000e+0	1.753636e+1	5.702439e-2	1	5.702439e-2	1.000000e+0	62	6.380257e-2	1.000000e+0	1.000000e+0	1.541966e+1	6.485228e-2	1	585	5.000000e-1	1.709402e-3	unnamed	ASPH
MSigDB Perturbation	PATIL_LIVER_CANCER	Genes up-regulated in hepatocellular carcinoma (HCC) compared to normal liver samples.	61	5.982431e-2	1.000000e+0	1.000000e+0	1.671561e+1	5.982431e-2	1	5.982431e-2	1.000000e+0	68	7.875969e-2	1.000000e+0	1.000000e+0	1.244207e+1	8.037248e-2	1	725	5.000000e-1	1.379310e-3	unnamed	CLVS1
MSigDB Perturbation	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN	Down-regulated genes in peripheral zone of human pancreatic cancer growing in the pancreas of nude mice compared to that of the tumor from the central zone.	62	6.253641e-2	1.000000e+0	1.000000e+0	1.599068e+1	6.253641e-2	1	6.253641e-2	1.000000e+0	64	6.508932e-2	1.000000e+0	1.000000e+0	1.510972e+1	6.618258e-2	1	597	5.000000e-1	1.675042e-3	unnamed	ASPH
MSigDB Perturbation	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8D	Genes with promoters bound by both PPARG and RXRA [GeneID=5468, 6256] at 8 day time point of adipocyte differentiation of 3T3-L1 cells (preadipocyte).	63	6.300120e-2	1.000000e+0	1.000000e+0	1.587271e+1	6.300120e-2	1	6.300120e-2	1.000000e+0	72	9.496795e-2	1.000000e+0	1.000000e+0	1.027392e+1	9.733385e-2	1	878	5.000000e-1	1.138952e-3	unnamed	ASPH
MSigDB Perturbation	MASSARWEH_TAMOXIFEN_RESISTANCE_UP	Genes up-regulated in breast cancer tumors (formed by MCF-7 xenografts) resistant to tamoxifen [PubChem=5376].	64	6.485064e-2	1.000000e+0	1.000000e+0	1.542005e+1	6.485064e-2	1	6.485064e-2	1.000000e+0	60	5.972199e-2	1.000000e+0	1.000000e+0	1.649086e+1	6.063965e-2	1	547	5.000000e-1	1.828154e-3	unnamed	ASPH
MSigDB Perturbation	MARTINEZ_RB1_TARGETS_UP	Genes up-regulated in mice with skin specific knockout of RB1 [GeneID=5925] by Cre-lox.	65	6.518802e-2	1.000000e+0	1.000000e+0	1.534024e+1	6.518802e-2	1	6.518802e-2	1.000000e+0	65	7.150984e-2	1.000000e+0	1.000000e+0	1.372983e+1	7.283410e-2	1	657	5.000000e-1	1.522070e-3	unnamed	ASPH
MSigDB Perturbation	SENESE_HDAC3_TARGETS_UP	Genes up-regulated in U2OS cells (osteosarcoma) upon knockdown of HDAC3 [GeneID=8841] by RNAi.	66	6.886261e-2	1.000000e+0	1.000000e+0	1.452167e+1	6.886261e-2	1	6.886261e-2	1.000000e+0	53	5.207398e-2	1.000000e+0	1.000000e+0	1.895063e+1	5.276869e-2	1	476	5.000000e-1	2.100840e-3	unnamed	ASPH
MSigDB Perturbation	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3	The 'group 3 set' of genes associated with acquired endocrine therapy resistance in breast tumors expressing ESR1 and ERBB2 [GeneID=2099;2064].	67	7.827498e-2	1.000000e+0	1.000000e+0	1.277547e+1	7.827498e-2	1	7.827498e-2	1.000000e+0	67	7.321825e-2	1.000000e+0	1.000000e+0	1.340342e+1	7.460784e-2	1	673	5.000000e-1	1.485884e-3	unnamed	ASPH
MSigDB Perturbation	MARSON_BOUND_BY_FOXP3_STIMULATED	Genes with promoters bound by FOXP3 [GeneID=50943] in hybridoma cells stimulated by PMA [PubChem=4792] and ionomycin [PubChem=3733].	68	7.982095e-2	1.000000e+0	1.000000e+0	1.252804e+1	7.982095e-2	1	7.982095e-2	1.000000e+0	73	1.065321e-1	1.000000e+0	1.000000e+0	9.130061e+0	1.095283e-1	1	988	5.000000e-1	1.012146e-3	unnamed	ASPH
MSigDB Perturbation	SMID_BREAST_CANCER_BASAL_DN	Genes down-regulated in basal subtype of breast cancer samles.	69	8.172677e-2	1.000000e+0	1.000000e+0	1.223589e+1	8.172677e-2	1	8.172677e-2	1.000000e+0	66	7.225746e-2	1.000000e+0	1.000000e+0	1.358509e+1	7.361011e-2	1	664	5.000000e-1	1.506024e-3	unnamed	ASPH
MSigDB Perturbation	NUYTTEN_NIPP1_TARGETS_DN	Genes down-regulated in PC3 cells (prostate cancer) after knockdown of NIPP1 [GeneID=5511] by RNAi.	70	8.207799e-2	1.000000e+0	1.000000e+0	1.218353e+1	8.207799e-2	1	8.207799e-2	1.000000e+0	70	8.767615e-2	1.000000e+0	1.000000e+0	1.115019e+1	8.968461e-2	1	809	5.000000e-1	1.236094e-3	unnamed	ASPH
MSigDB Perturbation	ONKEN_UVEAL_MELANOMA_UP	Genes up-regulated in uveal melanoma: class 2 vs class 1 tumors.	71	8.290379e-2	1.000000e+0	1.000000e+0	1.206218e+1	8.290379e-2	1	8.290379e-2	1.000000e+0	69	8.311719e-2	1.000000e+0	1.000000e+0	1.177611e+1	8.491769e-2	1	766	5.000000e-1	1.305483e-3	unnamed	ASPH
MSigDB Perturbation	JOHNSTONE_PARVB_TARGETS_3_DN	Genes down-regulated upon overexpression of PARVB [GeneID=29780] in MDA-MB-231 cells (breast cancer) cultured in 3D Matrigel only.	72	8.753961e-2	1.000000e+0	1.000000e+0	1.142340e+1	8.753961e-2	1	8.753961e-2	1.000000e+0	71	9.317413e-2	1.000000e+0	1.000000e+0	1.047677e+1	9.544925e-2	1	861	5.000000e-1	1.161440e-3	unnamed	ASPH
MSigDB Perturbation	GEORGES_TARGETS_OF_MIR192_AND_MIR215	Genes down-regulated in HCT116 cells (colon cancer) by expression of MIR192 or MIR215 [GeneID=406967;406997] at 24 h.	73	9.671084e-2	1.000000e+0	1.000000e+0	1.034010e+1	9.671084e-2	1	9.671084e-2	1.000000e+0	7	2.186114e-3	1.000000e+0	1.000000e+0	2.137559e+1	9.356466e-2	2	844	1.000000e+0	2.369668e-3	unnamed	ASPH,CLVS1
MSigDB Perturbation	BRUINS_UVC_RESPONSE_LATE	Late response genes: differentially expressed only 12 h after UV-C irradiation of MEF cells (embryonic fibroblast).	74	1.021113e-1	1.000000e+0	1.000000e+0	9.793235e+0	1.021113e-1	1	1.021113e-1	1.000000e+0	74	1.178136e-1	1.000000e+0	1.000000e+0	8.230383e+0	1.215010e-1	1	1096	5.000000e-1	9.124088e-4	unnamed	ASPH
MSigDB Perturbation	BLALOCK_ALZHEIMERS_DISEASE_DN	Genes down-regulated in brain from patients with Alzheimer's disease.	75	1.457059e-1	1.000000e+0	1.000000e+0	6.863142e+0	1.457059e-1	1	1.457059e-1	1.000000e+0	75	1.317114e-1	1.000000e+0	1.000000e+0	7.333740e+0	1.363561e-1	1	1230	5.000000e-1	8.130081e-4	unnamed	ASPH
MSigDB Perturbation	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN	Genes down-regulated in ME-A cells (breast cancer) undergoing apoptosis in response to doxorubicin [PubChem=31703].	76	1.826173e-1	1.000000e+0	1.000000e+0	5.475932e+0	1.826173e-1	1	1.826173e-1	1.000000e+0	76	1.827952e-1	1.000000e+0	1.000000e+0	5.208141e+0	1.920071e-1	1	1732	5.000000e-1	5.773672e-4	unnamed	ASPH
MSigDB Predicted Promoter Motifs	RNCTGNYNRNCTGNY_UNKNOWN	Motif RNCTGNYNRNCTGNY (no known TF)	1	9.088779e-3	1.000000e+0	1.000000e+0	1.100258e+2	9.088779e-3	1	9.088779e-3	1.000000e+0	3	8.518131e-3	1.000000e+0	1.000000e+0	1.171494e+2	8.536112e-3	1	77	5.000000e-1	1.298701e-2	unnamed	CLVS1
MSigDB Predicted Promoter Motifs	RYCACNNRNNRNCAG_UNKNOWN	Motif RYCACNNRNNRNCAG (no known TF)	2	9.981801e-3	1.000000e+0	1.000000e+0	1.001823e+2	9.981801e-3	1	9.981801e-3	1.000000e+0	2	8.076528e-3	1.000000e+0	1.000000e+0	1.235685e+2	8.092678e-3	1	73	5.000000e-1	1.369863e-2	unnamed	CLVS1
MSigDB Predicted Promoter Motifs	V$YY1_02	Motif NNNCGGCCATCTTGNCTSNW matches YY1: YY1 transcription factor	3	2.196693e-2	1.000000e+0	1.000000e+0	4.552296e+1	2.196693e-2	1	2.196693e-2	1.000000e+0	15	2.500727e-2	1.000000e+0	1.000000e+0	3.973789e+1	2.516490e-2	1	227	5.000000e-1	4.405286e-3	unnamed	CLVS1
MSigDB Predicted Promoter Motifs	V$MEF2_01	Motif CTCTAAAAATAACYCY (no known TF)	4	2.257525e-2	1.000000e+0	1.000000e+0	4.429630e+1	2.257525e-2	1	2.257525e-2	1.000000e+0	5	1.480029e-2	1.000000e+0	1.000000e+0	6.731716e+1	1.485505e-2	1	134	5.000000e-1	7.462687e-3	unnamed	ASPH
MSigDB Predicted Promoter Motifs	V$STAT_01	Motif TTCCCGKAA (no known TF)	5	2.382135e-2	1.000000e+0	1.000000e+0	4.197915e+1	2.382135e-2	1	2.382135e-2	1.000000e+0	26	2.653920e-2	1.000000e+0	6.277542e-1	3.742946e+1	2.671692e-2	1	241	5.000000e-1	4.149378e-3	unnamed	ASPH
MSigDB Predicted Promoter Motifs	V$NERF_Q2	Motif YRNCAGGAAGYRNSTBDS matches ELF2: E74-like factor 2 (ets domain transcription factor)	6	2.390919e-2	1.000000e+0	1.000000e+0	4.182491e+1	2.390919e-2	1	2.390919e-2	1.000000e+0	27	2.664858e-2	1.000000e+0	6.069954e-1	3.727479e+1	2.682778e-2	1	242	5.000000e-1	4.132231e-3	unnamed	CLVS1
MSigDB Predicted Promoter Motifs	V$RORA2_01	Motif NWAWNTAGGTCAN matches RORA: RAR-related orphan receptor A	7	2.451310e-2	1.000000e+0	1.000000e+0	4.079451e+1	2.451310e-2	1	2.451310e-2	1.000000e+0	6	1.546041e-2	1.000000e+0	1.000000e+0	6.443214e+1	1.552020e-2	1	140	5.000000e-1	7.142857e-3	unnamed	ASPH
MSigDB Predicted Promoter Motifs	V$AHR_Q5	Motif NTNGCGTGNNN matches AHR: aryl hydrocarbon receptor	8	2.624093e-2	1.000000e+0	1.000000e+0	3.810841e+1	2.624093e-2	1	2.624093e-2	1.000000e+0	11	2.303588e-2	1.000000e+0	1.000000e+0	4.316029e+1	2.316945e-2	1	209	5.000000e-1	4.784689e-3	unnamed	ASPH
MSigDB Predicted Promoter Motifs	V$HEB_Q6	Motif RCCWGCTG matches TCF12: transcription factor 12 (HTF4, helix-loop-helix transcription factors 4)	9	2.710963e-2	1.000000e+0	1.000000e+0	3.688726e+1	2.710963e-2	1	2.710963e-2	1.000000e+0	40	2.883484e-2	1.000000e+0	4.433357e-1	3.442939e+1	2.904495e-2	1	262	5.000000e-1	3.816794e-3	unnamed	CLVS1
MSigDB Predicted Promoter Motifs	YTAAYNGCT_UNKNOWN	Motif YTAAYNGCT (no known TF)	10	2.718888e-2	1.000000e+0	1.000000e+0	3.677975e+1	2.718888e-2	1	2.718888e-2	1.000000e+0	7	1.590037e-2	1.000000e+0	1.000000e+0	6.264236e+1	1.596364e-2	1	144	5.000000e-1	6.944444e-3	unnamed	CLVS1
MSigDB Predicted Promoter Motifs	V$AP1_Q2	Motif RSTGACTNANW matches JUN: jun oncogene	11	2.741221e-2	1.000000e+0	1.000000e+0	3.648010e+1	2.741221e-2	1	2.741221e-2	1.000000e+0	36	2.817922e-2	1.000000e+0	4.813950e-1	3.523633e+1	2.837980e-2	1	256	5.000000e-1	3.906250e-3	unnamed	CLVS1
MSigDB Predicted Promoter Motifs	V$SRF_Q4	Motif SCCAWATAWGGMNMNNNN matches SRF: serum response factor (c-fos serum response element-binding transcription factor)	12	2.819877e-2	1.000000e+0	1.000000e+0	3.546254e+1	2.819877e-2	1	2.819877e-2	1.000000e+0	12	2.358369e-2	1.000000e+0	1.000000e+0	4.215187e+1	2.372374e-2	1	214	5.000000e-1	4.672897e-3	unnamed	ASPH
MSigDB Predicted Promoter Motifs	V$NKX22_01	Motif TTAAGTRSTT matches NKX2-2: NK2 transcription factor related, locus 2 (Drosophila)	13	2.928313e-2	1.000000e+0	1.000000e+0	3.414935e+1	2.928313e-2	1	2.928313e-2	1.000000e+0	9	1.985555e-2	1.000000e+0	1.000000e+0	5.011389e+1	1.995455e-2	1	180	5.000000e-1	5.555556e-3	unnamed	CLVS1
MSigDB Predicted Promoter Motifs	V$AP4_Q6_01	Motif RNCAGCTGC matches TFAP4: transcription factor AP-4 (activating enhancer binding protein 4)	14	2.995730e-2	1.000000e+0	1.000000e+0	3.338085e+1	2.995730e-2	1	2.995730e-2	1.000000e+0	34	2.763270e-2	1.000000e+0	4.998268e-1	3.593825e+1	2.782551e-2	1	251	5.000000e-1	3.984064e-3	unnamed	CLVS1
MSigDB Predicted Promoter Motifs	V$OCT1_07	Motif TNTATGBTAATT matches POU2F1: POU domain, class 2, transcription factor 1	15	3.022557e-2	1.000000e+0	1.000000e+0	3.308458e+1	3.022557e-2	1	3.022557e-2	1.000000e+0	8	1.623027e-2	1.000000e+0	1.000000e+0	6.136395e+1	1.629621e-2	1	147	5.000000e-1	6.802721e-3	unnamed	CLVS1
MSigDB Predicted Promoter Motifs	V$STAT_Q6	Motif NNNNNTTCTKGGA (no known TF)	16	3.053925e-2	1.000000e+0	1.000000e+0	3.274475e+1	3.053925e-2	1	3.053925e-2	1.000000e+0	32	2.741405e-2	1.000000e+0	5.268638e-1	3.622691e+1	2.760379e-2	1	249	5.000000e-1	4.016064e-3	unnamed	ASPH
MSigDB Predicted Promoter Motifs	V$SMAD4_Q6	Motif GKSRKKCAGMCANCY matches SMAD4: SMAD, mothers against DPP homolog 4 (Drosophila)	17	3.056185e-2	1.000000e+0	1.000000e+0	3.272054e+1	3.056185e-2	1	3.056185e-2	1.000000e+0	19	2.566396e-2	1.000000e+0	8.307019e-1	3.871459e+1	2.583005e-2	1	233	5.000000e-1	4.291845e-3	unnamed	CLVS1
MSigDB Predicted Promoter Motifs	V$GATA1_01	Motif SNNGATNNNN matches GATA1: GATA binding protein 1 (globin transcription factor 1)	18	3.085231e-2	1.000000e+0	1.000000e+0	3.241249e+1	3.085231e-2	1	3.085231e-2	1.000000e+0	14	2.478833e-2	1.000000e+0	1.000000e+0	4.009111e+1	2.494318e-2	1	225	5.000000e-1	4.444444e-3	unnamed	CLVS1
MSigDB Predicted Promoter Motifs	V$YY1_01	Motif NNNNNCCATNTWNNNWN matches YY1: YY1 transcription factor	19	3.165537e-2	1.000000e+0	1.000000e+0	3.159022e+1	3.165537e-2	1	3.165537e-2	1.000000e+0	20	2.577339e-2	1.000000e+0	7.925317e-1	3.854915e+1	2.594091e-2	1	234	5.000000e-1	4.273504e-3	unnamed	CLVS1
MSigDB Predicted Promoter Motifs	V$SRF_Q6	Motif GNCCAWATAWGGMN matches SRF: serum response factor (c-fos serum response element-binding transcription factor)	20	3.192327e-2	1.000000e+0	9.816406e-1	3.132512e+1	3.192327e-2	1	3.192327e-2	1.000000e+0	32	2.741405e-2	1.000000e+0	5.268638e-1	3.622691e+1	2.760379e-2	1	249	5.000000e-1	4.016064e-3	unnamed	ASPH
MSigDB Predicted Promoter Motifs	TTCYNRGAA_V$STAT5B_01	Motif TTCYNRGAA matches STAT5B: signal transducer and activator of transcription 5B	21	3.281228e-2	1.000000e+0	9.609311e-1	3.047639e+1	3.281228e-2	1	3.281228e-2	1.000000e+0	43	3.516110e-2	1.000000e+0	5.028855e-1	2.818906e+1	3.547475e-2	1	320	5.000000e-1	3.125000e-3	unnamed	ASPH
MSigDB Predicted Promoter Motifs	CCCNNGGGAR_V$OLF1_01	Motif CCCNNGGGAR matches EBF2: early B-cell factor 2	22	3.302234e-2	1.000000e+0	9.231245e-1	3.028253e+1	3.302234e-2	1	3.302234e-2	1.000000e+0	42	3.407184e-2	1.000000e+0	4.989091e-1	2.909839e+1	3.436617e-2	1	310	5.000000e-1	3.225806e-3	unnamed	CLVS1
MSigDB Predicted Promoter Motifs	V$GATA3_01	Motif NNGATARNG matches GATA3: GATA binding protein 3	23	3.363639e-2	1.000000e+0	8.994078e-1	2.972971e+1	3.363639e-2	1	3.363639e-2	1.000000e+0	16	2.533565e-2	1.000000e+0	9.738390e-1	3.921957e+1	2.549748e-2	1	230	5.000000e-1	4.347826e-3	unnamed	CLVS1
MSigDB Predicted Promoter Motifs	V$RORA1_01	Motif NWAWNNAGGTCAN matches RORA: RAR-related orphan receptor A	24	3.423710e-2	1.000000e+0	8.773257e-1	2.920808e+1	3.423710e-2	1	3.423710e-2	1.000000e+0	31	2.730472e-2	1.000000e+0	5.416904e-1	3.637298e+1	2.749293e-2	1	248	5.000000e-1	4.032258e-3	unnamed	ASPH
MSigDB Predicted Promoter Motifs	V$RSRFC4_Q2	Motif ANKCTAWAAATAGMHNN matches MEF2A: MADS box transcription enhancer factor 2, polypeptide A (myocyte enhancer factor 2A)	25	3.458925e-2	1.000000e+0	8.508956e-1	2.891072e+1	3.458925e-2	1	3.458925e-2	1.000000e+0	10	2.248791e-2	1.000000e+0	1.000000e+0	4.421814e+1	2.261515e-2	1	204	5.000000e-1	4.901961e-3	unnamed	ASPH
MSigDB Predicted Promoter Motifs	V$MEF2_Q6_01	Motif RGCTATWTTTAR (no known TF)	26	3.670496e-2	1.000000e+0	8.682135e-1	2.724427e+1	3.670496e-2	1	3.670496e-2	1.000000e+0	20	2.577339e-2	1.000000e+0	7.925317e-1	3.854915e+1	2.594091e-2	1	234	5.000000e-1	4.273504e-3	unnamed	ASPH
MSigDB Predicted Promoter Motifs	V$PTF1BETA_Q6	Motif GRGAAAMBBWCAGS matches PTF1A: pancreas specific transcription factor, 1a	27	3.701249e-2	1.000000e+0	8.430623e-1	2.701791e+1	3.701249e-2	1	3.701249e-2	1.000000e+0	17	2.555453e-2	1.000000e+0	9.244727e-1	3.888147e+1	2.571920e-2	1	232	5.000000e-1	4.310345e-3	unnamed	CLVS1
MSigDB Predicted Promoter Motifs	V$TAL1BETAITF2_01	Motif NNNAACAGATGKTNNN matches TAL1: T-cell acute lymphocytic leukemia 1&lt;br&gt; TCF4: transcription factor 4	28	3.747869e-2	1.000000e+0	8.231927e-1	2.668183e+1	3.747869e-2	1	3.747869e-2	1.000000e+0	20	2.577339e-2	1.000000e+0	7.925317e-1	3.854915e+1	2.594091e-2	1	234	5.000000e-1	4.273504e-3	unnamed	CLVS1
MSigDB Predicted Promoter Motifs	V$TAL1BETAE47_01	Motif NNNAACAGATGKTNNN matches TAL1: T-cell acute lymphocytic leukemia 1&lt;br&gt; TCF3: transcription factor 3 (E2A immunoglobulin enhancer binding factors E12/E47)	29	3.770482e-2	1.000000e+0	7.996022e-1	2.652181e+1	3.770482e-2	1	3.770482e-2	1.000000e+0	17	2.555453e-2	1.000000e+0	9.244727e-1	3.888147e+1	2.571920e-2	1	232	5.000000e-1	4.310345e-3	unnamed	CLVS1
MSigDB Predicted Promoter Motifs	V$NFAT_Q6	Motif NANWGGAAAANN matches NFAT&lt;br&gt; NFATC	30	3.870436e-2	1.000000e+0	7.934394e-1	2.583688e+1	3.870436e-2	1	3.870436e-2	1.000000e+0	25	2.632043e-2	1.000000e+0	6.474826e-1	3.774268e+1	2.649521e-2	1	239	5.000000e-1	4.184100e-3	unnamed	CLVS1
MSigDB Predicted Promoter Motifs	TTAYRTAA_V$E4BP4_01	Motif TTAYRTAA matches NFIL3: nuclear factor, interleukin 3 regulated	31	3.926195e-2	1.000000e+0	7.789064e-1	2.546996e+1	3.926195e-2	1	3.926195e-2	1.000000e+0	39	2.839779e-2	1.000000e+0	4.478113e-1	3.496318e+1	2.860152e-2	1	258	5.000000e-1	3.875969e-3	unnamed	CLVS1
MSigDB Predicted Promoter Motifs	V$OCT1_03	Motif NNNRTAATNANNN matches POU2F1: POU domain, class 2, transcription factor 1	32	3.931439e-2	1.000000e+0	7.555734e-1	2.543598e+1	3.931439e-2	1	3.931439e-2	1.000000e+0	13	2.380277e-2	1.000000e+0	1.000000e+0	4.176157e+1	2.394546e-2	1	216	5.000000e-1	4.629630e-3	unnamed	CLVS1
MSigDB Predicted Promoter Motifs	V$HAND1E47_01	Motif NNNNGNRTCTGGMWTT matches HAND1: heart and neural crest derivatives expressed 1	33	3.945438e-2	1.000000e+0	7.352862e-1	2.534573e+1	3.945438e-2	1	3.945438e-2	1.000000e+0	37	2.828851e-2	1.000000e+0	4.702009e-1	3.509922e+1	2.849066e-2	1	257	5.000000e-1	3.891051e-3	unnamed	CLVS1
MSigDB Predicted Promoter Motifs	V$TAL1ALPHAE47_01	Motif NNNAACAGATGKTNNN matches TAL1: T-cell acute lymphocytic leukemia 1&lt;br&gt; TCF3: transcription factor 3 (E2A immunoglobulin enhancer binding factors E12/E47)	34	3.983393e-2	1.000000e+0	7.205255e-1	2.510423e+1	3.983393e-2	1	3.983393e-2	1.000000e+0	24	2.599222e-2	1.000000e+0	6.660506e-1	3.822246e+1	2.616263e-2	1	236	5.000000e-1	4.237288e-3	unnamed	CLVS1
MSigDB Predicted Promoter Motifs	V$CEBPA_01	Motif NNATTRCNNAANNN matches CEBPA: CCAAT/enhancer binding protein (C/EBP), alpha	35	4.127006e-2	1.000000e+0	7.251739e-1	2.423064e+1	4.127006e-2	1	4.127006e-2	1.000000e+0	23	2.588281e-2	1.000000e+0	6.920838e-1	3.838511e+1	2.605177e-2	1	235	5.000000e-1	4.255319e-3	unnamed	CLVS1
MSigDB Predicted Promoter Motifs	V$GFI1_01	Motif NNNNNNNAAATCACWGYNNNNNNN matches GFI1: growth factor independent 1	36	4.369827e-2	1.000000e+0	7.465121e-1	2.288420e+1	4.369827e-2	1	4.369827e-2	1.000000e+0	34	2.763270e-2	1.000000e+0	4.998268e-1	3.593825e+1	2.782551e-2	1	251	5.000000e-1	3.984064e-3	unnamed	CLVS1
MSigDB Predicted Promoter Motifs	V$MMEF2_Q6	Motif CKSNYTAAAAAWRMCY (no known TF)	37	4.418899e-2	1.000000e+0	7.344927e-1	2.263007e+1	4.418899e-2	1	4.418899e-2	1.000000e+0	37	2.828851e-2	1.000000e+0	4.702009e-1	3.509922e+1	2.849066e-2	1	257	5.000000e-1	3.891051e-3	unnamed	ASPH
MSigDB Predicted Promoter Motifs	V$GATA1_05	Motif NCWGATAACA matches GATA1: GATA binding protein 1 (globin transcription factor 1)	38	4.523793e-2	1.000000e+0	7.321402e-1	2.210534e+1	4.523793e-2	1	4.523793e-2	1.000000e+0	41	2.959946e-2	1.000000e+0	4.439919e-1	3.353346e+1	2.982096e-2	1	269	5.000000e-1	3.717472e-3	unnamed	CLVS1
MSigDB Predicted Promoter Motifs	V$TST1_01	Motif NNKGAATTAVAVTDN matches POU3F1: POU domain, class 3, transcription factor 1	39	4.596980e-2	1.000000e+0	7.249084e-1	2.175341e+1	4.596980e-2	1	4.596980e-2	1.000000e+0	28	2.708603e-2	1.000000e+0	5.949253e-1	3.666870e+1	2.727122e-2	1	246	5.000000e-1	4.065041e-3	unnamed	CLVS1
MSigDB Predicted Promoter Motifs	V$IPF1_Q4	Motif GHNNTAATGACM matches IPF1: insulin promoter factor 1, homeodomain transcription factor	40	4.597094e-2	1.000000e+0	7.068032e-1	2.175287e+1	4.597094e-2	1	4.597094e-2	1.000000e+0	28	2.708603e-2	1.000000e+0	5.949253e-1	3.666870e+1	2.727122e-2	1	246	5.000000e-1	4.065041e-3	unnamed	CLVS1
MSigDB Predicted Promoter Motifs	AAAYWAACM_V$HFH4_01	Motif AAAYWAACM matches FOXJ1: forkhead box J1	41	4.760964e-2	1.000000e+0	7.141446e-1	2.100415e+1	4.760964e-2	1	4.760964e-2	1.000000e+0	30	2.719538e-2	1.000000e+0	5.575053e-1	3.652024e+1	2.738207e-2	1	247	5.000000e-1	4.048583e-3	unnamed	CLVS1
MSigDB Predicted Promoter Motifs	CTAWWWATA_V$RSRFC4_Q2	Motif CTAWWWATA matches MEF2A: MADS box transcription enhancer factor 2, polypeptide A (myocyte enhancer factor 2A)	42	5.048395e-2	1.000000e+0	7.392293e-1	1.980828e+1	5.048395e-2	1	5.048395e-2	1.000000e+0	46	4.048959e-2	1.000000e+0	5.413282e-1	2.444580e+1	4.090682e-2	1	369	5.000000e-1	2.710027e-3	unnamed	ASPH
MSigDB Predicted Promoter Motifs	RGAANNTTC_V$HSF1_01	Motif RGAANNTTC matches HSF1: heat shock transcription factor 1	43	5.226437e-2	1.000000e+0	7.475020e-1	1.913349e+1	5.226437e-2	1	5.226437e-2	1.000000e+0	47	4.699418e-2	1.000000e+0	6.149238e-1	2.102681e+1	4.755834e-2	1	429	5.000000e-1	2.331002e-3	unnamed	CLVS1
MSigDB Predicted Promoter Motifs	YATGNWAAT_V$OCT_C	Motif YATGNWAAT (no known TF)	44	5.597032e-2	1.000000e+0	7.823124e-1	1.786661e+1	5.597032e-2	1	5.597032e-2	1.000000e+0	45	3.951200e-2	1.000000e+0	5.399973e-1	2.505694e+1	3.990910e-2	1	360	5.000000e-1	2.777778e-3	unnamed	CLVS1
MSigDB Predicted Promoter Motifs	AAAYRNCTG_UNKNOWN	Motif AAAYRNCTG (no known TF)	45	5.602604e-2	1.000000e+0	7.656892e-1	1.784884e+1	5.602604e-2	1	5.602604e-2	1.000000e+0	44	3.864260e-2	1.000000e+0	5.401182e-1	2.562642e+1	3.902223e-2	1	352	5.000000e-1	2.840909e-3	unnamed	ASPH
MSigDB Predicted Promoter Motifs	WGTTNNNNNAAA_UNKNOWN	Motif WGTTNNNNNAAA (no known TF)	46	9.536174e-2	1.000000e+0	1.000000e+0	1.048639e+1	9.536174e-2	1	9.536174e-2	1.000000e+0	48	5.724786e-2	1.000000e+0	7.334882e-1	1.721469e+1	5.808991e-2	1	524	5.000000e-1	1.908397e-3	unnamed	CLVS1
MSigDB Predicted Promoter Motifs	YTATTTTNR_V$MEF2_02	Motif YTATTTTNR matches MEF2A: MADS box transcription enhancer factor 2, polypeptide A (myocyte enhancer factor 2A)	47	1.016792e-1	1.000000e+0	1.000000e+0	9.834855e+0	1.016792e-1	1	1.016792e-1	1.000000e+0	49	7.268454e-2	1.000000e+0	9.122651e-1	1.350374e+1	7.405354e-2	1	668	5.000000e-1	1.497006e-3	unnamed	ASPH
MSigDB Predicted Promoter Motifs	RYTTCCTG_V$ETS2_B	Motif RYTTCCTG matches ETS2: v-ets erythroblastosis virus E26 oncogene homolog 2 (avian)	48	1.058331e-1	1.000000e+0	1.000000e+0	9.448844e+0	1.058331e-1	1	1.058331e-1	1.000000e+0	51	1.122862e-1	1.000000e+0	1.000000e+0	8.648610e+0	1.156255e-1	1	1043	5.000000e-1	9.587728e-4	unnamed	CLVS1
MSigDB Predicted Promoter Motifs	GCANCTGNY_V$MYOD_Q6	Motif GCANCTGNY matches MYOD1: myogenic differentiation 1	49	1.148568e-1	1.000000e+0	1.000000e+0	8.706491e+0	1.148568e-1	1	1.148568e-1	1.000000e+0	50	9.560063e-2	1.000000e+0	1.000000e+0	1.020419e+1	9.799900e-2	1	884	5.000000e-1	1.131222e-3	unnamed	CLVS1
MSigDB Predicted Promoter Motifs	TGANTCA_V$AP1_C	Motif TGANTCA matches JUN: jun oncogene	50	1.213675e-1	1.000000e+0	1.000000e+0	8.239440e+0	1.213675e-1	1	1.213675e-1	1.000000e+0	1	3.540845e-3	1.000000e+0	1.000000e+0	1.679795e+1	1.190621e-1	2	1074	1.000000e+0	1.862197e-3	unnamed	ASPH,CLVS1
MSigDB Predicted Promoter Motifs	GGGTGGRR_V$PAX4_03	Motif GGGTGGRR matches PAX4: paired box gene 4	51	1.242001e-1	1.000000e+0	1.000000e+0	8.051523e+0	1.242001e-1	1	1.242001e-1	1.000000e+0	53	1.337762e-1	1.000000e+0	1.000000e+0	7.216400e+0	1.385732e-1	1	1250	5.000000e-1	8.000000e-4	unnamed	CLVS1
MSigDB Predicted Promoter Motifs	CAGCTG_V$AP4_Q5	Motif CAGCTG matches REPIN1: replication initiator 1	52	1.626399e-1	1.000000e+0	1.000000e+0	6.148551e+0	1.626399e-1	1	1.626399e-1	1.000000e+0	54	1.532695e-1	1.000000e+0	1.000000e+0	6.264236e+0	1.596364e-1	1	1440	5.000000e-1	6.944444e-4	unnamed	CLVS1
MSigDB Predicted Promoter Motifs	CTTTGA_V$LEF1_Q2	Motif CTTTGA matches LEF1: lymphoid enhancer-binding factor 1	53	1.653166e-1	1.000000e+0	1.000000e+0	6.049001e+0	1.653166e-1	1	1.653166e-1	1.000000e+0	52	1.247763e-1	1.000000e+0	1.000000e+0	7.756234e+0	1.289286e-1	1	1163	5.000000e-1	8.598452e-4	unnamed	ASPH
MSigDB Predicted Promoter Motifs	TGGAAA_V$NFAT_Q4_01	Motif TGGAAA matches NFAT&lt;br&gt; NFATC	54	2.441014e-1	1.000000e+0	1.000000e+0	4.096659e+0	2.441014e-1	1	2.441014e-1	1.000000e+0	4	9.982823e-3	1.000000e+0	1.000000e+0	1.000610e+1	1.998781e-1	2	1803	1.000000e+0	1.109262e-3	unnamed	ASPH,CLVS1
MSigDB Predicted Promoter Motifs	CTTTGT_V$LEF1_Q2	Motif CTTTGT matches LEF1: lymphoid enhancer-binding factor 1	55	2.442153e-1	1.000000e+0	1.000000e+0	4.094747e+0	2.442153e-1	1	2.442153e-1	1.000000e+0	56	1.979574e-1	1.000000e+0	1.000000e+0	4.787951e+0	2.088576e-1	1	1884	5.000000e-1	5.307856e-4	unnamed	CLVS1
MSigDB Predicted Promoter Motifs	CAGGTG_V$E12_Q6	Motif CAGGTG matches TCF3: transcription factor 3 (E2A immunoglobulin enhancer binding factors E12/E47)	56	2.657598e-1	1.000000e+0	1.000000e+0	3.762796e+0	2.657598e-1	1	2.657598e-1	1.000000e+0	58	2.455801e-1	1.000000e+0	1.000000e+0	3.804513e+0	2.628457e-1	1	2371	5.000000e-1	4.217630e-4	unnamed	CLVS1
MSigDB Predicted Promoter Motifs	TTGTTT_V$FOXO4_01	Motif TTGTTT matches MLLT7: myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 7	57	2.767434e-1	1.000000e+0	1.000000e+0	3.613455e+0	2.767434e-1	1	2.767434e-1	1.000000e+0	57	2.050899e-1	1.000000e+0	1.000000e+0	4.611708e+0	2.168394e-1	1	1956	5.000000e-1	5.112474e-4	unnamed	CLVS1
MSigDB Predicted Promoter Motifs	AACTTT_UNKNOWN	Motif AACTTT (no known TF)	58	2.964325e-1	1.000000e+0	1.000000e+0	3.373449e+0	2.964325e-1	1	2.964325e-1	1.000000e+0	55	1.917900e-1	1.000000e+0	1.000000e+0	4.950878e+0	2.019844e-1	1	1822	5.000000e-1	5.488474e-4	unnamed	CLVS1
MSigDB miRNA Motifs	CACCAGC,MIR-138	Targets of MicroRNA CACCAGC,MIR-138	1	3.203648e-2	1.000000e+0	1.000000e+0	3.121441e+1	3.203648e-2	1	3.203648e-2	1.000000e+0	2	2.391230e-2	1.000000e+0	1.000000e+0	4.156912e+1	2.405632e-2	1	217	5.000000e-1	4.608295e-3	unnamed	CLVS1
MSigDB miRNA Motifs	AAGCAAT,MIR-137	Targets of MicroRNA AAGCAAT,MIR-137	2	3.818930e-2	1.000000e+0	1.000000e+0	2.618535e+1	3.818930e-2	1	3.818930e-2	1.000000e+0	1	2.336458e-2	1.000000e+0	1.000000e+0	4.254953e+1	2.350202e-2	1	212	5.000000e-1	4.716981e-3	unnamed	ASPH
MSigDB miRNA Motifs	TGGTGCT,MIR-29A,MIR-29B,MIR-29C	Targets of MicroRNA TGGTGCT,MIR-29A,MIR-29B,MIR-29C	3	6.013170e-2	1.000000e+0	1.000000e+0	1.663016e+1	6.013170e-2	1	6.013170e-2	1.000000e+0	3	5.487826e-2	1.000000e+0	1.000000e+0	1.796912e+1	5.565102e-2	1	502	5.000000e-1	1.992032e-3	unnamed	ASPH
MSigDB miRNA Motifs	TGCTGCT,MIR-15A,MIR-16,MIR-15B,MIR-195,MIR-424,MIR-497	Targets of MicroRNA TGCTGCT,MIR-15A,MIR-16,MIR-15B,MIR-195,MIR-424,MIR-497	4	7.670739e-2	1.000000e+0	1.000000e+0	1.303655e+1	7.670739e-2	1	7.670739e-2	1.000000e+0	4	6.369530e-2	1.000000e+0	1.000000e+0	1.544606e+1	6.474142e-2	1	584	5.000000e-1	1.712329e-3	unnamed	ASPH
InterPro	IPR007803	Aspartyl/Asparaginyl beta-hydroxylase	1	4.520962e-4	1.000000e+0	1.000000e+0	2.211919e+3	4.520962e-4	1	4.520962e-4	1.000000e+0	2	3.325574e-4	1.000000e+0	1.000000e+0	3.006833e+3	3.325758e-4	1	3	5.000000e-1	3.333333e-1	unnamed	ASPH
InterPro	IPR027443	Isopenicillin N synthase-like	1	4.520962e-4	1.000000e+0	1.000000e+0	2.211919e+3	4.520962e-4	1	4.520962e-4	1.000000e+0	2	3.325574e-4	1.000000e+0	1.000000e+0	3.006833e+3	3.325758e-4	1	3	5.000000e-1	3.333333e-1	unnamed	ASPH
InterPro	IPR007943	Aspartyl beta-hydroxylase/Triadin domain	3	6.141009e-4	1.000000e+0	1.000000e+0	1.628397e+3	6.141009e-4	1	6.141009e-4	1.000000e+0	1	2.217111e-4	1.000000e+0	1.000000e+0	4.510250e+3	2.217172e-4	1	2	5.000000e-1	5.000000e-1	unnamed	ASPH
InterPro	IPR001071	Cellular retinaldehyde binding/alpha-tocopherol transport	4	8.765973e-4	1.000000e+0	1.000000e+0	1.140775e+3	8.765973e-4	1	8.765973e-4	1.000000e+0	4	1.108309e-3	1.000000e+0	1.000000e+0	9.020500e+2	1.108586e-3	1	10	5.000000e-1	1.000000e-1	unnamed	CLVS1
InterPro	IPR011074	CRAL/TRIO, N-terminal domain	5	1.216107e-3	1.000000e+0	1.000000e+0	8.222962e+2	1.216107e-3	1	1.216107e-3	1.000000e+0	5	1.440682e-3	1.000000e+0	1.000000e+0	6.938846e+2	1.441162e-3	1	13	5.000000e-1	7.692308e-2	unnamed	CLVS1
InterPro	IPR001251	CRAL-TRIO domain	6	3.268975e-3	1.000000e+0	1.000000e+0	3.059063e+2	3.268975e-3	1	3.268975e-3	1.000000e+0	6	3.433759e-3	1.000000e+0	1.000000e+0	2.909839e+2	3.436617e-3	1	31	5.000000e-1	3.225806e-2	unnamed	CLVS1
InterPro	IPR019734	Tetratricopeptide repeat	7	9.988429e-3	1.000000e+0	1.000000e+0	1.001158e+2	9.988429e-3	1	9.988429e-3	1.000000e+0	7	1.171681e-2	1.000000e+0	1.000000e+0	8.509906e+1	1.175101e-2	1	106	5.000000e-1	9.433962e-3	unnamed	ASPH
InterPro	IPR013026	Tetratricopeptide repeat-containing domain	8	1.020362e-2	1.000000e+0	1.000000e+0	9.800445e+1	1.020362e-2	1	1.020362e-2	1.000000e+0	8	1.226779e-2	1.000000e+0	1.000000e+0	8.126577e+1	1.230530e-2	1	111	5.000000e-1	9.009009e-3	unnamed	ASPH
InterPro	IPR011990	Tetratricopeptide-like helical	9	1.477874e-2	1.000000e+0	1.000000e+0	6.766478e+1	1.477874e-2	1	1.477874e-2	1.000000e+0	9	1.919691e-2	1.000000e+0	1.000000e+0	5.184195e+1	1.928940e-2	1	174	5.000000e-1	5.747126e-3	unnamed	ASPH
TreeFam	TF312799	ASPH, ASPHD1, ASPHD2	1	4.520962e-4	1.000000e+0	1.000000e+0	2.211919e+3	4.520962e-4	1	4.520962e-4	1.000000e+0	1	3.325574e-4	1.000000e+0	1.000000e+0	3.006833e+3	3.325758e-4	1	3	5.000000e-1	3.333333e-1	unnamed	ASPH
Ensembl Genes	18206	ASPH	1	3.337541e-4	1.000000e+0	1.000000e+0	2.996218e+3	3.337541e-4	1	3.337541e-4	1.000000e+0	1	1.108586e-4	1.000000e+0	1.000000e+0	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	ASPH
Ensembl Genes	18205	CLVS1	2	3.612918e-4	1.000000e+0	1.000000e+0	2.767846e+3	3.612918e-4	1	3.612918e-4	1.000000e+0	1	1.108586e-4	1.000000e+0	1.000000e+0	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	CLVS1
MSigDB Oncogenic Signatures	PDGF_UP.V1_DN	Genes down-regulated in SH-SY5Y cells (neuroblastoma) in response to PDGF [Gene ID=] stimulation.	1	1.340738e-2	1.000000e+0	1.000000e+0	7.458580e+1	1.340738e-2	1	1.340738e-2	1.000000e+0	4	1.391979e-2	1.000000e+0	6.507502e-1	7.159127e+1	1.396818e-2	1	126	5.000000e-1	7.936508e-3	unnamed	ASPH
MSigDB Oncogenic Signatures	CRX_NRL_DN.V1_DN	Genes down-regulated in retina cells from CRX and NRL [Gene ID=1406, 4901] double knockout mice.	2	1.639008e-2	1.000000e+0	1.000000e+0	6.101250e+1	1.639008e-2	1	1.639008e-2	1.000000e+0	3	1.369960e-2	1.000000e+0	8.539417e-1	7.274597e+1	1.374647e-2	1	124	5.000000e-1	8.064516e-3	unnamed	ASPH
MSigDB Oncogenic Signatures	MEL18_DN.V1_UP	Genes up-regulated in DAOY cells (medulloblastoma) upon knockdown of PCGF2 [Gene ID=7703] gene by RNAi.	3	1.727608e-2	1.000000e+0	1.000000e+0	5.788352e+1	1.727608e-2	1	1.727608e-2	1.000000e+0	5	1.535041e-2	1.000000e+0	5.741053e-1	6.489568e+1	1.540935e-2	1	139	5.000000e-1	7.194245e-3	unnamed	ASPH
MSigDB Oncogenic Signatures	BMI1_DN.V1_UP	Genes up-regulated in DAOY cells (medulloblastoma) upon knockdown of BMI1 [Gene ID=648] gene by RNAi.	4	1.751053e-2	1.000000e+0	8.186173e-1	5.710849e+1	1.751053e-2	1	1.751053e-2	1.000000e+0	6	1.601034e-2	1.000000e+0	4.989889e-1	6.221034e+1	1.607450e-2	1	145	5.000000e-1	6.896552e-3	unnamed	ASPH
MSigDB Oncogenic Signatures	GCNP_SHH_UP_EARLY.V1_DN	Genes down-regulated in granule cell neuron precursors (GCNPs) after stimulation with Shh for 3h.	5	1.849399e-2	1.000000e+0	6.916752e-1	5.407163e+1	1.849399e-2	1	1.849399e-2	1.000000e+0	8	1.842821e-2	1.000000e+0	4.307594e-1	5.401497e+1	1.851339e-2	1	167	5.000000e-1	5.988024e-3	unnamed	ASPH
MSigDB Oncogenic Signatures	RAPA_EARLY_UP.V1_UP	Genes up-regulated in BJAB (lymphoma) cells by everolimus [PubChem = 6442177].	6	1.909440e-2	1.000000e+0	5.951088e-1	5.237137e+1	1.909440e-2	1	1.909440e-2	1.000000e+0	9	1.897731e-2	1.000000e+0	3.943063e-1	5.244477e+1	1.906768e-2	1	172	5.000000e-1	5.813953e-3	unnamed	ASPH
MSigDB Oncogenic Signatures	KRAS.DF.V1_UP	Genes up-regulated in epithelial lung cancer cell lines over-expressing an oncogenic form of KRAS [Gene ID=3845] gene.	7	2.141496e-2	1.000000e+0	5.720854e-1	4.669632e+1	2.141496e-2	1	2.141496e-2	1.000000e+0	13	2.084310e-2	1.000000e+0	2.998200e-1	4.772751e+1	2.095228e-2	1	189	5.000000e-1	5.291005e-3	unnamed	ASPH
MSigDB Oncogenic Signatures	ERB2_UP.V1_UP	Genes up-regulated in MCF-7 cells (breast cancer) positive for ESR1 [Gene ID=2099] and engineered to express ligand-activatable ERBB2 [Gene ID=2064].	8	2.153724e-2	1.000000e+0	5.034330e-1	4.643121e+1	2.153724e-2	1	2.153724e-2	1.000000e+0	11	2.040425e-2	1.000000e+0	3.468722e-1	4.875946e+1	2.050884e-2	1	185	5.000000e-1	5.405405e-3	unnamed	ASPH
MSigDB Oncogenic Signatures	BMI1_DN_MEL18_DN.V1_UP	Genes up-regulated in DAOY cells (medulloblastoma) upon knockdown of BMI1 and PCGF2 [Gene ID=648, 7703] genes by RNAi.	9	2.179143e-2	1.000000e+0	4.527775e-1	4.588960e+1	2.179143e-2	1	2.179143e-2	1.000000e+0	6	1.601034e-2	1.000000e+0	4.989889e-1	6.221034e+1	1.607450e-2	1	145	5.000000e-1	6.896552e-3	unnamed	ASPH
MSigDB Oncogenic Signatures	LTE2_UP.V1_UP	Genes up-regulated in MCF-7 cells (breast cancer) positive for ESR1 [Gene ID=2099] MCF-7 cells (breast cancer) and long-term adapted for estrogen-independent growth.	10	2.269124e-2	1.000000e+0	4.243262e-1	4.406987e+1	2.269124e-2	1	2.269124e-2	1.000000e+0	10	2.007505e-2	1.000000e+0	3.754034e-1	4.956319e+1	2.017627e-2	1	182	5.000000e-1	5.494505e-3	unnamed	ASPH
MSigDB Oncogenic Signatures	MEK_UP.V1_UP	Genes up-regulated in MCF-7 cells (breast cancer) positive for ESR1 [Gene ID=2099] MCF-7 cells (breast cancer) stably over-expressing constitutively active MAP2K1 [Gene ID=5604] gene.	11	2.317759e-2	1.000000e+0	3.940190e-1	4.314513e+1	2.317759e-2	1	2.317759e-2	1.000000e+0	14	2.106249e-2	1.000000e+0	2.813347e-1	4.722775e+1	2.117399e-2	1	191	5.000000e-1	5.235602e-3	unnamed	ASPH
MSigDB Oncogenic Signatures	VEGF_A_UP.V1_DN	Genes down-regulated in HUVEC cells (endothelium) by treatment with VEGFA [Gene ID=7422].	12	2.493383e-2	1.000000e+0	3.885522e-1	4.010616e+1	2.493383e-2	1	2.493383e-2	1.000000e+0	15	2.117217e-2	1.000000e+0	2.639464e-1	4.698177e+1	2.128485e-2	1	192	5.000000e-1	5.208333e-3	unnamed	ASPH
MSigDB Oncogenic Signatures	RAF_UP.V1_UP	Genes up-regulated in MCF-7 cells (breast cancer) positive for ESR1 [Gene ID=2099] MCF-7 cells (breast cancer) stably over-expressing constitutively active RAF1 [Gene ID=5894] gene.	13	2.564597e-2	1.000000e+0	3.689074e-1	3.899248e+1	2.564597e-2	1	2.564597e-2	1.000000e+0	16	2.139152e-2	1.000000e+0	2.500134e-1	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	ASPH
MSigDB Oncogenic Signatures	EGFR_UP.V1_UP	Genes up-regulated in MCF-7 cells (breast cancer) positive for ESR1 [Gene ID=2099] and engineered to express ligand-activatable EGFR [Gene ID=1956].	14	2.791601e-2	1.000000e+0	3.728781e-1	3.582173e+1	2.791601e-2	1	2.791601e-2	1.000000e+0	12	2.051397e-2	1.000000e+0	3.196760e-1	4.849731e+1	2.061970e-2	1	186	5.000000e-1	5.376344e-3	unnamed	ASPH
MSigDB Oncogenic Signatures	STK33_SKM_UP	Genes up-regulated in SKM-1 cells (AML) after knockdown of STK33 [Gene ID=65975] by RNAi.	15	3.004525e-2	1.000000e+0	3.745641e-1	3.328314e+1	3.004525e-2	1	3.004525e-2	1.000000e+0	17	3.069123e-2	1.000000e+0	3.376035e-1	3.233154e+1	3.092955e-2	1	279	5.000000e-1	3.584229e-3	unnamed	ASPH
MSigDB Oncogenic Signatures	STK33_UP	Genes up-regulated in NOMO-1 and SKM-1 cells (AML) after knockdown of STK33 [Gene ID=65975] by RNAi.	16	3.471853e-2	1.000000e+0	4.057728e-1	2.880306e+1	3.471853e-2	1	3.471853e-2	1.000000e+0	2	2.417504e-4	4.520732e-2	2.260366e-2	6.420285e+1	3.115127e-2	2	281	1.000000e+0	7.117438e-3	unnamed	ASPH,CLVS1
MSigDB Oncogenic Signatures	STK33_NOMO_UP	Genes up-regulated in NOMO-1 cells (AML) after knockdown of STK33 [Gene ID=65975] by RNAi.	17	3.573783e-2	1.000000e+0	3.931161e-1	2.798155e+1	3.573783e-2	1	3.573783e-2	1.000000e+0	1	2.332086e-4	4.361001e-2	4.361001e-2	6.536594e+1	3.059697e-2	2	276	1.000000e+0	7.246377e-3	unnamed	ASPH,CLVS1
MSigDB Immunologic Signatures	GSE17721_0.5H_VS_4H_POLYIC_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with poly(I:C) (TLR3 agonist) at 0.5 h versus those stimulated at 8 h.	1	1.351280e-2	1.000000e+0	1.000000e+0	7.400389e+1	1.351280e-2	1	1.351280e-2	1.000000e+0	28	2.150119e-2	1.000000e+0	1.000000e+0	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	CLVS1
MSigDB Immunologic Signatures	GSE9988_ANTI_TREM1_VS_LOW_LPS_MONOCYTE_UP	Genes up-regulated in comparison of monocytes treated with anti-TREM1 [GeneID=54210] versus monocytes treated with 1 ng/ml LPS (TLR4 agonist).	2	1.485798e-2	1.000000e+0	1.000000e+0	6.730392e+1	1.485798e-2	1	1.485798e-2	1.000000e+0	14	2.073340e-2	1.000000e+0	1.000000e+0	4.798138e+1	2.084142e-2	1	188	5.000000e-1	5.319149e-3	unnamed	ASPH
MSigDB Immunologic Signatures	GSE31082_DP_VS_CD8_SP_THYMOCYTE_DN	Genes down-regulated in comparison of CD4+ [GeneID=920] CD8+ thymocytes versus CD4- [GeneID=920] CD8+ thymocytes.	3	1.675402e-2	1.000000e+0	1.000000e+0	5.968715e+1	1.675402e-2	1	1.675402e-2	1.000000e+0	28	2.150119e-2	1.000000e+0	1.000000e+0	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	ASPH
MSigDB Immunologic Signatures	GSE17721_PAM3CSK4_VS_GADIQUIMOD_16H_BMDM_DN	Genes down-regulated in comparison of dendritic cells (DC) stimulated with Pam3Csk4 (TLR1/2 agonist) at 16 h versus DC cells stimulated with Gardiquimod (TLR7 agonist) at 16 h.	4	1.708449e-2	1.000000e+0	1.000000e+0	5.853262e+1	1.708449e-2	1	1.708449e-2	1.000000e+0	37	2.193980e-2	1.000000e+0	1.000000e+0	4.532915e+1	2.206086e-2	1	199	5.000000e-1	5.025126e-3	unnamed	ASPH
MSigDB Immunologic Signatures	GSE9988_ANTI_TREM1_VS_LPS_MONOCYTE_UP	Genes up-regulated in comparison of monocytes treated with anti-TREM1 [GeneID=54210] versus monocytes treated with 5000 ng/ml LPS (TLR4 agonist).	5	1.716252e-2	1.000000e+0	1.000000e+0	5.826650e+1	1.716252e-2	1	1.716252e-2	1.000000e+0	16	2.084310e-2	1.000000e+0	1.000000e+0	4.772751e+1	2.095228e-2	1	189	5.000000e-1	5.291005e-3	unnamed	ASPH
MSigDB Immunologic Signatures	GSE17721_LPS_VS_POLYIC_6H_BMDM_DN	Genes down-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 6 h versus DC cells stimulated with poly(I:C) (TLR3 agonist) at 6 h.	6	1.731911e-2	1.000000e+0	1.000000e+0	5.773970e+1	1.731911e-2	1	1.731911e-2	1.000000e+0	34	2.172051e-2	1.000000e+0	1.000000e+0	4.578934e+1	2.183914e-2	1	197	5.000000e-1	5.076142e-3	unnamed	ASPH
MSigDB Immunologic Signatures	GSE9988_LPS_VS_LPS_AND_ANTI_TREM1_MONOCYTE_DN	Genes down-regulated in comparison of monocytes treated with 5000 ng/ml LPS (TLR4 agonist) versus monocytes treated with anti-TREM1 [GeneID=54210].	7	1.734844e-2	1.000000e+0	1.000000e+0	5.764208e+1	1.734844e-2	1	1.734844e-2	1.000000e+0	5	1.974579e-2	1.000000e+0	1.000000e+0	5.039385e+1	1.984369e-2	1	179	5.000000e-1	5.586592e-3	unnamed	ASPH
MSigDB Immunologic Signatures	GSE17721_PAM3CSK4_VS_GADIQUIMOD_2H_BMDM_DN	Genes down-regulated in comparison of dendritic cells (DC) stimulated with Pam3Csk4 (TLR1/2 agonist) at 2 h versus DC cells stimulated with Gardiquimod (TLR7 agonist) at 2 h.	8	1.744759e-2	1.000000e+0	1.000000e+0	5.731451e+1	1.744759e-2	1	1.744759e-2	1.000000e+0	28	2.150119e-2	1.000000e+0	1.000000e+0	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	ASPH
MSigDB Immunologic Signatures	GSE24634_TREG_VS_TCONV_POST_DAY10_IL4_CONVERSION_DN	Genes down-regulated in comparison of CD25+ regulatory T cell (Treg) treated with IL4 [GeneID=3565] at day 10 versus CD25- T cells treated with IL4 [GeneID=3565] at 10 h.	9	1.764296e-2	1.000000e+0	1.000000e+0	5.667984e+1	1.764296e-2	1	1.764296e-2	1.000000e+0	34	2.172051e-2	1.000000e+0	1.000000e+0	4.578934e+1	2.183914e-2	1	197	5.000000e-1	5.076142e-3	unnamed	ASPH
MSigDB Immunologic Signatures	GSE9988_LOW_LPS_VS_ANTI_TREM1_AND_LPS_MONOCYTE_DN	Genes down-regulated in comparison of monocytes treated with 1 ng/ml LPS (TLR4 agonist) versus monocytes treated with anti-TREM1 [GeneID=54210] and 5000 ng/ml LPS (TLR4 agonist).	10	1.826476e-2	1.000000e+0	1.000000e+0	5.475025e+1	1.826476e-2	1	1.826476e-2	1.000000e+0	12	2.029452e-2	1.000000e+0	1.000000e+0	4.902446e+1	2.039798e-2	1	184	5.000000e-1	5.434783e-3	unnamed	ASPH
MSigDB Immunologic Signatures	GSE3982_NEUTROPHIL_VS_NKCELL_UP	Genes up-regulated in comparison of neutrophils versus NK cells.	11	1.828007e-2	1.000000e+0	1.000000e+0	5.470438e+1	1.828007e-2	1	1.828007e-2	1.000000e+0	43	2.303588e-2	1.000000e+0	1.000000e+0	4.316029e+1	2.316945e-2	1	209	5.000000e-1	4.784689e-3	unnamed	ASPH
MSigDB Immunologic Signatures	GSE20715_0H_VS_6H_OZONE_LUNG_DN	Genes down-regulated in comparison of lung tissue from wild type mice subjected to ozone for 0 h versus that from wild type mice subjected to ozone for 6 h.	12	1.854444e-2	1.000000e+0	1.000000e+0	5.392452e+1	1.854444e-2	1	1.854444e-2	1.000000e+0	25	2.128185e-2	1.000000e+0	1.000000e+0	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	CLVS1
MSigDB Immunologic Signatures	GSE3982_EOSINOPHIL_VS_DC_DN	Genes down-regulated in comparison of eosinophils versus dendritic cells (DC).	13	1.858188e-2	1.000000e+0	1.000000e+0	5.381588e+1	1.858188e-2	1	1.858188e-2	1.000000e+0	39	2.226868e-2	1.000000e+0	1.000000e+0	4.465594e+1	2.239344e-2	1	202	5.000000e-1	4.950495e-3	unnamed	ASPH
MSigDB Immunologic Signatures	GSE17721_PAM3CSK4_VS_CPG_12H_BMDM_DN	Genes down-regulated in comparison of dendritic cells (DC) stimulated with Pam3Csk4 (TLR1/2 agonist) at 12 h versus DC cells stimulated with CpG DNA (TLR9 agonist) at 12 h.	14	1.865290e-2	1.000000e+0	1.000000e+0	5.361096e+1	1.865290e-2	1	1.865290e-2	1.000000e+0	36	2.183015e-2	1.000000e+0	1.000000e+0	4.555808e+1	2.195000e-2	1	198	5.000000e-1	5.050505e-3	unnamed	ASPH
MSigDB Immunologic Signatures	GSE9988_ANTI_TREM1_VS_VEHICLE_TREATED_MONOCYTES_UP	Genes up-regulated in comparison of monocytes treated with anti-TREM1 [GeneID=54210] versus monocytes treated wth vehicle.	15	1.871033e-2	1.000000e+0	1.000000e+0	5.344641e+1	1.871033e-2	1	1.871033e-2	1.000000e+0	7	1.996530e-2	1.000000e+0	1.000000e+0	4.983702e+1	2.006541e-2	1	181	5.000000e-1	5.524862e-3	unnamed	ASPH
MSigDB Immunologic Signatures	GSE12366_GC_VS_NAIVE_BCELL_UP	Genes up-regulated in comparison of germinal center B cells versus naive B cells.	16	1.903828e-2	1.000000e+0	1.000000e+0	5.252575e+1	1.903828e-2	1	1.903828e-2	1.000000e+0	22	2.117217e-2	1.000000e+0	1.000000e+0	4.698177e+1	2.128485e-2	1	192	5.000000e-1	5.208333e-3	unnamed	ASPH
MSigDB Immunologic Signatures	GSE16522_ANTI_CD3CD28_STIM_VS_UNSTIM_NAIVE_CD8_TCELL_UP	Genes up-regulated in comparison of stimulated naive CD8 T cells from pmel-1 mice versus unstimulated naive CD8 T cells from pmel-1 mice.	17	1.916864e-2	1.000000e+0	1.000000e+0	5.216853e+1	1.916864e-2	1	1.916864e-2	1.000000e+0	16	2.084310e-2	1.000000e+0	1.000000e+0	4.772751e+1	2.095228e-2	1	189	5.000000e-1	5.291005e-3	unnamed	CLVS1
MSigDB Immunologic Signatures	GSE3982_DC_VS_TH2_UP	Genes up-regulated in comparison of dendritic cells (DC) versus Th2 cells.	18	1.929899e-2	1.000000e+0	1.000000e+0	5.181620e+1	1.929899e-2	1	1.929899e-2	1.000000e+0	20	2.106249e-2	1.000000e+0	1.000000e+0	4.722775e+1	2.117399e-2	1	191	5.000000e-1	5.235602e-3	unnamed	ASPH
MSigDB Immunologic Signatures	GSE24634_NAIVE_CD4_TCELL_VS_DAY10_IL4_CONV_TREG_UP	Genes up-regulated in comparison of naive T cells at day 0 versus CD25+ regulatory T cell (Treg) treated with IL4 [GeneID=3565] at day 10.	19	1.951050e-2	1.000000e+0	1.000000e+0	5.125446e+1	1.951050e-2	1	1.951050e-2	1.000000e+0	20	2.106249e-2	1.000000e+0	1.000000e+0	4.722775e+1	2.117399e-2	1	191	5.000000e-1	5.235602e-3	unnamed	ASPH
MSigDB Immunologic Signatures	GSE17721_PAM3CSK4_VS_GADIQUIMOD_8H_BMDM_DN	Genes down-regulated in comparison of dendritic cells (DC) stimulated with Pam3Csk4 (TLR1/2 agonist) at 8 h versus DC cells stimulated with Gardiquimod (TLR7 agonist) at 8 h.	20	1.953032e-2	1.000000e+0	1.000000e+0	5.120244e+1	1.953032e-2	1	1.953032e-2	1.000000e+0	27	2.139152e-2	1.000000e+0	1.000000e+0	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	ASPH
MSigDB Immunologic Signatures	GSE17721_LPS_VS_CPG_12H_BMDM_DN	Genes down-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 12 h versus DC cells stimulated with CpG DNA (TLR9 agonist) at 12 h.	21	1.968026e-2	1.000000e+0	1.000000e+0	5.081233e+1	1.968026e-2	1	1.968026e-2	1.000000e+0	32	2.161085e-2	1.000000e+0	1.000000e+0	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	ASPH
MSigDB Immunologic Signatures	GSE9988_ANTI_TREM1_AND_LPS_VS_VEHICLE_TREATED_MONOCYTES_UP	Genes up-regulated in comparison of monocytes treated with anti-TREM1 [GeneID=54210] and 5000 ng/ml LPS (TLR4 agonist) versus monocytes treated with vehicle (control).	22	1.971112e-2	1.000000e+0	1.000000e+0	5.073277e+1	1.971112e-2	1	1.971112e-2	1.000000e+0	4	1.952626e-2	1.000000e+0	1.000000e+0	5.096328e+1	1.962197e-2	1	177	5.000000e-1	5.649718e-3	unnamed	ASPH
MSigDB Immunologic Signatures	GSE20715_0H_VS_6H_OZONE_TLR4_KO_LUNG_DN	Genes down-regulated in comparison of lung tissue from wild type mice subjected to ozone for 0 h versus that from TLR4 [GeneID=7099] deficient mice subjected to ozone for 6 h.	23	1.992545e-2	1.000000e+0	1.000000e+0	5.018708e+1	1.992545e-2	1	1.992545e-2	1.000000e+0	22	2.117217e-2	1.000000e+0	1.000000e+0	4.698177e+1	2.128485e-2	1	192	5.000000e-1	5.208333e-3	unnamed	ASPH
MSigDB Immunologic Signatures	GSE13484_UNSTIM_VS_3H_YF17D_VACCINE_STIM_PBMC_DN	Genes down-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) cultured for 0 h  versus PBMC cultured for 3 h with YF17D vaccine.	24	2.018845e-2	1.000000e+0	1.000000e+0	4.953326e+1	2.018845e-2	1	2.018845e-2	1.000000e+0	25	2.128185e-2	1.000000e+0	1.000000e+0	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	ASPH
MSigDB Immunologic Signatures	GSE20715_0H_VS_24H_OZONE_LUNG_DN	Genes down-regulated in comparison of lung tissue from wild type mice subjected to ozone for 0 h versus that from wild type mice subjected to ozone for 24 h.	25	2.026175e-2	1.000000e+0	1.000000e+0	4.935409e+1	2.026175e-2	1	2.026175e-2	1.000000e+0	37	2.193980e-2	1.000000e+0	1.000000e+0	4.532915e+1	2.206086e-2	1	199	5.000000e-1	5.025126e-3	unnamed	CLVS1
MSigDB Immunologic Signatures	GSE7460_CTRL_VS_FOXP3_OVEREXPR_TCONV_UP	Genes up-regulated in comparison of Ctrlrv versus Foxp3rv (see Fig. 1 in the paper for details).	26	2.047381e-2	1.000000e+0	1.000000e+0	4.884288e+1	2.047381e-2	1	2.047381e-2	1.000000e+0	11	2.018479e-2	1.000000e+0	1.000000e+0	4.929235e+1	2.028712e-2	1	183	5.000000e-1	5.464481e-3	unnamed	ASPH
MSigDB Immunologic Signatures	GSE17974_0H_VS_2H_IN_VITRO_ACT_CD4_TCELL_UP	Genes up-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the untreated cells at 2 h.	27	2.052460e-2	1.000000e+0	1.000000e+0	4.872203e+1	2.052460e-2	1	2.052460e-2	1.000000e+0	6	1.985555e-2	1.000000e+0	1.000000e+0	5.011389e+1	1.995455e-2	1	180	5.000000e-1	5.555556e-3	unnamed	ASPH
MSigDB Immunologic Signatures	GSE29618_BCELL_VS_PDC_DN	Genes down-regulated in comparison of B cells versus plasmacytoid dendritic cells (pDC) .	28	2.057738e-2	1.000000e+0	1.000000e+0	4.859706e+1	2.057738e-2	1	2.057738e-2	1.000000e+0	18	2.095280e-2	1.000000e+0	1.000000e+0	4.747632e+1	2.106313e-2	1	190	5.000000e-1	5.263158e-3	unnamed	ASPH
MSigDB Immunologic Signatures	GSE9988_ANTI_TREM1_VS_CTRL_TREATED_MONOCYTES_UP	Genes up-regulated in comparison of monocytes treated with anti-TREM1 [GeneID=54210] versus monocytes treated with control IgG.	29	2.092453e-2	1.000000e+0	1.000000e+0	4.779080e+1	2.092453e-2	1	2.092453e-2	1.000000e+0	18	2.095280e-2	1.000000e+0	1.000000e+0	4.747632e+1	2.106313e-2	1	190	5.000000e-1	5.263158e-3	unnamed	ASPH
MSigDB Immunologic Signatures	GSE9988_ANTI_TREM1_AND_LPS_VS_CTRL_TREATED_MONOCYTES_UP	Genes up-regulated in comparison of monocytes treated with anti-TREM1 [GeneID=54210] and 5000 ng/ml LPS (TLR4 agonist) versus monocytes treated with control IgG.	30	2.100856e-2	1.000000e+0	1.000000e+0	4.759964e+1	2.100856e-2	1	2.100856e-2	1.000000e+0	9	2.007505e-2	1.000000e+0	1.000000e+0	4.956319e+1	2.017627e-2	1	182	5.000000e-1	5.494505e-3	unnamed	ASPH
MSigDB Immunologic Signatures	GSE17721_PAM3CSK4_VS_GADIQUIMOD_4H_BMDM_DN	Genes down-regulated in comparison of dendritic cells (DC) stimulated with Pam3Csk4 (TLR1/2 agonist) at 4 h versus DC cells stimulated with Gardiquimod (TLR7 agonist) at 4 h.	31	2.116789e-2	1.000000e+0	1.000000e+0	4.724136e+1	2.116789e-2	1	2.116789e-2	1.000000e+0	28	2.150119e-2	1.000000e+0	1.000000e+0	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	ASPH
MSigDB Immunologic Signatures	GSE3982_DC_VS_NKCELL_UP	Genes up-regulated in comparison of dendritic cells (DC) versus NK cells.	32	2.124184e-2	1.000000e+0	1.000000e+0	4.707691e+1	2.124184e-2	1	2.124184e-2	1.000000e+0	39	2.226868e-2	1.000000e+0	1.000000e+0	4.465594e+1	2.239344e-2	1	202	5.000000e-1	4.950495e-3	unnamed	ASPH
MSigDB Immunologic Signatures	GSE32423_CTRL_VS_IL7_MEMORY_CD8_TCELL_DN	Genes down-regulated in comparison of memory CD8 T cells versus those  treated with IL7 [GeneID=3574].	33	2.159361e-2	1.000000e+0	1.000000e+0	4.631000e+1	2.159361e-2	1	2.159361e-2	1.000000e+0	9	2.007505e-2	1.000000e+0	1.000000e+0	4.956319e+1	2.017627e-2	1	182	5.000000e-1	5.494505e-3	unnamed	ASPH
MSigDB Immunologic Signatures	GSE15767_MED_VS_SCS_MAC_LN_UP	Genes up-regulated in comparison of medullary macrophages versus subcapsular sinus (SCS) macrophages.	34	2.163087e-2	1.000000e+0	1.000000e+0	4.623022e+1	2.163087e-2	1	2.163087e-2	1.000000e+0	1	1.150435e-4	2.197331e-1	2.197331e-1	9.299485e+1	2.150657e-2	2	194	1.000000e+0	1.030928e-2	unnamed	ASPH,CLVS1
MSigDB Immunologic Signatures	GSE29618_PDC_VS_MDC_UP	Genes up-regulated in comparison of plasmacytoid dendritic cells (DC) versus myeloid DCs.	35	2.182687e-2	1.000000e+0	1.000000e+0	4.581509e+1	2.182687e-2	1	2.182687e-2	1.000000e+0	12	2.029452e-2	1.000000e+0	1.000000e+0	4.902446e+1	2.039798e-2	1	184	5.000000e-1	5.434783e-3	unnamed	ASPH
MSigDB Immunologic Signatures	GSE29618_MONOCYTE_VS_PDC_DN	Genes down-regulated in comparison of monocytes versus plasmacytoid dendritic cells (pDC).	36	2.207467e-2	1.000000e+0	1.000000e+0	4.530079e+1	2.207467e-2	1	2.207467e-2	1.000000e+0	14	2.073340e-2	1.000000e+0	1.000000e+0	4.798138e+1	2.084142e-2	1	188	5.000000e-1	5.319149e-3	unnamed	ASPH
MSigDB Immunologic Signatures	GSE20715_WT_VS_TLR4_KO_24H_OZONE_LUNG_UP	Genes up-regulated in comparison of lung tissue from wild type mice subjected to ozone for 24 h versus that from TLR4 [GeneID=7099] deficient mice subjected to ozone for 24 h.	37	2.220560e-2	1.000000e+0	1.000000e+0	4.503368e+1	2.220560e-2	1	2.220560e-2	1.000000e+0	32	2.161085e-2	1.000000e+0	1.000000e+0	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	CLVS1
MSigDB Immunologic Signatures	GSE17974_0H_VS_72H_IN_VITRO_ACT_CD4_TCELL_UP	Genes up-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the untreated cells at 72 h.	38	2.233305e-2	1.000000e+0	1.000000e+0	4.477668e+1	2.233305e-2	1	2.233305e-2	1.000000e+0	2	1.941648e-2	1.000000e+0	1.000000e+0	5.125284e+1	1.951111e-2	1	176	5.000000e-1	5.681818e-3	unnamed	ASPH
MSigDB Immunologic Signatures	GSE24634_NAIVE_CD4_TCELL_VS_DAY3_IL4_CONV_TREG_UP	Genes up-regulated in comparison of naive T cells at day 0 versus CD25+ regulatory T cell (Treg) treated with IL4 [GeneID=3565] at day 3.	39	2.288473e-2	1.000000e+0	1.000000e+0	4.369726e+1	2.288473e-2	1	2.288473e-2	1.000000e+0	7	1.996530e-2	1.000000e+0	1.000000e+0	4.983702e+1	2.006541e-2	1	181	5.000000e-1	5.524862e-3	unnamed	ASPH
MSigDB Immunologic Signatures	GSE17721_CTRL_VS_LPS_1H_BMDM_DN	Genes down-regulated in comparison of control dendritic cells (DC) at 1 h versus those stimulated with LPS (TLR4 agonist) at 1 h.	40	2.307295e-2	1.000000e+0	1.000000e+0	4.334080e+1	2.307295e-2	1	2.307295e-2	1.000000e+0	22	2.117217e-2	1.000000e+0	1.000000e+0	4.698177e+1	2.128485e-2	1	192	5.000000e-1	5.208333e-3	unnamed	CLVS1
MSigDB Immunologic Signatures	GSE24142_ADULT_VS_FETAL_DN2_THYMOCYTE_DN	Genes down-regulated in comparison of adult DN2 thymocytes versus fetal DN2 thymocytes.	41	2.410654e-2	1.000000e+0	1.000000e+0	4.148253e+1	2.410654e-2	1	2.410654e-2	1.000000e+0	39	2.226868e-2	1.000000e+0	1.000000e+0	4.465594e+1	2.239344e-2	1	202	5.000000e-1	4.950495e-3	unnamed	CLVS1
MSigDB Immunologic Signatures	GSE24142_ADULT_VS_FETAL_DN3_THYMOCYTE_DN	Genes down-regulated in comparison of adult DN3 thymocytes versus fetal DN3 thymocytes.	42	2.424551e-2	1.000000e+0	1.000000e+0	4.124475e+1	2.424551e-2	1	2.424551e-2	1.000000e+0	42	2.270712e-2	1.000000e+0	1.000000e+0	4.378883e+1	2.283687e-2	1	206	5.000000e-1	4.854369e-3	unnamed	CLVS1
MSigDB Immunologic Signatures	GSE17974_0H_VS_48H_IN_VITRO_ACT_CD4_TCELL_UP	Genes up-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the untreated cells at 48 h.	43	2.453797e-2	1.000000e+0	1.000000e+0	4.075317e+1	2.453797e-2	1	2.453797e-2	1.000000e+0	2	1.941648e-2	1.000000e+0	1.000000e+0	5.125284e+1	1.951111e-2	1	176	5.000000e-1	5.681818e-3	unnamed	ASPH
#
# Ontology	TermsTested	MinAnnotCount	MaxAnnotCount
#
# GO Molecular Function	3688	1	Inf
# GO Biological Process	10440	1	Inf
# GO Cellular Component	1265	1	Inf
# Mouse Phenotype	7918	1	Inf
# Human Phenotype	6146	1	Inf
# Disease Ontology	2235	1	Inf
# MSigDB Cancer Neighborhood	427	1	Inf
# Placenta Disorders	3	1	Inf
# PANTHER Pathway	152	1	Inf
# BioCyc Pathway	332	1	Inf
# MSigDB Pathway	1320	1	Inf
# MGI Expression: Detected	9337	1	Inf
# MSigDB Perturbation	3364	1	Inf
# MSigDB Predicted Promoter Motifs	615	1	Inf
# MSigDB miRNA Motifs	221	1	Inf
# InterPro	9422	1	Inf
# TreeFam	8126	1	Inf
# HGNC Gene Families	478	1	Inf
# Ensembl Genes	18041	1	Inf
# MSigDB Oncogenic Signatures	187	1	Inf
# MSigDB Immunologic Signatures	1910	1	Inf
